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Abstract 
Abstract  
 
A great deal of natural product biosynthetic pathways have been detected following 
the development of bacterial genome-sequencing projects. Reconstruction, genetic 
modification and heterologous expression of the biosynthetic gene clusters provide an 
effective approach to discover novel natural product derivatives, while also improving 
productivities and yields, which sets the stage to expand understanding of their 
structural diversity and biological activity. 
The present thesis copes with several natural product biosynthetic gene clusters of 
large size (>50kb) and severe complexity with high GC content and repetitive 
sequences. Typically, it is more challenging to engineer such colossal and complex 
gene clusters using traditional approaches. Conversely, Red/ET recombineering, 
without the size and site limitation of DNA engineering established in E. coli, appears 
to enrich the toolbox of molecular biology and break the size and site limitations of 
DNA manipulation. Here, we have improved the Red/ET recombination method by 
changing the long-standing protocol of electrocompetent cell preparation from cold 
conditions to room temperature, such that the DNA transformation efficiency has 
been greatly increased. This interesting finding should facilitate the cloning of large 
fragments from genomic DNA preparations and metagenomic samples. 
To exemplify this improvement, the core disorazol biosynthetic pathway (~58kb) 
from Sorangium cellulosum So ce12 was cloned by improved Red/ET recombineering 
and heterologously expressed in Myxococcus xanthus DK1622, resulting in an 
appreciable increase of disorazol production by promoter exchange.  
The full-length salinomycin gene cluster (106kb) from Streptomyces albus 
DSM41398 was isolated from the genome by direct cloning and stitching, and this 
gene cluster was transferred into the heterologous host S. coelicolor A3 (2). 
As a third example of the efficacy of this technique, the magnetosomes gene clusters 
within a large genomic magnetosome island (~115kb) from magnetotactic bacteria 
Magnetospirillum gryphiswaldense was cloned and expressed in Rhodospirillum 
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rubrum. A visible red spot near the pole of a permanent magnet could be observed at 
the edge of a culture flask of heterologous mutants, signifying that the magnetosome 
products had been successfully expressed in the pink-colored heterologous host. 
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Ein großer Teil der Naturprodukt Biosynthesewege wurden nach der Entwicklung von 
bakteriellen Genom-Sequenzierungsprojekten entdeckt. Konstruktion, Modifikation 
und heterologe Expression der Biosynthesegencluster bieten einen effektiven Ansatz 
an der Entdeckung von neuen Derivaten der Naturstoffe sowie der Verbesserung der 
Produktionsausbeute. Dies führt zu der Etablierung einer Plattform zur Erweiterung 
ihrer strukturellen Vielfalt und der biologischen Aktivität. 
Die vorliegende Arbeit beschäftigt sich mit mehreren 
Naturprodukt-Biosynthesegencluster in großen (>50 kb) und komplexen Genclustern 
mit hohem GC-Gehalt und repetitiven Sequenzen. Herkömmlicherweise ist es kaum 
möglich, so kolossale und komplexe Gencluster mit traditionellen Ansätzen zu 
konstruieren. Folglich erschien Red / ET Recombineering die Toolbox der 
Molekularbiologie zu bereichern und die Begrenzung der DNA-Manipulation 
aufzulösen. Wir verbesserten die Red/ET-Rekombination durch Optimierung des 
langjährig verwendeten Protokolls der Vorbereitung elektrokompetenter Zellen, 
welches aus dem kalten Zustand auf Raumtemperatur verändert wurde, so dass die 
DNA-Transformationseffizienz stark erhöht werden konnte. Diese interessante 
Erkenntnis sollte das Klonieren von großen Fragmente aus genomischer DNA und 
Metagenomen erleichtern.  
Der Disorazol Biosyntheseweg (disA-D, ~58kb) von Sorangium cellulosum So ce12 
wurde durch diese verbesserte Red/ET Recombineering Methode kloniert und in 
Myxococcus xanthus DK1622 exprimiert. Durch Promoter Austausch war die 
Erhöhung der Disorazol Produktionausbeute möglich. 
Das gesamte Salinomycin-Gencluster (salO-orf18, 106kb) aus Streptomyces albus 
DSM41398 wurde durch direct-cloning ebenfalls kloniert. Das Gencluster wurde in 
den heterologen Wirt S. coelicolor A3 (2) übertragen. 
Die Magnetosom-Gene innerhalb eines großen genomischen Magnetosom-Insel 
(115kb) des magnetotaktischen Bakteriums Magnetospirillum gryphiswaldense wurde 
kloniert und in Rhodospirillum rubrum experimiert. Ein sichtbarer roter Fleck in der 
Nähe der Pole eines Permanentmagneten konnte am Rande einer Kulturflasche von 
heterologen Mutanten beobachtet werden. 
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1. Natural products in drug discovery 
Nature has been an immense source of natural products for millennia, with various 
useful compounds developed from plants and animals.1-3 These molecules have 
played a considerable and meaningful feature for treating and inhibiting human 
diseases and agricultural pests across the world over a long time.4,5 Following the 
discovery of penicillin by A. Fleming, H. W. Florey in 1928,6 pharmaceutical 
research began to focus on microbes, triggering a subsequent “golden era” in massive 
screening efforts to identify a substantial amount of new microbial antibiotics 
(1945-1960). Over 23, 000 natural products have been characterized, many of which 
are still used in clinic to date.7,8 Currently, approximately 40% of pharmaceuticals in 
clinical use are either natural products or their derivatives.9 Moreover, they are 
broadly applied not only in clinics, as antibiotics, lipid control agents, 
immunosuppressive agents, or as compounds exhibiting antitumor or antimalarial 
properties, but also in agriculture and veterinary applications, including pesticide, 
insecticides, herbicides, miticides, feed additives, antiparasitic agents and so on 
(Figure 1-1).10-14  
Natural products from microorganisms are believed to be a dominant source in 
searching for drug candidates, in comparison with other natural compound producers, 
such as plants or insects.15 This perspective is substantiated by the impression that 
microbial natural products describe the blueprint of an evolutionary optimization 
process comprising selection for a specific biological activity.16 However, the 
diversity of microorganisms is enormous and only a very minor portion (as low as 1%) 
of bacteria and fungi has been described so far.11 Thus, the identification of novel 
bacterial secondary metabolite producers is expected to result in the discovery of 
novel natural products with interesting biological activities in the near future. 
Moreover, the increasing insights of microbial secondary metabolite biosynthesis and 
regulation coupled with progresses in molecular genetics drive us to focus on the 
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discovery and the optimization of natural products in the post-genomic era. 
Figure 1-1. Selected examples of natural products derived from microbes used in the 
clinic/clinical trials, agriculture, and veterinary applications. The structure, name, original 
producer and type of application are given. 
2. Biosynthetic logics of microbial natural products
A wide array of natural products with useful bioactivities and diverse structures are 
produced by microorganisms via various complex biosynthetic pathways.17 So far, 
several important major groups of natural products have already been established by 
multimodular megasynthase systems such as polyketide synthases (PKS), 
non-ribosomal peptide synthetases (NRPS), or hybrids thereof.18-20 Additionally, there 
are also multitudinous bacterial natural products which are derived from other 
different metabolic routes, such as shikimate or isoprenoid pathway.21-23 
A great deal of microbial natural products are biosynthesized from simple monomeric 
building blocks (e.g. amino acids or short chain carboxylic acids) into enormous 
multifunctional enzymes via PKSs and NRPSs, respectively (Figure 1-2).24,25 In PKS 
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A. Introduction 
systems, the vast majority of monomer units incorporated during chain elongation are 
malonyl-CoA and methylmalonyl-CoA. In some cases, the acyltransferase (AT) 
domain directly selects the thioesters of monoacyl groups such as acetyl-, propionyl-, 
and benzoyl-CoAs, or structural variants, such as malonamyl-CoA or 
methoxymalonyl-CoA to be the start units (Figure 1-3A).26 Meanwhile, in NRPS 
systems, as well as the typical 20 proteinogenic amino acids, a broad variety of 
nonproteinogenic amino acids such as aryl acids are utilized as monomer building 
blocks for oligomerization and diversification during chain elongation and 
termination (Figure 1-3B).27 Recent studies exhibit that NRP chains can be modified 
with both C-capped and N-capped functionalities, such as C-capped amines as in 
bleomycin,28 or N-capped acyl groups such as the long-chain β-OH fatty acid in 
daptomycin.29 Although PKS and NRPS systems employ different building blocks, 
they manifest remarkable similarities in the modular architecture of various catalytic 
domains and assembly-like mechanisms. 
Figure 1-2. Core PKS and NRPS domains. Schematic abbreviations used throughout the 
whole text are shown30. 
In enzymatic machinery, PKS possesses catalytic core domains along with a carrier 
protein that not only organizes the minimal machinery for chain assembly but also can 
be post-assembled with additional catalytic domains (Figure 1-3C).19 In principle, a 
typical PKS module includes three essential domains: (i) the C–C bond-forming 
ketosynthase (KS) domain with 45kDa, which performs a decarboxylative claisen 
thioester condensation of the extender unit (generally malonyl-CoA or 
methylmalonyl-CoA) with the acyl thioester intermediate from the upstream module, 
3
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(ii) the 50kDa AT domain for extender unit selection and loading, and (iii) the acyl 
carrier protein (ACP) domain, also known as a thiolation (T) domain with around 
8-10kDa, where the acyl chain is assembled and elongated (Figure 1-3C). The typical 
order of domains is KS-AT-ACP. Additionally, several optional domains could be 
also involved to modify the polyketide intermediate, such as ketoreductase (KR), 
dehydratase (DH) and enoyl reductase (ER) domains.19,31,32 This process is usually 
completed with a thioesterase (TE) domain that releases and controls the form of the 
biosynthetic intermediate, such as in linear, cyclic or branched cyclic forms (Figure 
1-2).33 
Similarly, in an NRPS elongation minimal module, the basic machinery also consists 
of three necessary domains: (i) a 50kDa condensation (C) domain that catalyzes the 
peptide bond formation, (ii) a 50kDa adenylation (A) domain responsible for amino 
acid recognition and activation, and also (iii) a 8-10kDa peptidyl carrier protein (PCP) 
or thiolation (T) domain to which the activated amino acid is covalently attached as 
thioester (Figure 1-3D).19 The typical order of domains is C-A-PCP. The specificity of 
A domains towards corresponding amino acids act crucially in the peptide sequence 
of the final natural product and the biological activity as well. Nevertheless, the 
optional domains for modification in NRPS cover epimerase (E), methyltransferase 
(MT), heterocyclization (HC) and oxidase (Ox) domains.19 In the same fashion as the 
PKS system, the TE domain turns out to be the last biosynthetic step in most cases of 
NRPS by catalyzing the hydrolysis or cyclization of nascent products to constitute 
linear or cyclic peptides (Figure 1-2). 
4
A. Introduction 
Figure 1-3. Use of thioester monomers and core domains of PKS and NRPS system. (A) 
Common acyl-CoA thioesters used for chain initiation and elongation by PKSs. (B) Shared 
amino and aryl acid monomers used for chain initiation and elongation by NRPSs. (C) Core 
domains of PKS system. A minimal module consists of a KS domain (45 kDa), an AT domain 
(50 kDa) and an ACP domain (8-10 kDa). (D) Core domains of NRPS system. A minimal 
module consists of a C domain (50 kDa), an A domain (50 kDa) and a PCP domain (8-10 
kDa). 
In summary, the core domains of PKS (KS, AT, CP) possess similar counterparts in 
NRPS (C, A, PCP) which catalyze three main steps as explained previously, covering 
two catalytic domains and one thiolation domain. The possible combinations of these 
various domains present thousands of different PKS and NRPS biosynthetic gene 
clusters in the bacterial chromosome, offering a rich and valuable source of natural 
products.34,35 According to the current sequenced genomes of abundant bacteria, it 
should be noted that PKS and NRPS clusters are infrequent in bacteria with genomes 
less than 3 Mb. Conversely, in the bacteria with genomes more than 5 Mb, a linear 
correlation between the genome size and the number of PKS and NRPS gene clusters 
is finally discovered.30 
The biosynthetic machinery of PKS and NRPS systems can be explained in four 
strategies: (1) A serine side chain in the carrier protein facilitates the pyrophosphate 
linkage of coenzyme A. In this case, an important post-translational modification by a 
phosphopantetheinyl transferase (PPTase) is required for both PKS and NRPS, 
converting the enzyme from the inactive apo- to the active holo-form (Figure 1-4).36,37 
(2) Monomers are supplied into the assembly lines to generate elongated 
intermediates, and in PKS assembly lines, benzoyl-, butyryl-, cyclohexyl or 
propionyl-CoAs are employed as starter units26 and malonyl-CoA, 
methylmalonyl-CoA, alkyl-, hydroxyl or aminomalonyl-CoAs are utilized as the 
chain extender blocks.38 In contrast, several hundred nonproteinogenic amino acids 
participate in the biosynthesis of NRP microbial metabolites.39 (3) Chain initiation 
(including monomer selection, loading and acylation), chain elongation (including 
claisen, amide and ester condensations) and chain termination are carried out 
subsequently during the assembly (see detailed description below). (4) Post 
5
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assembly-line tailoring of nascent released products (Figure 1-5). 
In addition, chain elongation in the step 3 includes three basic reactions: 
(i) Substrate recognition, involving recognition of acyl-CoA thioesters by PKS 
and aminoacyl-adenylate by NRPS; 
(ii) Covalent binding, e.g. thioester bound to a carrier protein, whether ACP in 
PKS or PCP in NRPS; 
(iii) Condensation with the acyl- or peptidyl- residues from the upstream module. 
Each of these enzymatic modification steps are performed on individual catalytic 
domains within the module (Figure 1-5). 
Figure 1-4. Post-translational activation of carrier proteins (CPs) by a 
phosphopantetheinyl transferase (PPTase). 
6
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Figure 1-5. Schematic exhibitions of PKS (up) and NRPS (down) biochemistry. Domains 
involved in the particular reaction steps are highlighted in grey. 
 
2.1 Polyketide natural products 
Polyketides are a wide group of natural products occurring in bacteria, fungi, animals 
and plants, which represent numerous clinical compounds such as macrolide 
antibiotic erythromycin, polyene immunosuppressant rapamycin, antibiotic 
tetracycline, anti-cholesterol lovastatin, polyene antifungal amphotericin B and 
mycotoxin carcinogen aflatoxin B1.40 All of them are biosynthesized from acyl-CoA 
precursors by PKS enzymes. Much of the research in polyketide biosynthesis in last 
two decades has focused on biochemistry and genetic studies characterizing that three 
types of bacterial PKSs.41 Type I PKSs are large multifunctional enzymes in which 
both catalytic domains and carrier ACP domains are linked in cis to constitute 
modules that are joined together to form a multimodular assembly line (Figure 1-5 up). 
Type II PKSs are multienzyme complexes that carry a single set of iteratively acting 
activities. Contrary to type I PKSs, the catalytic domains and the carrier ACP domains 
interact in trans to achieve acyl- chain elongations in type II PKSs. Lastly, type III 
PKSs can be distinguished from type I and type II PKSs by this groups preference to 
utilize malonyl-CoA rather than malonyl-S-pantetheinyl-T species as substrates, and 
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thus type III PKS do not possess ACP domains.31,41 Type I and type II PKSs utilize 
ACP domain to activate the acyl-CoA substrates and to channel the growing 
polyketide intermediates, whereas type III PKSs, independent of ACP, act directly on 
the acyl-CoA substrates. 
Type I PKSs are further subdivided into two groups: modular type I PKSs and 
iterative type I PKSs (iPKSs). iPKSs have nearly been discovered in fungi with 
reusing domains in a cyclic style.236 In iPKSs, the KS domain repetitively modifies 
the growing polyketide chain after each round of condensation and terminates 
polyketide biosynthesis at a mathematical perform.42 Interestingly, the same catalytic 
domains for multiple rounds of chain extension are repetitively utilized in both iPKSs, 
type II PKSs and type III PKSs systems.43 
Type II PKSs are composed of partite enzymes harboring the minimal PKS module as 
well as a set of tailoring enzymes.44 Each minimal PKS module consists of two KS 
domains (KSα and KSβ) and an ACP domain to catalyze the individual reactions of 
chain assembly and modification.18,45 The subunit KSβ has also been known as “chain 
length factor”.46 Additionally, post assembly of the aromatic polyketides in type II 
PKSs systems require several specialized enzymes which exist in the genetic 
sequencing scaffold, such as aromatase (ARO), cyclase (CYC) and ketoreductase 
(KR).47 
Type III PKSs catalyze the condensation of one to several molecules of extender 
substrate onto a starter substrate,48 and these are mostly found in plants, including 
stilbene synthases and naringenin-chalcone synthases.49,50 However, a lot of studies of 
have already revealed the fact that type III PKSs can also exist in bacteria, such as 
quinolone alkaloid aurachins from the myxobacterium Stigmatella aurantiaca.51  
It is well known that polyketide elongation depends on at least three enzymatic 
domains: a KS, an AT and an ACP. Of late the conventional model of complex 
polyketide biosynthesis was broadened by discovery a special type of modular system 
named trans-AT PKS (Figure 1-6).52-56 The first report of this trans-AT PKS system 
was from pederin that was produced by an uncultured bacterial symbiont of Paederus 
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beetles.240 Several multimodular systems containing PKS modules lacking proper AT 
domains were discovered not only in actinomycetes, but also in a wide range of 
bacteria group.57 Previous studies of trans-AT phylogeny had emphasized these PKSs 
undergo a remarkable capacity to develop by horizontal gene transfer, allowing 
substantial recombination of PKS gene fragments.58 Furthermore, with the continuous 
detections of an increasing number of trans-AT PKS-derived polyketides 
demonstrating significant bioactivities, and a great deal of research had focused on a 
detailed understanding of trans-AT PKS function, including mechanistic and 
structural insights.56 Recent studies indicated that trans-AT PKSs possessed several 
distinct domains only existed in these systems. Some domains were proved to be 
useless, skipped or even iterative practice.56 Moreover, another visible characteristic 
of trans-AT PKS was named β-branching which present a variety of complex 
modifications in the β-keto position.241 Nowadays, with increasing discovery of 
trans-AT PKS-derived compounds from varying microorganisms, more details and 
specifics in this exceptional system would be understood and disclosed in the near 
future. 
 
Figure 1-6. Domain organization of cis-AT (A) and trans-AT (B) PKS. (A) Protein 
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domains are connected in cis. (B) Protein domains interact in trans. The figure was 
reproduced from reference19. 
 
2.2 Nonribosomal peptide natural products 
NRPSs are linear, cyclic or branched peptides with no more than 20 amino residues 
after various modifications, such as acylation, epimerization, glycosylation, 
heterocyclization or N-methylation of the amide nitrogen. Hence, the monomers for 
NRPS assembly are not only proteinogenic but also nonproteinogenic amino acids as 
well as other carboxylic acids.59 There are also many well-known NRP antibiotics 
including penicillin G, cephamycin C and vancomycin that have already been 
developed to clinically used drugs. 
According to their sphere of activity, the nonribosomal peptides have been separated 
into several classifications: (1) Antibiotics, such as vancomycin, which is antibiotic of 
critical importance used when typical antibiotics are found to be ineffective. (2) 
Antibiotic precursors, such as ACV-tripeptide, which is a precursor of the penicillin 
and cephalosporine families.60 (3) Cytostatics. (4) Immunosuppressive agents. (5) 
Nitrogen storage polymers. (6) Phytotoxins, such as victorin, a chlorinated cyclic 
pentapeptide made by the pathogenic fungus Cochliobolus victoriae.61 (7) Pigments, 
such as indigoidine.62 (8) Siderophores, such as Enterobactin and Vibriobactin are 
iron-chelating compounds.63 (9) Toxins, such as cyanotoxins from Cyanobacteria.64 
 
2.3 PKS/NRPS hybrid systems 
PKS and NRPS possess such similar catalytic activity and structural organization, that 
there could therefore be significant potential in the cooperation of these two types of 
multimodular enzymes, representing an enormous variety of potential structures. For 
instance, functional interactions between PKS and NRPS modules mean that a 
PKS-bound acyl intermediate could be directly transferred and subsequently 
elongated by a NRPS module or a NRPS-bound peptidyl intermediate could be 
directly transferred and elongated further by a PKS module.19,65 Up until to now, a 
great number of natural products have been expressed following such a hybrid 
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pathway.66-70 In this case, the intermodular communication is essential for the 
functionality of the hybrid systems. Although PKS and NRPS have distinct domains 
to yield metabolic compounds, they share a similar modular organization, and both 
systems use carrier proteins, such as ACP for PKS and PCP for NRPS to manage the 
growing chain.65 In PKS/NRPS hybrid systems, the critical domains are the ACP 
domain of PKS and the C domain of NRPS, wherein the C domains in PKS/NRPS 
hybrids must accept an acyl-S-ACP for chain elongation, instead of an 
aminoacyl-S-PCP.71 On the other hand for a NRPS/PKS interface, the key domains 
are the PCP domain of NRPS and the KS domain of PKS. The KS domain must 
approve the peptidyl intermediate bound to upstream PCP and condense it with the 
downstream acyl-S-ACP.72 
Moreover, the availability of a PPTase with broad substrate specificity is of 
paramount importance if both species of CPs (ACPs and PCPs) involve in a 
functional hybrid system are to be activated (Figure 1-4). To date, previous studies 
have already stated that several biochemically characterized PPTases (e.g. MtaA, Sfp, 
Svp) can also activate both ACPs and PCPs.73-75 
 
2.4 Magnetic particle production in microorganisms 
Besides PKSs and NRPSs compounds, microbial natural products arise from a 
multitude of different types of complex biosynthetic pathways. Among these products, 
the magnetosome is famous for its magnetotaxis and possible commercialization in 
bright future. Magnetosome chains are membranous prokaryotic structures, consisting 
of 15 to 20 magnetite crystals that together act like a compass needle to orient 
magnetotactic bacteria in geomagnetic fields.76 
Magnetotactic bacteria are a polyphyletic group of bacteria first reported in 197577 
which can utilize the iron from the surrounding environment to assemble an internal 
chain of nanomagnetic particles within lipid vesicles,78,79 allowing the bacteria to 
orient along the magnetic field lines of Earth's magnetic field. Magnetotactic bacteria 
usually mineralize either iron oxide magnetosomes, which contain crystals of 
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magnetite (Fe3O4), or iron sulfide magnetosomes, which contain crystals of greigite 
(Fe3S4). Several other iron sulfide minerals have also been identified in iron sulfide 
magnetosomes — including mackinawite (tetragonal FeS) and a cubic FeS - which 
are thought to be precursors of Fe3S4.79 Magnetosome crystals are typically 35-120 
nm long, which make them single-domain crystals, which have the maximum possible 
magnetic moment per unit volume for a given composition.76 Magnetosome 
biosynthesis in magnetotactic bacteria is controlled by a set of about 30 genes within a 
large (~115kb) genomic magnetosome island.80 However, these microbes are 
challenging with respect to strain cultivation or genetic modification on a molecular 
level. 
 
3. Red/ET Recombineering 
In modern natural products research, metabolic engineering intrigues scientists to 
manipulate biosynthetic pathways to yield new analogues as drug candidates. 
However, it is usually very challenging to manipulate the DNA in the native 
producing strains, and Red/ET recombineering, which is a highly efficient and 
straightforward technology established in E. coli, has recently emerged as a promising 
new technique for working with large genomes.81-83 
Red/ET recombineering, as a research hotspot studied by several different groups for 
many years, which is also known as “λ Red recombination”84,85, “recombineering”86,87, 
“ET recombination”81,82 or “ET cloning”83, relies on in vivo homologous 
recombination mediated by bacteriophage recombinases. The Red operon of the λ 
phage and the RecET operon of the Rac prophage are basically equivalent in terms of 
enzymatic function. As can be seen in Figure 1-7,88 Redα and RecE are dsDNA 
exonucleases, while Redβ and RecT are single strand DNA annealing proteins 
(SSAP). In the Red operon the Redγ is an inhibitor of RecBCD which is the major 
host exonuclease, aggressively degrading dsDNA fragments.89 
Redα or RecE bind to double-stranded DNA (dsDNA) ends, and progressively 
degrades linear dsDNA in a 5’ to 3’ direction, leaving long 3’ single strand DNA 
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(ssDNA) overhangs. Redβ or RecT bind to the ssDNA to form ssDNA-SSAP 
nucleoprotein filaments, which are able to pair their complementary ssDNA. Once 
aligned, the 3’- end becomes a primer for DNA replication.88 The host factors then act 
an important part in finalizing the recombinant DNA by DNA replication and repair 
machinery (Figure 1-7). 90-92 
Under the effect of recombinases, the chosen DNA regions are amplified in E. coli, 
not in vitro, and thus are subject to review by the E. coli replication machinery by a 
new simple, efficient and more flexible approach. This methodology breaks through 
the size and site limitation of DNA engineering and allows an extensive range of 
modifications by insertion, deletion, substitution, fusion, point mutation, subcloning 
and direct cloning for almost any given DNA molecule at any chosen position. 
Notably, the homology sequence at the ends of the linear DNA can be as short as 35 
bp for efficient homologous recombination, and single-strand oligonucleotides as 
short as 70 bases can be transformed for direct mutagenesis. These short homology 
sequences can be easily integrated into synthetic oligonucleotides, greatly expanding 
the utility of the technology. 
Redβ was associated in a complex with Redα when it was isolated from the cell.93,94 
Some of the Redβ mutations were found to be defective of not only Redβ function, 
but also the exonuclease activity of Redα.95,96 These imply that redα recruits Redβ 
loading onto the single-stranded 3’ overhang. A specific protein-protein interaction 
between RecE and RecT has also been shown in coimmunoprecipitation experiments, 
suggesting that recombination requires cooperative functions between the 
exonucleases and the respective DNA annealing proteins.88,97-99 It was also shown that 
substitution of the protein from one system to another can impede function, further 
confirming protein-protein interaction specificity of each pair.88 In this thesis, both 
Redα/Redβ and RecE/RecT systems were investigated for application, and hereby 
defined as Red/ET recombineering. 
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Figure 1-7. Mechanism of Red/ET recombineering. The diagram was reproduced from 
www.genebridges.com. 
 
3.1 Development of Red/ET recombineering 
Conventional methods to generate recombinant DNA use restriction enzymes and T4 
DNA ligases,100 and invention of PCR technology101 greatly expanded the capacity 
and flexibility of this technology. However, these methods are disable to precisely 
manipulate DNA fragments larger than 15kb, such as cosmids, fosmids, P1 vectors, 
bacterial artificial chromosomes (BACs) and bacterial chromosomes.102-106 
Recombination-mediated genetic engineering was first demonstrated in 
Saccharomyces cerevisiae, using a gapped plasmid for cloning genes off the 
chromosome and a linear plasmid for targeting genes,107,108 with further experiments 
using single-strand oligonucleotides as short as 20 bp for efficient site-directed 
mutagenesis.109 The homology sequence at the ends of the linear DNA were as short 
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as 35 bp, which could be easily incorporated in oligonucleotide synthesis, and this 
simplicity encouraged the biologists to establish an equivalent system in E. coli strain. 
However the host RecA-mediated homologous recombination requires much larger 
homologous sequence and usually resulted in very low efficiency. The first attempt at 
exploring λ phage Red recombinases used long homology arms (about 1kb) and the 
recombination was more efficient than that from RecA.110 Independently, Zhang and 
colleagues in the Stewart laboratory published that either RecE/RecT or Redα/Redβ 
could mediate efficient homologous recombination between very short homology 
arms (40-50 bps), and the Redαβ system was much more efficient than the RecET 
system.83 Thus, Red recombineering has become a popular technology for rapid and 
precise modification of DNA, including insertion, deletion or replacement by a drug 
selectable marker,81,83 subcloning by gap repair,82 oligonucleotide-directed 
mutagenesis111,112 and counter-selection mediated by variable negative selectable 
markers to recombine DNA sequence without selection.113-115 
Subsequently, the differences between the Red system and RecET system were 
distinguished by biologists. Specifically, when the plasmid replication was required in 
the homologous recombination, the Redαβ system was preferred. Conversely, when 
an unreplicable linear vector was used to recombine with another DNA fragment to 
form a circular plasmid, RecET was found to be dramatically more efficient. 
Consequently, a novel RecET-based direct cloning method was invented, using 
PCR-amplified linear vectors to retrieve sequences of interest from digested genomic 
DNA, by passing the tedious DNA library construction.116 
To date, recombineering has been established not only in E. coli, but also in several 
other species, such as Agrobacterium tumefaciens,117 Mycobacterium 
tuberculosis,118,119 Photorhabdus luminescens,120 Xenorhabdus,120 Salmonella 
enterica,121 Yersinia pseudotuberculosis,122 Burkholderia thailandensis and 
Burkholderia pseudomallei123. 
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3.2 Application of Red/ET recombineering 
Recombineering is now an alternative for conventional recombinant DNA technology, 
and it is especially favourable for large DNA molecular engineering.116,124 Based on 
the DNA substrate to be recombined, recombineering can be divided into two 
categories, with each utilizing different phage recombinases. Linear plus circular 
homologous recombination (LCHR) is typically catalysed by Redα/Redβ,125 and is 
principally used for engineering various vectors and bacterial chromosome. Linear 
plus linear homologous recombination (LLHR) utilizes RecE/RecT,116 which is 
primarily exploited for linear DNA cloning (PCR cloning)82 and direct cloning.116 
The initial step of Redαβ recombineering is oligonucleotide synthesis, in which the 
homologous sequence is attached to the PCR primer. The PCR-generated DNA 
fragment usually contains an antibiotic selectable marker and a terminal sequence 
identical to the target. After transformation of this DNA fragment in the Redαβ 
expressed cell containing the target plasmid, the linear fragment recombines into the 
plasmid as positioned by the homologous sequence, endowing the cell with new 
antibiotic resistance (Figure 1-8). Each oligonucleotide for use in recombineering 
consists of at least two parts, yet could include a third or even fourth part to 
incorporate restriction enzyme recognition sites, site specific recombinase recognition 
sites (loxP, FRT, Rox, etc.) or sequence for a short protein tag (His, Strep, Flag, etc.). 
The target DNA can be a gene locus on the E. coli chromosome or any other stretch of 
DNA in a BAC or plasmid vector.81-83 
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Figure 1-8: Redαβ recombineering for a circular DNA modification. 
This figure illustrates the principle of a circular DNA modification. Sm, selectable marker; 
the small blue arrow indicates a prokaryotic promoter. Parts A, B and C are the 
oligonucleotide regions. Part A is the required homology arm in the range of 30-50 bp shared 
by the target circular molecule and the linear molecule. The sequence of the homology 
regions can be chosen freely according to the locus on the target circular DNA. Part B is 
optional (protein tags, restriction sites, site-specific recombination target sites, etc.). Part C is 
the required primer for PCR, which is usually 18 to 24 nucleotides according to the provided 
template.232 
 
LLHR mediated by RecET is capable of multiple linear DNA fragment assembly, if 
each fragment has an overlapping region of sequence identity with its neighbour 
(Figure 1-9A). The final recombination product should contain a plasmid origin for 
replication and an antibiotic resistance gene for selection. Another merit of RecET 
recombineering is direct cloning, with application of this technique to the 15.6 kb 
plu3263 gene providing a good example (Figure 1-9B). Specifically, the genomic 
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DNA of Photorhabdus luminescens is digested with NdeI and PacI to release a 
fragment containing plu3262. The PCR-generated linear vector is composed of a 
pBR322 origin, with an ampicillin selectable marker, tetO promoter and its repressor 
tetR. One homology sequence of the PCR is from the ATG start codon extending 70 
bp downstream and another is the PacI site extending 70 bp upstream. After linear 
plus linear homologous recombination in E. coli expressing RecET, the plu3262 is 
directly cloned under the tetO promoter. Notably, the gene is being directly cloned 
under a regulated promoter to avoid potential toxicity to the host, and the chosen 
homologous sequence is designed 552 base pairs inside of the dsDNA end. An 
additional interesting fact is that RecET is able to align the identical sequences even 
when they are not exposed.116 
 
 
Figure 1-9. RecET recombineering for a circular DNA modification. (A) Schematic 
illustration of multiple linear DNA recombination to generate a circular plasmid. (B) An 
example of direct cloning of plu3263 from the Photorhabdus luminescens genome. The figure 
was reproduced from reference116. 
 
Natural microbial metabolites with promising medicinal and agricultural values, are 
always expressed from secondary metabolite pathway gene clusters. These gene 
clusters are often too large to engineer via conventional arrangements. Hence, 
components of the gene clusters were reconstituted into a single vector with several 
essential elements for gene transfer by using recombineering-direct cloning 
techniques.116 The gene clusters could be shaped further to ensure the successful 
expression in suitable heterologous hosts.124,126,127 Many “unusual” novel compounds 
have already been synthesized and identified via Red/ET recombineering technology 
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in the past few years.128-130 
 
3.3 Improvement of Red/ET recombineering 
Along with the application of recombineering, technical improvements have been 
always made in different ways. For instance, the temperature-sensitive pSC101 
plasmid was used to express the recombinases. After a temperature shift the 
expression plasmid will be lost and the recombinant DNA product will not be 
contaminated.129 Another example is that transient co-expression of RecA results in 
higher survival rate of the cells after electroporation, consequently promoting 
recombinant yield.85  
Genetic engineering relies on the transfer of foreign DNA into cells, and optimization 
of DNA transformation efficiency methods are important. Compared to various 
methods to prepare chemical competent cells for DNA transformation, electroporation 
is much more efficient, especially when the DNA molecule is large.131-133 In E. coli 
electroporation procedure, the cells will turn exceptionally competent through 
high-voltage pulse treatment after rinsing with ice-cold water or 10% glycerol.133-135 
The foreign DNA material will easily and rapidly enter into the permeabilized cell 
through the holes in the membrane transiently caused by the high voltage 
(1200-1350V).136 
According to previous research, electrocompetent cell preparation has to be made at 
ice-cold conditions and therefore both equipment and washing solutions need to be 
kept at low temperatures all times.137-139 Holding the cells at chilling conditions is the 
pivotal aim in the most of the protocols for electroporating Gram-negative bacterial 
strains involving E. coli without an adequate account.137 
Furthermore, the Red/ET recombineering has also been coordinated with other 
genetic tools to widen its application scope, for instance site specific recombination120 
and transposition.126 Recently an efficient RNA-guided site-specific DNA cleavage 
technology has been developed based on the Streptococcus pyogenes type II CRISPR 
(Clustered Regularly Interspaced Short Palindromic Repeats) adaptive immune 
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system.140-142 The system contains the CRISPR associated protein Cas9, a 
trans-activating CRISPR RNA (tracrRNA), and a programmable CRISPR targeting 
RNA (crRNA), which processes a Cas9-mediated double-stranded break (DSB) at 
almost any target DNA locus.143 CRISPR/Cas9 has caught massive attention for its 
feasibility, and pioneer data shows that combination of CRISPR-Cas9 and Red/ET 
recombineering could lead to efficient multigene editing of not only in the E. coli 
genome but also in Tatumella citrea with very high efficiency.144,145 
 
4. Heterologous expression of natural products in surrogate hosts 
Natural products, exhibiting a broad range of distinct structures and biological activity, 
are usually synthesized by large multienzymes mega synthetases, such as PKSs, NRPs, 
hybrid or Ripps. Hence, it is obviously much more economical and time-saving to 
produce these specified natural products during fermentation. Nevertheless, the ideal 
approach is not easy to achieve. For instance, the yield of target compounds in native 
producer is too low to achieve the minimum demands of industrialization or 
environmentally unfriendly byproducts are generated in the reactions. Furthermore, 
many native producers harboring these biosynthetic pathways show slow growth rates 
even in optimized laboratory conditions and are resistant to genetically 
manipulation.34 Thus, heterologous expression of the corresponding secondary 
metabolite pathways into a more amenable host organism can play an important role 
in developing novel derivatives and potential drugs.146 It also affords a high-level 
investigative platform for the detailed research of complex biosynthetic mechanisms, 
allowing careful identification of the products from silent biosynthetic gene clusters, 
and the generation of fresh analogs through biosynthetic engineering in suitable 
heterologous hosts which are genetically more tractable and easily 
cultivated.17,127,147-151 
With respect to heterologous expression of increasing number of complex natural 
products, it is obvious that a general overview of the workflow for cloning and 
production of large natural product assembly lines has been concluded (Figure 
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1-10).127,128 According to this approach, several general considerations and procedures 
should be assumed into account:  
1) Identification and isolation of the corresponding biosynthetic pathway in the 
native producer. In the past dozen years, more and more natural product 
biosynthetic gene clusters have been investigated, with an accompaniment of a 
variety of increasing published genome sequencing data.152 For heterologous 
expression of a biosynthetic gene cluster, the genes should first be isolated so that 
they can be mobilized into an appropriate heterologous host, either using 
traditional ways (a BAC or cosmid library) or by direct cloning, and the clusters 
from genomic DNA should be transferred to a vector. 
2) Identification of a suitable vector for transfer and integration into the 
chromosome of heterologous host, functional promoter architecture and the 
corresponding regulatory factors in the related host. For our direct cloning of 
large gene clusters, the replication origin and the copy number of the plasmid are 
two main considerations. We often use several types of vectors: (i) pBR322 
plasmids presenting 15-20 copies per cell153 with an insert capacity of ~50 kb.154 
(ii) p15A plasmids presenting 10-12 copies per cell153 with an insert capacity of 
~70 kb.116 (iii) pBAC2015 plasmids presenting a single copy per cell with an 
insert capacity of ~150kb.155 Afterwards, the tetracycline inducible promoter 
(tetR-Ptet) is included in these plasmids to regulate the expression of the gene 
clusters in order to minimize the potential toxic effect of natural product gene 
clusters to the host.123,156 
3) Heterologous host selection. An amenable heterologous host is the most crucial 
aspect to be considered. Firstly, the phylogenetic distance between the native 
producer and heterologous host is a key consideration. In general, the more 
closely related the heterologous host is to the native strain, the high success rate of 
functional transcription of the biosynthetic pathway. Additionally, the codon 
usage may be similar in comparison between with the closely-related species and 
the original producer, which may increase the efficiency. In the case of PKSs and 
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NRPSs heterologous expression, the host must principally contain PPTase, which 
is required for post-translational activation of PKS-NRPS proteins.157 Meanwhile, 
various necessary precursors or substrates, such as CoA-activated short chain 
carboxylic acids, both proteinogenic and non-proteinogenic amino acids, and 
short-chain fatty acids must be provided satisfactorily in the parasitifer. 
Additionally, the genetic engineering availability and cultivation conditions are 
also very important for heterologous host selection. Higher titer production and 
lower product cost are the pursuant goals to be achieved through heterologous 
expression. 
4) Genetic engineering of expression constructs. Following the successful 
heterologous expression of biosynthetic gene cluster, yield of heterologous 
expression may be still not satisfactory. Due to this view, promoter exchange, 
reconstitution of essential clusters and insertion of regulatory regions are entailed 
for the expression construct. Depending on the host system selected, there are a 
number of alternative designs for the conservation of the clusters. 
5) Transformation into the heterologous hosts. In the successful heterologous 
expression, the maintenance of a foreign biosynthetic gene cluster stability in a 
surrogate host is foundational for sustainable product expression. In principle, 
there are only two available options for exogenous gene cluster, wherein one is to 
maintain a steady host-compatible plasmid episomally, and another is direct 
integration into the chromosome. 
Biosynthetic gene clusters can be expressed from self-replicating plasmids, either 
from a single plasmid with the entire biosynthetic pathway, or from multiple 
plasmids individually expressing modules in cis. For example, the 36kb 
echinomycin gene cluster from St. lasaliensis was expressed in E. coli BL21 (DE3) 
using three pET-derived vectors with the yield of 0.3mg/L.158 During the 
plasmid-based expression, increasing the copy number of the biosynthetic gene 
cluster resulted in improvement of compound production due to an ample supply 
of precursors.159 An additional convenience is afforded by the use of shuttle 
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vectors for the concurrent expression of biosynthetic gene cluster in multiple 
hosts.160,161 However, plasmid-based expression is not suitable to all the 
heterologous hosts as it depends on the availability of plasmid replicons capable 
of functioning in the host, and this is a risk for recombination-competent hosts and 
also for prolonged expression.162 
In order to secure a stable heterologous expression, the biosynthetic gene 
clusters should be integrated into the host chromosome. Furthermore, such 
integration is essential approaches using the plasmid replicons fail in the host. 
Homologous recombination, transposition and phage-mediated integration are the 
most popular and frequent applications in chromosomal integrations.  
6) Product analysis and optimization. The successful expression of target 
compounds in suitable surrogate hosts is not the destination for our purpose. Often 
times, an ocean of novel compounds have already been discovered and identified 
and are in the progress of heterologous expression128,163 as are drug candidates. 
Nowadays, wide array of advanced techniques, involving liquid 
chromatography-coupled mass spectrometry (LC-MS), fast chromatographic 
separation (UPLC), electrospray ionization (ESI), high-resolution (HR) 
time-of-flight mass spectrometry (ToF-MS) and nuclear magnetic resonance 
(NMR), are employed in the hunt for new natural products to cope with the 
increasing appearance of novel infectious diseases. 
Furthermore, to maximally harvest target metabolites in actual production process, 
several efficient approaches can be carried out to solve difficulties in the 
fermentation, such as precursor feeding and growth conditions optimization (in 
control of concentrations of CO2 and O2, pH, stirring rate, reaction time, 
etc.).164,165  
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Figure 1-10. Typical strategy for the heterologous expression of natural product 
biosynthetic gene clusters. Refer to text in the corresponding sections for a specific 
description of each step. The figure was reproduced from reference.128 
 
Heterologous expression is a time-saving method, especially for biosynthetic 
pathways from slow-growing bacteria, and the biosynthetic pathways can be 
expressed in a bacterium which cultivates relatively fast. Over the past decade, several 
complete biosynthetic pathways from fastidious bacteria have already been 
reassembled by re-construction via Red/ET recombineering and successfully 
expressed in several different heterologous hosts, such as epothilones in M. 
xanthus,126 human alpha-defensin 5 mature peptide in Pichia pastoris,166 nikkomycin 
in Streptomyces ansochromogenes,167 pretubulysin in P. putida and M. xanthus,168 
myxochromide S and myxothiazol in Pseudomonas putida and M. xanthus,126,146,165,169 
salinomycin in Streptomyces coelicolor,170 luminmycin and glidobactin in E. coli 
Nissle1917,129,130 and magnetosome products in Rhodospirillum rubrum.171 
Additionally, transformation-associated recombination (TAR) cloning, another classic 
recombineering method, widely uses in vivo recombination in Saccharomyces 
cerevisiae to directly and specifically isolate desired large gene clusters from complex 
genomes.172,173 This great technology was discovered in late 1990s but had been 
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modified and received a high degree of development during the last ten years.174-176 
Fragments up to 250kb can be directly fished out in yeast from multiple samples 
within 14 days via an optimized TAR cloning approach.175 Many applications based 
on this powerful method have been already established in the post-genomic era. 
According to the protocol, the 56kb Colibactin gene cluster from Citrobacter koseri 
was directly cloned into the vector for heterologous expression.177 Another good 
example of the application of TAR cloning is the reconstruction of the evolutionary 
history of the SPANX gene family in primates.178,179 Unfortunately, an obvious 
disadvantage of TAR cloning is that cloning efficiency drops with a high 
chromosomal GC content, in both yeast and bacteria.175 
Furthermore, several practical synthetic biological technologies for gene clusters 
assembly have also been developed recently years, such the Gibson assembly and 
DNA assembler techniques.180-182 In comparison with Red/ET recombineering and 
TAR cloning, they only are capable of assembling small genetic segments prepared 
by standard PCR or direct chemical synthesis, but for insertions, deletions and point 
mutations, these methods are flexible and variable during DNA engineering. 
Recent research indicates that the challenges of genetic engineering on biosynthetic 
pathways have been generally solved by Red/ET recombineering plus TAR 
cloning.176,183 The following strategy is to select a suitable surrogate host for 
expression. An ideal heterologous host should grow fast, be genetically tractable, 
provide all necessary precursors in sufficient quantities, ensuring functional 
expression of the required proteins and a low background for native secondary 
metabolites.184 It is usually arduous to meet all the requirements above for all natural 
products, but with better growth and genetic characteristics are the basic goals for our 
research. According to previous data, several specific strains are good models for 
expression of heterologous genes, including E. coli,17 Myxococcus xanthus,126 several 
Streptomyces species (S. albus,185 S. lividans186 and S. coelicolor187), Pseudomonas 
putida165 and Rhodospirillum rubrum.188  
While E. coli has been proven to be a powerful and cogent model microorganism for 
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genetic and metabolic engineering with a quick growth rate and its use for biological 
products overproduction are also well established.17 However, original E. coli often 
lacks the essential intracellular machinery to produce natural products. Thus, before 
heterologous expression, important modifications are required in E. coli strain. For 
example, in order to express luminmide via direct cloning, a PPTase from Stigmatella 
aurantiaca73 was introduced into our standard recombineering host, E. coli GB05 to 
form E. coli GB05-MtaA.116 Coincidentally, in the heterologous epothilone 
production, the methylmalonyl-CoA decarboxylase gene (ygfG) was replaced by the 
pcc genes to cumulate MM-CoA.189 All the evidence illuminate that E coli could 
successfully express large PKS/NRPS gene clusters after selective alterations. 
M. xanthus is the best characterized myxobacterium and can be genetically engineered 
much more easily than any other myxobacteria.126 Moreover, in native producers, a 
variety of PKS/NRPS secondary metabolites are manufactured, such as myxochromid 
A2, myxalamid, myxovirescin, myxochelin and DKxanthene,190 demonstrating the 
appearances of PPTases, MM-CoA and self-resistance related to bioactive compounds. 
Furthermore, demonstrating an amazing performance, M. xanthus presents a much 
shorter generation time (5h) than S. cellulosum (16h), another major species of 
myxobacteria harboring miscellaneous antibiotics, such as epothilone. Up until now, 
the Müller group have established heterologous production of many myxobacterial 
secondary metabolites involving pretubulysin, myxochromide S, myxothiazol in M. 
xanthus.126,168,169 M. xanthus can heterologously express not only myxobacterial 
biosynthetic gene clusters, but also streptomycete-derived biosynthetic gene clusters, 
e.g. Oxytetracycline yield in M. xanthus reached up to a high titer 10 mg/L.191 Those 
results suggest that M. xanthus is a promising candidate for heterologous host to 
express PKS/NRPS biosynthetic pathways from both myxobacteria and 
actinomycetes. 
Ultimately, the majority of antibiotics and other pharmaceutically relevant bioactive 
compounds were isolated from actinomycetes (mainly belonging to the genus 
Streptomyces) that had been best analyzed for dozens of years. Several Streptomyces 
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species, such as S. avermitilis,185, Saccharopolyspora erythraea192 and S. coelicolor187 
have been sequenced and harnessed as heterologous hosts to produce their own 
bioactive compounds. Intense efforts of heterologous expression the 
streptomycete-derived secondary metabolites in these Streptomyces hosts have 
already been reviewed by Baltz.193 
Rhodospirillum rubrum (R. rubrum) is a photosynthetic model organism because of 
its pink color in the medium.188 The photosynthesis of R. rubrum differs from that of 
plants as it possesses not chlorophyll, but bacteriochlorophylls. For past decade, R. 
rubrum has already been developed into a modified heterologous host for several 
natural products, such as Pseudomonas aeruginosa membrane protein MscL,194 
various PHA (polyhydroxyalkanoates) synthase genes195 and magnetosome 
biosynthetic gene cluster from Magnetospirillum gryphiswaldense.171 Based on these 
achievements, it is believed that more and more natural products are planning to be 
developed in R. rubrum. 
 
5. Outline of the dissertation 
The goal of the work described in this thesis is to improve heterologous 
transformation of genomic DNA, which is related to bacterial natural products, based 
on the increasing numbers of sequenced microbial genomes. The large gene clusters 
encoding secondary metabolite biosynthesis pathways can now be rapidly cloned and 
modified by Red/ET recombineering. In order to enhance the efficiency of 
recombineering, technical improvement for electrocompetent bacterial cell 
preparation was described in this thesis. Compared to long-standing ice-cold 
preparation method, the room temperature electrocompetent bacterial cells have 
resulted in increased transformation efficiency, which consequently promote the 
efficiency of Red/ET recombineering. Afterwards, three typical bioactive compound 
groups had been analyzed: the cytotoxic disorazols from myxobacterium Sorangium 
cellulosum So ce12, the magnetotactic magnetosomes from alphaproteobacterium 
Magnetospirillum gryphiswaldense and the antibacterial and antitumor salinomycin 
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A. Introduction 
from Streptomyces albus DSM41398. 
An important direction of the thesis is to improve the efficiency of Red/ET 
recombineering by optimization of the conditions for electrocompetent cell 
preparation. DNA transformation is the routine work in most molecular biology 
laboratories, and the electroporation has been proven to be more efficient than the 
chemical transformation. The long-standing protocol for electrocompetent cell 
preparation is rinsing the cells by ice-cold water or 10% glycerol. However, we found 
that the electrocompetent E. coli cells prepared at room temperature was 5 folds more 
efficient for transformation of plasmids with different sizes, replication origins and 
selectable markers. The room temperature electrocompetent E. coli cells also resulted 
in 6-10 folds increased efficiency of RecET recombineering. The beneficial effect of 
room temperature preparation of electrocompetent cells was not been only shown in E. 
coli but also in several other gram-negative bacteria. Ultimately, these results and data 
were presented in publication II. 
Disorazols represent a family of 29 structurally complex macrocyclic polyketides, 
which were first isolated from the myxobacterium Sorangium cellulosum So ce12.196 
These compounds inhibit cancer cell proliferation at picomolar concentrations by 
preventing tubulin polymerization and inducing destabilization of microtubules, 
which ultimately leads to the induction of apoptosis.197-199 According to the 
biosynthetic model four core genes disA-D encode eleven PKS modules and one 
NRPS module, with an acyltransferase domain is missing in the polyketide synthase 
modules. The last separate gene disD encodes an AT protein revealing the disorazol 
gene cluster falls into trans-AT PKS family. Thus, we intend to clone and engineer 
disorazol biosynthetic gene cluster by Red/ET recombineering. Followed by 
successful expression in heterologous host Myxococcus xanthus DK1622, the minor 
product disorazol A2 was changed to be prominent in several derivate without 
significant modifications. Interestingly, the yields of disorazols increased seven times 
after overexpression the solitary AT domain (disD gene) by insertion of a stronger 
promoter. These results were reported in publication I. 
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A. Introduction 
The magnetosomes, which are membrane-enclosed crystals of a magnetic iron 
mineral, are biosynthesized by magnetotactic bacterium Magnetospirillum 
gryphiswaldense.200 Magnetotactic bacteria are a peculiar natural phenomenon that 
can absorb iron (mostly Fe3O4) from the surrounding solution and take it to produce 
an interior chain of nanomagnetic particles within lipid vesicles which are regarded as 
magnetosome chains. However, it is difficult to cultivate the bacterium in the 
optimized laboratory conditions. Through the use of Red/ET recombineering, we 
direct cloned a set of large genomic magnetosome island (~115kb) into several 
vectors and transferred them into the photosynthetic bacterium Rhodospirillum 
rubrum, respectively. Small magnetosome particles could be detected by transmission 
electron microscopy (TEM) and purified from disrupted cells by magnetic separation. 
Four main gene clusters, either essential mamAB or regulatory mamGFDC, mms6 and 
mamXY in magnetosome formation, have been identified and defined through 
heterologous expression in Rhodospirillum rubrum. This biosynthesis of 
magnetosomes within other organisms enlarges the probability of commercialization 
of tailored magnetosome production within microorganisms, and these results were 
recently described in publication III. 
The natural compound salinomycin, produced by Streptomyces albus,201 has a potent 
and selective activity against cancer stem cells and is therefore a potential anti-cancer 
drug. The salinomycin biosynthetic gene cluster (salO-orf18) from Streptomyces 
albus DSM41398 was separately cloned into three plasmids and stitched into an intact 
gene cluster (106kb) under the native promoter using Red/ET recombineering in E. 
coli. The large gene cluster was transferred in to Streptomyces coelicolor A3 (2) for 
heterologous expression, and this was the first report of such a large genomic region 
directly cloned from a Gram-positive strain. These studies suggested a new approach 
to characterization of the relevant functional genes to identify novel analogues by 
module exchange, and the data and analysis were presented in publication IV. 
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I. Genetic engineering and heterologous expression of the disorazol biosynthetic 
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Genetic engineering and 
heterologous expression of the 
disorazol biosynthetic gene cluster 
via Red/ET recombineering
Qiang Tu1,2, Jennifer Herrmann1, Shengbiao Hu3, Ritesh Raju1,†, Xiaoying Bian2, 
Youming Zhang2 & Rolf Müller1
Disorazol, a macrocyclic polykitide produced by the myxobacterium Sorangium cellulosum So ce12 and 
it is reported to have potential cytotoxic activity towards several cancer cell lines, including multi-drug 
resistant cells. The disorazol biosynthetic gene cluster (dis) from Sorangium cellulosum (So ce12) was 
identified by transposon mutagenesis and cloned in a bacterial artificial chromosome (BAC) library. 
The 58-kb dis core gene cluster was reconstituted from BACs via Red/ET recombineering and expressed 
in Myxococcus xanthus DK1622. For the first time ever, a myxobacterial trans-AT polyketide synthase 
has been expressed heterologously in this study. Expression in M. xanthus allowed us to optimize 
the yield of several biosynthetic products using promoter engineering. The insertion of an artificial 
synthetic promoter upstream of the disD gene encoding a discrete acyl transferase (AT), together with 
an oxidoreductase (Or), resulted in 7-fold increase in disorazol production. The successful reconstitution 
and expression of the genetic sequences encoding for these promising cytotoxic compounds will allow 
combinatorial biosynthesis to generate novel disorazol derivatives for further bioactivity evaluation.
Natural products from microorganisms, fungi, plants and insects display a broad spectrum of biological activities. 
Currently, approximately 49% of anti-infectives compounds and 61% of anticancer pharmaceutical agents in clin-
ical use are natural products or their derivatives1. Over the last decades, myxobacteria have become well known 
producer organisms, offering a rich and valuable source of natural products2,3. Most of these compounds are 
biosynthesized by multifunctional megasynthetases, such as polyketide synthases (PKSs)4, nonribosomal peptide 
synthetases (NRPSs)5 and hybrids thereof 6. Genes encoding these PKSs and NRPSs in bacteria are often clustered 
together on the chromosome, so a gene cluster can be cloned into a vector and then transferred to a heterologous 
host for functional expression7. Recent studies demonstrate the usefulness of heterologously expressed secondary 
metabolite pathways for the production of natural products8. Heterologous expression can improve fermentation 
yields and generate new natural or synthetic products that can be evaluated as potential pharmacological agents 
in the course of targeted derivatization or structure-activity relationship studies9.
Reconstructing biosynthetic gene clusters in various vectors for heterologous expression in more productive 
hosts can help show how newly discovered biosynthetic gene clusters function. Derivatives of the new available 
pharmacologically active compounds can then be produced by biomolecular re-engineering and combinatorial 
biosynthesis10.
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Large clusters of genes that encode the enzymes for natural product biosynthesis have been difficult to engineer 
using conventional technology. Red/ET recombineering in combination with TAR (Transformation-associated 
recombination) cloning is necessary for large biosynthetic gene clusters to be engineered conveniently11,12.
Red/ET recombineering is based on in vivo homologous recombination in E. coli13–15. The greatest advantage 
of the technology is that it works regardless of restriction enzyme binding sites or the size of DNA fragments to 
be shuffled. This technology has made it much easier to genetically manipulate complex biosynthetic pathways in 
bacteria. Over the past decade, several complete biosynthetic pathways from fastidious bacteria have been heter-
ologously expressed via Red/ET recombineering, e.g. myxochromide S and myxothiazol in Pseudomonas putida 
and M. xanthus16–19, epothilones in M. xanthus19, human alpha-defensin 5 mature peptide in Pichia pastoris20, 
nikkomycin in Streptomyces ansochromogenes21, pretubulysin in P. putida and M. xanthus22, luminmycin and 
glidobactin in E. coli Nissle191723,24, salinomycin in Streptomyces coelicolor25 and even a minimal set of genes for 
magnetosome biosynthesis from the magnetotactic bacterium in Rhodospirillum rubrum26.
Secondary metabolite gene clusters in microbes express natural products with potential medicinal and values 
agricultural qualities27. However, many of the microorganisms hosting these biosynthetic pathways grow slowly 
even in optimized laboratory conditions and can not be genetically manipulated2. Heterologous expression of 
complete secondary metabolite pathways plays a significant role in hunting for new natural products and devel-
oping them into useful drugs16. Many heterologous expression instruments for secondary metabolite pathways 
have been reported so far, ranging from targeted expression by shuttle vectors to the random expression of large 
DNA fragments from chromosomes by transposition9.
Disorazols, a family of structually complex macrocyclic polyketides, are produced by the myxobacterium 
Sorangium cellulosum So ce12 (Fig. S1) and firstly isolated in 199428. Disorazols inhibit cancer cell proliferation 
at low picomolar concentrations by preventing tubulin polymerization and inducing destabilization of microtu-
bules, which ultimately leads to the induction of apoptosis29–31. The extraordinary potency of disorazols fostered 
their development as peptide-conjugates for cancer therapy32,33 and encouraged the generation of new and sim-
plified disorazol derivatives by means of chemical synthesis34–36. However, there are no reports to date on genetic 
engineering approaches for the production of new analogs of the disorazol compound class.
The dis biosynthetic gene cluster was identified by transposon mutagenesis. In 2005, the cluster was cloned 
into a BAC or cosmid library of S. cellulosum So ce12 by two independent groups37,38. The clusters showed the 
anticipated disA-C genes encoding hybrid trans-AT type I PKS/NRPS megaenzymes, and also another gene, disD, 
that encoded an additional acyl transferase protein (Fig. 1).
According to the biosynthetic model, seven malonyl-CoA units and one serine are incorporated as extender 
units, forming half of the disorazol bis-lactone core unit. Two polyketide monomers may dimerize to form disora-
zol via the thioesterase (TE) domain38, possibly requiring an esterase encoded by orf3′ 37 (Table S4).
The native strain produces only small amounts of disorazols (~1 mg per liter fermentation medium) and 
is difficult to cultivate28. Consequently, it is challenging to produce large quantities of disorazol for further 
Figure 1. Domain organization of the dis biosynthetic gene cluster from S. cellulosum So ce12 and a model 
for biosynthesis of disorazol A1 (scheme according to Kopp et al.). 
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development. Using an amenable heterologous host should be a rational way to assure higher and stable disorazol 
yields and possibly optimize its structure by molecular engineering.
Here we report the Red/ET recombineering of the dis biosynthetic gene cluster into a stable vector contain-
ing a p15A replication origin and a MycoMar transposase element. When the dis gene cluster was transposed 
into the chromosome of the heterologous host M. xanthus DK1622 several disorazol derivatives were produced. 
Subsequent gene deletions proved that only the disA-D genes and not orf9 or the putative esterase gene orf3′ 
were needed for disorazol production37. Further, we also improved disorazol production in the heterologous host 
M. xanthus DK1622 by replacing the native promoter of the disD gene encoding a discrete AT protein with an 
artificial synthetic promoter.
Results and Discussion
Reconstitution of the disorazol A biosynthetic gene cluster. The disorazol A biosynthetic gene clus-
ter has been cloned, sequenced and identified previously from a BAC library of So ce1237. The BAC contained 
most of the dis gene cluster from disA to disD. However, the BAC pBeloBAC11-dis was a large and low copy vec-
tor and very difficult to transfer between hosts for heterologous expression. To construct a more efficient expres-
sion vector and to insert elements for transfer and expression into different heterologous hosts, we sequentially 
modified the original BAC (pBeloBAC11-dis) by Red/ET recombineering13,14. The backbone of pBeloBAC11-dis 
was replaced by a cassette containing the p15A replication origin (p15A ori), the origin of transfer (oriT) for con-
jugation purposes, two inverted repeats (IRs), a MycoMar transposase gene (Tps) for transposition, an inducible 
promoter tetR-Ptet for driving the dis gene cluster upstream of disA and a kanamycin resistance gene for selection 
in M. xanthus DK1622.
In the resulting construct p15A-dis, the dis gene cluster (containing disA-D and orf9) is in a relatively high 
copy number vector (20–30 copies per cell in E. coli). Instead of the native promoter, expression in this vector 
is controlled by a tetracycline inducible promoter in this vector works in several heterologous hosts, e.g. E. coli, 
M. xanthus and P. putida39 (Figs 2 and S2).
We previously found that disorazol production was no longer detectable when an esterase gene (orf3′ ) was 
mutated by transposon insertion in mutant strain So12_EXI_IE-337. This mutated esterase gene was implicated 
in bis-lactone formation during disorazol biosynthesis. We recovered plasmid pTn-Rec_IE2 (Fig. S6), which con-
tained several genes near the transposition in the mutant So12_EXI_IE-3. The transposon was found in the mid-
dle of the carboxyl esterase gene orf3′ (only 6.7 kb upstream of the disA start codon).
The plasmid pTn-Rec_IE2 also included a S-adenosyl methionine (SAM) dependent methyl transferase gene 
orf2′ 37. As the product of orf2′ may O-methylate the OH group at C-6′ adjacent to the orf3′ gene, it might also 
be essential for disorazol biosynthesis (Fig. S6, Table S4). Hence, we inserted both, the repaired carboxyl esterase 
gene orf3′ and the SAM-dependent methyl transferase gene orf2′ together into p15A-dis to form p15A-dis-est 
by Red/ET recombineering. To gain the fusion plasmid p15A-dis-est, firstly, two separate PCR cassette “cmR” 
and “spectR” with suitable homologous arms to the region (containing two Hind III restriction sites in both sides) 
between the orf9 and the disD genes were introduced into the vector, respectively. After digestion by Hind III 
restriction enzyme in correct clones, the linear fragment “cmR-orf2′ -orf3′ -spectR” was integrated to obtain the 
final construct p15A-dis-est. By this, the cmR gene was introduced to drive orf2′ and orf3′ genes. Likewise, the 
spectR gene was introduced to drive the disD gene (Figs 2 and S2).
Certain gene products may be toxic to the host cell, potentially limiting the nature of downstream applications 
when introduced into E. coli directly at high copy number40. All E. coli strains containing the dis gene cluster with 
the native promoter were found to carry mutations after recombineering. Therefore, it was very challenging to 
obtain the expression construct containing the dis gene cluster directly in E. coli because the growth of the host 
was impeded. We reasoned that one of the dis proteins interfered with a primary metabolic pathway in E. coli 
to disrupt growth. To address this issue, an inducible promoter Ptet, was used to regulate gene expression. Ptet is 
a versatile tetracycline-based regulatory system that is usually used to selectively control expression of down-
stream genes39. No other promoter system is suitable for so many diverse hosts, including E. coli, M. xanthus and 
P. putida10,22,23,41. Besides, Ptet had already enabled several mixed PKS/NRPS natural products to be produced in 
heterologous hosts unrelated to the native producing organisms, such as myxochromide S from myxobacterium 
Stigmatella aurantiaca, which has been engineered into P. putida19.
The transposon method, which was also applied in this study, is clearly more stable and efficient than using 
shuttle vectors19. Several indispensable elements were inserted into the target vectors, for instance Tps and oriT. 
The mariner transposon MycoMar is frequently used in Gram-negative hosts for genetic modification42,43 and to 
transfer and integrate a gene cluster into the chromosome of heterologous host strains19,22. The transformation 
efficiency of large gene sets is higher when using the MycoMar transposon than using homologous recombina-
tion, as has been described for the heterologous expression of epothilone and myxochromide S19. This powerful 
tool for transforming large genes was used in the disorazol heterologous expression system to make it easier to 
integrate the dis gene cluster into the genome of host strains. The oriT was also incorporated for conjugation in 
other heterologous hosts strains, such as P. putida44.
Heterologous expression of dis gene cluster in M. xanthus DK1622. Both expression constructs 
p15A-dis and p15A-dis-est (Fig. S2) were introduced into the heterologous host M. xanthus DK1622 by elec-
troporation as previously described19. The dis gene cluster was randomly transposed into the chromosome of 
M. xanthus. Transformants were screened on CTT agar containing kanamycin to select for M. xanthus::p15A-dis 
and M. xanthus::p15A-dis-est mutants. Six randomly chosen colonies of each mutant were verified by PCR19, 
which confirmed that the dis gene cluster had been integrated into the M. xanthus chromosome in each case. All 
the checked mutants contained the whole disorazol gene clusters. Several resulting mutants M. xanthus::p15A-dis 
and M. xanthus::p15A-dis-est were cultivated (both induction by anhydrotetracycline (AHT)) for compound 
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extraction and detection. All the mutants produced detectable amounts of disorazols by the analysis of high 
performance liquid chromatography-tandem mass spectrometry (HPLC-MS)45. We have found small amounts 
of various disorazol compounds (including disrazols A1, A2, A3, A4, B2, B4 and F2) in both extracts of M. xanthus:: 
p15A-dis and M. xanthus:: p15A-dis-est (Figs 3 and S3, Table S2), upon comparing the secondary metabolite pro-
files from M. xanthus wild type strain and mutants. As expected, these results indicate that the chosen set of genes 
is sufficient to produce the polyketide-nonribosomal peptide skeleton of the disorazols.
Unexpectedly, without the orf2′ and the orf3′ genes, M. xanthus:: p15A-dis can also produce disorazols. The 
overall yields of disorazols in M. xanthus:: p15A-dis (averagely were 0.4 mg/L) match with that in M. xanthus:: 
p15A-dis-est (averagely were 0.42 mg/L). Result exhibited that the orf3′ gene is dispensable in the disorazol bio-
synthesis in the chosen heterologous host. There might be an enzyme that can substitute for the similar function 
of the orf3′ gene product in M. xanthus host. The dis gene cluster could be inactivated in the transposon mutant 
So12_EXI_IE-3 due to a strong polar effect37 because it is adjacent to the disA gene, possibly preventing down-
stream genes in an operon from being transcribed46,47.
The HPLC-MS and NMR data showed that the major compound in both mutants M. xanthus:: p15A-dis and 
M. xanthus:: p15A-dis-est was disorazol A2 which constituted 55% of final product after purification from crude 
extracts (Figs S3 and S4, Table S3), whereas disorazol A1 was 20%. But in the native host So ce12, disorazol A1 was 
the chief component (nearly 70% after purification, 10 times higher than disorazol A2 ) produced among the 29 
derivatives28. The most probable explanation was that an O-methyl transferase that methylates the OH group at 
C-6′ was absent in the heterologous expression of dis gene cluster. This methyl transferase gene could be possibly 
located elsewhere in the chromosome of the native producer So ce12, which still needs further investigation. Only 
small amounts of the C-6′ methylated disorazols A1, A3 and A4 were produced in M. xanthus (Fig. S3), which 
might be due to partial methylation by a nonspecific M. xanthus O-methyl transferase. After 5 L fermentation of 
mutant strain M. xanthus::p15A-dis, the yield of disorazol A2 was approximately 0.24 mg/L, which is 5-fold higher 
than described in the native producer strain So ce1228,48. The result unambiguously demonstrated again that sec-
ondary metabolites can be produced in heterologous hosts under the control of the versatile Ptet promoter which 
encouraged further investigation of disorazol formation.
Figure 2. Diagram of disorazol A gene cluster engineering. Firstly, the backbone of plasmid pBeloBAC11-
dis (i) was replaced by p15A ori-tps casstte to form p15A-dis (ii) which containing an original MycoMar 
transposon by Red/ET recombineering. In this way dis gene cluster was driven by Ptet promoter. Then, the 
interrupted esterase gene orf3’ in pTn-Rec_IE2 plasmid (iii) from transposon mutant So12_EXI_IE-336 was 
recovered, repaired and engineered to form the vector p15A-amp-cm-orf2’-orf3’-spect (iv) that contained 
the whole length of the esterase gene orf3’. Next, linear DNA fragment released by Hind III was integrated 
into disorazol vector p15A-dis (ii) to get the final construct p15A-dis-est (v) via Red/ET recombinantion. 
Finally, two types of modified vectors p15A-dis (ii) and p15A-dis-est (v) were electroporated into M. xanthus 
respectively and kanamycin-resistant colonies were selected for further analysis. Hind III restriction sites used 
for releasing linear fraction “cmR-orf2’-orf3’-spectR” were indicated in ↑. The insertion site of the linear fragment 
DNA containing orf2’ and orf3’ gene was marked with ↓.
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Biological activity of disorazol compounds. After having isolated disorazols from our heterologous 
host M. xanthus, biological studies revealed exceptional high cytotoxicity of disorazol A2 on eukaryotic cells. We 
determined IC50 values against several established human cancer cell lines from different origin and disorazol 
A2 strongly inhibited the growth of these cell lines with IC50 values between 0.05 and 4.9 nM (Table 1). However, 
compared to disorazol A1, the antiproliferative activity of disorazol A2 was less pronounced on most cell lines, 
except for human U-937 histiocytic lymphoma. Most likely, the higher IC50 values for disorazol A2 are due to the 
lack of a methyl group at C-6′ compared to disorazol A1, which in turn might lead to a less favourable binding 
to the traget structure tubulin. Nevertheless, when compared to other anticancer drugs, such as epothilone B or 
vinblastine, disorazol A2 is still much more effective in vitro29,49.
Optimized production with biomolecular technology. An unusual feature of the disorazol biosyn-
thetic gene cluster is that it has only one discrete AT domain on the DisD module, and hence it is called a trans-AT 
type of PKS50. In recent years, trans-AT PKSs have been found in an important group of biosynthetic enzymes 
that produce bioactive natural products, including pederin, rhizoxin, leinamycin, myxovirescin, chivosazol and 
psymberin51,52. Accessing functionally-optimized polyketides by modifying PKSs through targeted synthase 
re-engineering is an encouraging approach to optimize natural products for application52. However, in contrast 
to ATs from cis-AT PKSs, the mechanisms and structures of trans-acting ATs are still unexplored.
The disD gene has been modified here to show how trans-acting ATs affect the disorazol biosynthesis path-
way. In order to enhance the expression of the solitary AT domain, we introduced another strong promoter 
Pcp25 upstream of the disD gene. Pcp25 is a highly active, constitutive lactococcal consensus promoter, whose 
sequence has already been reported53,54. Previous studies have illustrated that overexpression of single genes or 
multigene transcriptional units by promoter exchange in myxobacteria can improve the production of secondary 
metabolites19,55–57.
On the other hand, the role of orf9 gene (showing similarity to hypothetical proteins), which separates the disC 
and disD genes, in the dis gene cluster has not been defined37. To discover the actual function of the orf9 gene in 
disorazol biosynthesis, we inactivated it on the expression construct p15A-dis and then performed heterologous 
production in M. xanthus.
The PCR cassette “Pcp25-spectR” (P18–P20 in Table S1), containing promoter Pcp25 and a spectinomycin resist-
ance gene (spectR), with two different pairs of homologous arms, was inserted into p15A-dis by Red/ET recom-
bineering to form two plasmids p15A-dis-Pcp25 and p15A-dis-Pcp25Δ orf9 (Figs 4A and S5). In the first plasmid 
p15A-dis-Pcp25, the promoter Pcp25 was inserted directly upstream of the disD gene. In the second plasmid, the 
orf9 gene was deleted by using a synthetic promoter cassette with selection for spectinomycin resistance to obtain 
p15A-dis-Pcp25Δ orf9. The disD gene was thereby controlled by the Pcp25 promoter in both expression constructs. 
The recombinants were analyzed after growth on low-salt Luria-Bertani (LB) broth plates plus spectinomycin. 
The verified constructs were transformed into M. xanthus DK1622 and three randomly picked positive trans-
formants of each type of strain were cultivated to analyze the production by HPLC-MS. To clearly identify 
disorazol, retention times (RT) and the MS2 fragmentation pattern were compared to authentic reference sub-
stances. The concentration of disorazol A2 in the culture was determined by UPLC-HRMS. A standard curve 
between peak area and concentration was established from serial dilutions for disorazol A2 down to 0.01μ g/mL. 
Figure 3. Analysis of disorazol production in M. xanthus wildtype (WT) and M. xanthus::p15A-dis grown 
at 30 °C and induced with 0.5 μg/ml AHT. (A) HPLC-MS analysis (base peak chromatogram [BPC] m/z 720–
780) of M. xanthus::p15A-dis and M. xanthus WT. (B) MS2 fragmentation pattern of disorazol A1 (1). (C) MS2 
fragmentation pattern of disorazol A2 (2).
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The peak area of disorazol A2 (base peak chromatograms, BPC + 759.3 ± 0.1, RT = 18.2 min) was calculated by 
BrukerDaltonics compass data analysis 4.0. The yields of all disorazols were estimated from their relative peak 
areas in the HPLC-MS chromatogram by comparison with the standard curve for each derivative.
All the resulting host strains still produced disorazols with growing production titres based on HPLC-MS 
analysis. The generated M. xanthus:: p15A-dis-Pcp25 expression host produced on average seven times more dis-
orazol A2 compared to M. xanthus:: p15A-dis and mutant strain M. xanthus:: p15A-dis-Pcp25Δ orf9 produced 
approximately 2.5-fold when compared to M. xanthus:: p15A-dis (Figs 4B and 5). Hence, the orf9 gene ablation 
did reduce disorazol production although it was described as having “no functional prediction” in BLAST anal-
ysis37. The orf9 gene, following the TE domain, might affect the biosynthetic formation of the final product by 
incorporation and cyclization of two sides of the disorazol bis-lactone. The successful enhancement of disorazol 
heterologous production suggested that re-engineering trans-AT PKSs domains on the molecular level was a 
feasible and practicable approach in investigating the characteristic enzymes.
Trans-AT PKSs are an important but still less known family of biosynthetic systems in comparison to cis-AT 
PKSs58,59. There are significant differences in the existing biosynthetic protocols between trans-AT and cis-AT 
PKSs. A single discrete AT DisD recognize and load all molonyl-CoAs for all the dis PKS modules. Here we 
change the native promoter of disD gene with a stronger and artifical synthetic Pcp25 promoter which it would 
increase the transcription of disD gene and most likely raises the amount of DisD protein. Sufficient ATs could 
Human Cell line Origin
IC50 [nM]
Disorazol A1 Disorazol A2
A-431 epidermoid carcinoma 1.866 4.908
A-549 lung carcinoma 0.072 0.408
HCT-116 colon carcinoma 0.032 0.071
HepG2 hepatocellular carcinoma 0.002 0.051
HL-60 acutemyeloid leukemia 0.058 0.084
K-562 chronicmyeloid leukemia 0.074 0.140
KB-3.1 cervix carcinoma 0.025 0.106
SW480 colonadeno carcinoma 0.030 0.128
U-2 OS osteosarcoma 0.038 0.206
U-87 MG glioblastoma-astrocytoma 0.072 0.119
U-937 histiocytic lymphoma 0.293 0.210
Table 1.  Activity of disorazol A1 and disorazol A2 against human cancer cell lines. IC50 values refer to 
antiproliferative activities.
Figure 4. Promoter insertion in front of disD gene. (A) Three different types of expression constructs used for 
disorazol heterologous production. The first one is the original plasmid p15A-dis. The second one was modified 
via Red/ET recombineering by insertion of promoter Pcp25 in front of disD directly. The third one was deletion 
orf9 gene by Pcp25-spectR so that Pcp25 was also upstream disD. (B) Quantification of heterologous disorazol 
production by HPLC-MS analysis of the culture extracts from different M. xanthus DK1622 mutant strains. 
Sections of extracted ion chromatograms at m/z = 745.45 corresponding to the [M + H]+ ion of disorazol A2 
are illustrated as representative readout of productivity. The M. xanthus DK1622 host strains contain one of the 
three expression constructs shown in (A).
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provide abundant substrates, thus promote the PKS module efficiency for polyketide chain extension of disorazol 
biosynthesis leading to improved production52,60,61. As trans-AT PKSs are a special group of enzymes responsible 
for natural product biosynthesis in the organisms, it is essential to understand their functions in order to develop 
more heterologous expression systems for these special polyketides. Here, we have established a pioneer protocol 
to overexpress an independent AT resulted in increased yield of the final product, which can be used for the pro-
duction optimzation of trans-AT directed natural products in the native or heterologous hosts.
Methods
Bacterial strains and culture conditions. All recombineering was performed in E. coli strain GB2005 and 
its derivatives cultured in LB medium and antibiotics (kanamycin [km], 15 μ g/ml; ampicillin [amp], 100 μ g/ml; 
spectinomycin [spect], 40 μ g/ml; chloramphenicol [cm], 30 μ g/ml and tetracycline [tet], 5 μ g/ml). The strains 
used were: GB2005, derived from DH10B by deletion of fhuA, ybcC and recET19,62; GB05-red, derived from 
GB2005 by insertion of the PBAD-gbaA cassette at the ybcC locus41,62; GB05-dir, derived from GB2005 by the PBAD-
ETgA operon, which was integrated into the ybcC locus in GB200541. The integration ablates expression of ybcC, 
which encoded a putative exonuclease similar to that encoded by Redα . The heterologous host for PKS/NRPS 
gene cluster expression was M. xanthus DK1622 grown at 30 °C in CTT medium (1% casitone, 8mM MgSO4, 
10mM Tris-HCl, pH 7.6, and 1mM potassium phosphate, pH 7.6)63 with or without km (50 μ g/ml) before or after 
introduction of the disorazol gene cluster.
Red/ET recombineering. All methods were essentially as described previously62. By using Red/ET recom-
bineering, 0.3 μ g of one linear DNA fragment (either a PCR product or a fragment obtained from restriction 
enzyme digestion) was electroporated into 50 μ l Red/ET-competent E. coli cells (such as GB-red cells). After 
electroporation, colonies grew on the LB-agar plates under selection for the antibiotic resistance gene and then 
were examined for the intended Red/ET recombination product by restriction analysis with a set of different 
suitable enzymes.
All PCR reactions carried out using Taq polymerase (Invitrogen GmbH, Karlsruhe, Germany) according to 
the manufacturer’s protocol. For the amplification of the ~1000 bp cassette with high GC content, DMSO was 
added to a final concentration of 3%. The conditions using an Eppendorf master cycler were as follows: 10 min 
at 95 °C to activate the polymerase, denaturation at 95 °C (30 s), annealing at 58 °C (30 s), and extension at 72 °C 
(35 s); 35 cycles. The PCR product was directly used without any purification.
Reconstitution of dis gene cluster. To harvest the full length of the esterase gene orf3′ in plasmid 
pTn-Rec_IE2, we first changed the backbone of pTn-Rec_IE2 into p15A-amp-orf2′ -Tn-hyg in order to get 
more stable and higher copies of DNA (P3, P4 in Table S1). Then two linear fragments, p15A-amp-orf2′ -Tn-hyg 
digested by Sal I and primer P5 (see Table S1), were co-transformed into E. coli GB05-dir cells41 to remove 
R6k-Tn-hygR genes and recover the whole size of orf3′ gene. Thus, we obtained plasmid p15A-amp-orf3′ har-
boring the full-length esterase gene. In order to insert the whole length orf2′ and orf3′ genes into the disora-
zol plasmid, we inserted two single PCR cassettes “spectR” and “cmR” with suitable homologous arms (P6-P9 
Table S1) into the vector to engineer plasmid p15A-amp-cm-orf2′ -orf3′ -spect and then digested the new con-
struct with Hind III to release the linear cassette “cmR-orf2′ -orf3′ -spectR” whose Hind III restriction site were 
homologous to p15A-dis vector. In the last step, the “cmR-orf2′ -orf3′ -spectR” cassette was transformed into strain 
GB-red::p15A-dis strain to generate the final plasmid (Figure S7). Two expression constructs p15A-dis and 
p15A-dis-est were obtained, containing four core-large genes from the disorazol A pathway (ten PKSs and one 
NRPS, ~58kb), with the Ptet promoter located upstream of the first PKS domain (Fig. 2).
Figure 5. Production of disorazol A after insertion of Pcp25 promoter. Quantification of disorazol 
heterologous production by HPLC-MS analysis of the culture extracts from different M. xanthus DK1622 
mutant strains. All LC-MS- derived area values are normalized to the crude extracts of each sample by method 
of standard curves. The depicted values are mean values from three independent mutants. Error bars show 
calculated SDs, yield, control strain.
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Electroporation of M. xanthus DK 1622. The engineered gene clusters were introduced into the chro-
mosome of M. xanthus DK1622 by electroporation. Briefly, M. xanthus cells from 1.7 ml of overnight culture with 
OD600 ~ 0.6 were collected and electrocompetent cells were prepared after washing twice with ice-cold water. A 
mixture of 50 μ l cell suspension in cold water and 3 μ g DNA was electroporated (Electroporator 2500, Eppendorf 
AG, Hamburg, Germany) at 1300V using a 0.1 cm cuvette. After electroporation, the cells were resuspended in 
1.7 ml fresh CTT medium, and incubated at 30 °C in a 2 ml Eppendorf tube with a hole punched in the lid on a 
Thermomixer (Eppendorf) at 11000 r.p.m. for 6 h. Then 1 ml 1.5% CTT agar solution at 42 °C was added to the 
tube and the cells were plated in soft agar for selection on CTT agar plates supplemented with km (50 μ g/ml). 
Km-resistant colonies appeared after 4 days and were checked by colony PCR as follows. Part of a single colony 
was washed once in 1 ml H2O and resuspended in 100 μ l H2O. Then, 2 μ l of the resulting suspension was used as 
a PCR template using Taq polymerase according to the manufacturer’s protocol. The disorazol-specific primers 
used to check the integration of the disC gene into the M. xanthus chromosome were the same as used in a previ-
ous study16. For PCR amplification, primers 10 and 11 were used (see Table S1).
Expression and analysis of disorazol production. Plasmids harboring a core-region or reconstituted 
dis gene cluster were introduced into M. xanthus DK1622 by electroporation. The resulting mutants (M. xanthus 
DK1622:: p15A-dis) were cultivated in 100ml shake flasks containing 30 ml CTT medium. The medium was inoc-
ulated with 0.5 mL of the overnight culture and incubated at 30 °C on a rotary shaker at 180 rpm. After induction 
(anhydrotetracycline, final concentration 0.5 μ g/mL) and addition of XAD adsorber resin (2%, 24 h), incubation 
was continued for 2 more days. The cells and the resin were harvested by centrifugation and extracted with 
methanol. The extracts were evaporated and then redissolved in 1 mL MeOH. A 5 μ L solution was analyzed by 
HPLC-MS and analysis was performed on an Agilent 1100 series solvent delivery system that was equipped with 
a photodiode array detector and coupled to a Burker HCTultra ion trap mass spectrometer. Chromatographic 
conditions were as follows: Luna RP-C18 column, 100 × 2 mm, 2.5 μ m particle size, and precolumn C18, 8 × 3 mm, 
5 μ m. Solvent gradient (with solvents A [water and 0.1% formic acid] and B [CH3CN and 0.1% formic acid]): 
20% B from 0 to 20 min, 20% B-95% B within 10 min, followed by 5 min with 95% B at a flow rate of 0.4 mL/min. 
Detection was carried out in positive ion mode, auto MSn. Disorazols were identified by comparison to the reten-
tion times and the MS2 data of disorazols identified from the original producer in our myxo-database (target 
screening, Table S2)28. The relative production of disorazols was calculated from the peak areas of the extracted 
ion chromatograms (EICs) of each derivative.
High-resolution mass spectrometry was performed on an Accela UPLC-system (Thermo-Fisher) coupled to 
a linear trap-FT-Orbitrap combination (LTQ-Orbitrap), operating in positive ionization mode. Separation was 
achieved on a Waters BEH RP- C18 column (50 × 2.1 mm; 1.7 μ m particle diameter; flow rate 0.6 mL/min, Waters), 
with a mobile phase of H2O/CH3CN (each containing 0.1% formic acid) and a gradient of 5–95% CH3CN over 
9 mins. UV and MS detection were performed simultaneously. Coupling of HPLC to MS was supported by an 
Advion Triversa Nanomate nano-ESI system attached to a Thermo Fisher Orbitrap. Mass spectra were acquired 
in centroid mode at 200–2000 m/z with a resolution of R = 30000.
Target screening method. The HPLC-HR-MS data of crude extracts were further analyzed to identify 
the known compounds present in the extracts using the software Target Analysis (Bruker Daltonik GmbH). The 
known compounds were identified on the basis of their high resolution mass, isotope pattern and retention time 
according to the known method45. With this approach, re-isolation of known but less interesting compounds 
could be avoided whereas unknown compounds with potential bioactivity could be identified easily.
Isolation of disorazol A2. M. xanthus containing p15A-dis was cultivated in 5 L CTT medium supple-
mented with 30 μ g/mL kanamycin and 2% XAD 16 resin (after 2 days of incubation) at 30 °C for 5 days63. The 
resin was collected by sieving, washed with H2O twice, and then extracted stepwise with acetoacetate (5 L). The 
extract was concentrated in vacuo, followed by suspension in MeOH and extraction with n-hexane to defat. The 
resulting MeOH extract (0.87 g) was fractionated initially on a Sephadex LH-20 column (100 × 2.5 cm) using 
MeOH as a mobile phase, and 55 fractions were obtained. Fractions containing disorazol A2 were subjected to 
semi-preparative reversed-phase HPLC system (Jupiter Proteo C12, 250 × 10 mm, 4 μ m, DAD at 254 nm) with an 
isocratic system of 75% MeOH/H2O with 0.05% TFA to yield (1.2 mg, tR ≈ 22 min).
NMR. NMR spectra were recorded in CD3OD on a DRx 500 MHz spectrometer (1H at 500 MHz, 13C at 
125 MHz) equipped with a 5-mm probe and a Bruker Ascend 700 MHz spectrometer (1H at 700 MHz, 13C at 
175 MHz) equipped with a 5-mm TXI cryoprobe system (Bruker Biospin GmbH, Germany). Chemical shift 
values of 1H- and 13C-NMR spectra are reported in ppm relative to the residual solvent signal given as an inter-
nal standard. Multiplicities are described using the following abbreviations: s = singlet, d = doublet, t = triplet, 
q = quartet, m = multiplet, b = broad; corrected coupling constants are reported in Hz.
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Figure S1. Chemical structures of disorazols. 
1. Disorazol A1 
2. Disorazol A2 
3. Disorazol A3 
4. Disorazol A4 
5. Disorazol A5 
6. Disorazol A6 
7. Disorazol A7 
8. Disorazol B1 
9. Disorazol B2 
10. Disorazol B3 
11. Disorazol B4 
12. Disorazol C1 
13. Disorazol C2 
14. Disorazol D1 
15. Disorazol D2 
16. Disorazol D3 
17. Disorazol D4 
18. Disorazol D5 
19. Disorazol E1 
20. Disorazol E2 
21. Disorazol E3 
22. Disorazol F1 
23. Disorazol F2 
24. Disorazol F3 
25. Disorazol G1 
26. Disorazol G2 
27. Disorazol G3 
28. Disorazol H 
29. Disorazol I 
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Figure S2. Heterologous expression constructs of two type of expression plasmids 
p15A-dis and p15A-dis-est. 
Construct 1 is p15A-dis. Then we insert the repaired carboxyl esterase gene orf3’ and 
the SAM-dependent methyl transferase gene orf2’ together into p15A-dis by Red/ET 
recombineering to form construct 2 p15A-dis-est. After insertion, two genes are in the 
middle of orf9 gene and disD gene. 
 
 
 
  
  
Figure S3. related to Figure 3. HPLC-MS analysis (BPC m/z 720-780) of extracts 
from M. xanthus:: p15A-dis. 
The peaks are disB4 (1), m/z 761 [M+H]+; dis762 (2), m/z 763 [M+H]+; disB2 (3), m/z 
779 [M+H]+; disA2 (4), m/z 745 [M+H]+; disA1 (5), m/z 759 [M+H]+; disF2 (6), m/z 
729 [M+H]+.  
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Figure S4. 1H NMR spectrum of disorazol A2. 
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Figure S5. Modify disD gene through Red/ET recombineering. 
1: only insert promoter Pcp25 in front of disD gene. 
2: insert promoter Pcp25 in front of disD gene by deletion orf9 gene. 
  
 
Figure S6. Construct of the recovered plasmid pTn-Rec_IE2. (data according to Kopp 
et al.) 
Diagram of the genes encoded adjacent to the transposition site of mutant 
So12_EXI_IE-3 that was cloned into the recovered plasmid pTn-Rec_IE-2. ↓ is the 
location of the transposon insertion site. 
 
  
Table S1 Oligonucleotides used in this study 
 
name sequences(5’-3’) Notes 
P1 AATGTCGCACAATGTGCGCCATTTTTC
ACTTCACAGGTCAACGCTCACGCTGA
CGCTGTCCGCCGAGACCGACTTGGGC
TTCTACCTGCGGATCCTGGTGATGATG
GCGGGATCGTTG 
Used to replace the backbone of disBAC 
plasmid 
P2 AATGAATAGTTCGACAAAAATCTAGA
TAACGAGGATCAACGATGGAGCAGGA
CGCCATTGCGATCATCGGCGTAGCGT
GCCGATTTCCCGGGATCCTGTGACGG
AAGATCACTTCG 
P3 TCCGCTGCATCCTGGATCTGGATATGG
ACAGGAAGGCGTTTGAAGAAGTCGAG
TTTGAACAAAACAACTTATATCG 
Used to replace the backbone of pTn- 
Rec_IE2 plasmid 
P4 CTCAGCCCGCGTCGAGCGCGTAGACG
GCCGTGGCCGTCTTTCGCCCCGTCAGG
TCTTACCAATGCTTAATCAGTGAG 
P5 TACCGTCGCGGCCACGCGCATCTGGG
GCCCCCTCGGCATGAACGATACGATG
TACAACCCGCCCGCGGAGCTCCACGA
GCGCGTGGCGGCCACGGGCTACTCGA
CC 
Used to delete R6k-Tn-hyg genes in order to 
form full length of esterase gene 
P6 CAGATCGCTGAGATAGGTGCCTCACT
GATTAAGCATTGGTAAGCTTGAGACC
CTTGCCCGGGAAACATGTATGCTTTCA
TCGGTTCTTCCTCTTATAATTTTTTTAA
TCTGTTA 
Used to form the homology arm to p15A-dis 
plasmid 
P7 CCTCAGCCCGCGTCGAGCGCGTAGAC
GGCCGTGGCCGTCTTTCGCCTAACGTG
ACTGGCAAGAGATAT 
P8 TGACCTCCGGCTCGAGCACGCGCGCC
AGCGACATGCTCGCATCCTTCTCCGTT
ACGCCCCGCCCTGCCACTC 
Used to form the homology arm to p15A-dis 
plasmid 
P9 TCAGCCCCATACGATATAAGTTGTTTT
GTTCAAACTCGACTTCAAGCTTGCGCC
GAGGCGAGCCCCTGGCGGGCACGTCG
TGGCGGCGCGCCTCCTGGTGTCCCTGT
TGATACC 
P10 TGGAAAGCGCGATGACCATCCAGGAG
TTTGCCAACTTGTCTGCGGAG 
Used to verify M. xanthus::p15A-dis mutant. 
P11 TGTGGGAGGCGAGGGCCTCGGCGAAG
AGGGTGAGGAGCAGGGCCGTCGG 
P12 TGGAGGTCCGCCCGATCGCCGAGGGC
GAGCTGCACGAGCGCCTCGCGCGGCA
GGAGCCCTTACGCCCCGCCCTGCCACT
CATCGCAG 
Used to inactivate disA gene 
P13 TGATAGAGAAAAGTGAAATGAATAGT
TCGACAAAAATCTAGGAGGATGATGA
CGCCAACTTTTGGCGAAAATGAGAC 
P14 CGTAGGACACCCGGTTGGCGATCGAC
GAGTAATCGGCGCTCGCGATCACGGG
GTTTCCCTTGTGGAGCTCGTCCTGTTA
CGCCCCGCCCTGCCACTCATCGCA 
Used to inactivate disB gene 
P15 TGCGCCGCTCGGCTATTACCAATCGAC
CTGGACCAGAAGCGCGCTTTGAACGT
CGGGGTAACCTCCCAACTTTTGGCGA
AAATGAGAC 
P16 CGGCTCGGTGAGCGAGAGCCGCAGCT
CGAAGAAGGGCCACTGATCCAGGGGG
AATACCCTTTACGCCCCGCCCTGCCAC
TCATCGCAG 
Used to inactivate disC gene 
P17 TGGCCGGCGTACCGGGCGAGGAGCTG
ACTCGGCTCTACGCCATCCTGCAAGA
GGAATGATGACCAACTTTTGGCGAAA
ATGAGAC 
P18 TGAGACCCTTGCCCGGGAAACATGTA
TGCTTTCATCGGTTCTTCCTCTCTATCA
CTGATAGGGAGTGGTAAAATAACTCT
ATCAATGATAGAGTGTCAACAGTACT
ATGTGATTATACC 
Used to insert Pcp25 promoter in front of disD 
gene 
P19 CGCGCCGAGGCGAGCCCCTGGCGGGC
ACGTCGTGGCGGCGCGCCTCCTCCCCG
CGAGCACGTGTTGACAATTAATC 
P20 TGCGTTTGATATCGAGCGATCCGCATG
ATAGACGACCCCGCGCTGAACCGAGC
ACGTGTTGACAATTAATC 
Used to delete orf9 gene by insertion of Pcp25 
promoter in front of disD gene 
 
  
Table S2 related to Figure 3. Target screening analysis data of extracts from M. 
xanthus::p15A-dis. 
RT [min] m/z Compound  sum formula 
4.36 335.16205  Ar001-23-2   C 14 H 27 N 2 O 5 S 1  
12.48 384.28846  AS_DK1622_383-1   C 25 H 38 N 1 O 2  
12.48 384.28846  AS_DK1622_383-2   C 25 H 38 N 1 O 2  
5.1 631.27543  Cittilin A   C 34 H 39 N 4 O 8  
12.81 729.37322  Disorazol F2  C 42 H 52 N 2 O 9 
11.58 745.36879  Disorazol A2   C 42 H 53 N 2 O 10  
12.24 759.38345  Disorazol A1   C 43 H 55 N 2 O 10  
12.24 759.38345  Disorazol A3   C 43 H 55 N 2 O 10  
12.24 759.38345  Disorazol A4   C 43 H 55 N 2 O 10  
7.77 779.37324  Disorazol B2   C 42 H 55 N 2 O 12  
9.49 761.36162  Disorazol B4   C 42 H 53 N 2 O 11  
10.04 763.37894  Disorazol 762  C 42 H 54 N 2 O 11 
7.44 519.25799  DKxanthen-518   C 29 H 35 N 4 O 5  
7.8 519.25783  DKxanthen-518   C 29 H 35 N 4 O 5  
7.18 535.25311  DKxanthen-534   C 29 H 35 N 4 O 6  
7.54 535.25281  DKxanthen-534   C 29 H 35 N 4 O 6  
8.07 549.26825  Dkxanthen-548   C 30 H 37 N 4 O 6  
3.56 183.09128  Marinoquinoline A   C 12 H 11 N 2  
5.36 225.13794  Marinoquinoline B   C 15 H 17 N 2  
5.84 259.12181  Marinoquinoline C   C 18 H 15 N 2  
2.55 197.12852  Mediacompound-Amb-001   C 10 H 17 N 2 O 2  
3.56 245.12887  Mediacompound-Amb-002   C 14 H 17 N 2 O 2  
4.01 245.12862  Mediacompound-Amb-003   C 14 H 17 N 2 O 2  
3.51 211.14406  Mediacompound-Amb-004   C 11 H 19 N 2 O 2  
13.01 416.31467  Myxalamid A   C 26 H 42 N 1 O 3  
12.59 402.2989  Myxalamid B   C 25 H 40 N 1 O 3  
11.84 388.28299  Myxalamid C   C 24 H 38 N 1 O 3  
13.83 430.33012  Myxalamid-430   C 27 H 44 N 1 O 3  
5.4 405.16444  Myxochelin A   C 20 H 25 N 2 O 7  
3.93 404.18101  Myxochelin B   C 20 H 26 N 3 O 6  
13 624.4456  Myxovirescin A   C 35 H 62 N 1 O 8  
12.73 622.42858  Myxovirescin B   C 35 H 60 N 1 O 8  
16.86 632.44647  Myxovirescin C   C 35 H 63 N 1 Na 1 O 7  
11.03 642.45472  Myxovirescin Variante KP641   C 35 H 64 N 1 O 9  
2.3 261.12324  Tyr-Pro Dioxopiperazin   C 14 H 17 N 2 O 3  
2.41 261.1234  Tyr-Pro Dioxopiperazin   C 14 H 17 N 2 O 3  
 
The shadow part are disorazol and its derivatives (in bold in the table). 
 
  
Table S3 related to Figure 3. NMR data for disA2 comparison with the natural 
product. 
 
pos δH, mult (J in Hz) Disorazol1 A2 δH, mult (J in Hz) Disorazol2 A2 
3-H 8.34, s br 8.42, s 
5-H 6.18, d br (11.7) 6.17, d (11.9) 
6-H 6.47, dd (11.7, 11.9) 6.41, m 
7-H 7.36, dd (11.9, 15) 7.16, dd (11.4, 14.7) 
8-H 5.71, m 5.75, m 
9-H 3.66, dd (4.2, 9.9) 3.64, dd (4.4, 9.9) 
10-H 4.06, dd (4.2, 9.7) 3.96, dd (4.2, 10.0) 
11-H 5.34, dd (9.7, 11.5) 5.28, dd (9.0, 11.2) 
12-H 5.86, ddd (5.5, 11, 11) 5.77, m 
13-Ha 2.88, m 2.71, m 
13-Hb 2.46, ddbr 2.43, dd (3.2, 14.6) 
14-H 5.35, dd (2.5, 11) 5.15, m 
16-H 3.88, d (7.5) 3.73 
17-H 5.64, m 5.74, m 
18-H 5.71, m 5.15, m 
19-H3 1.74, d (1, 6) 1.65 
20-H3 1.07a, s 0.94a, s 
21-H3 1.03a, s 0.93a, s 
3’-H 8.49, s 8.62, s 
5’-Ha 3.11, dd (5.4, 14.9) 2.95, dd (6.0, 14.7) 
5’-Hb 2.65, dd (3.8, 14.9) 2.43, dd (3.3, 14.4) 
6’-H 4.42, m 4.66, m 
7’-H 5.88, dd (9, 15.1) 5.93, dd (9.4, 12.0) 
8’-H 6.43, dd (11, 15.1) 6.39, m 
9’-H 6.01, dd (11, 11) 6.17, d (11) 
10’-H 6.37, dd(11, 11) 6.36, m 
11’-H 6.48, dd(11, 11) 6.40, m 
12’-H 5.55, ddd (5.5, 11, 11) 5.54, m 
13’-Ha 2.88, m 2.72, m 
13’-Hb 2.36, m 2.26, m 
14’-H 5.35, dd (2.5, 11.6) 5.15, m 
16’-H 3.88, d (7.5) 3.72, m 
17’-H 5.64, m 5.54, m 
18’-H 5.71, m 5.50, m 
19’-H3 1.74, d 1.65 
20’-H3 1.02b, s 0.85b, s 
21’-H3 1.01b, s 0.87b, s 
1NMR data taken in MeOH-d4, 2 DMSO-d6 a,b overlapping signals. 
 
 
Table S4 Proteins encoded on the recovered plasmid pTn-Rec_IE-2 and their putative 
function in disorazol biosynthesis (data according to Kopp et al.) 
 
Gene Size (bp) Proposed function of the similar protein Similarity/ Identity 
orf1’ 522 arylesterase-related protein 29%/ 43% 
orf2’ 591 SAM- dependent methyl transferase 48%/ 58% 
orf3’ 1284 putative esterase β-lactamase 35%/ 51% 
orf4’ 1782 adenylate cyclase 31%/ 51% 
orf5’ 854 outer membrane protein (incomplete) 36%/ 46% 
 
 
 
 
 
 
 
 
  
Genetic inactivation of the disorazol biosynthetic genes 
As mentioned earlier, ten PKS modules and one NRPS module are encoded in the 
genes disA-C in the conserved disorazol biosynthetic gene cluster. To confirm that 
disA-C is involved in the biosynthesis of disorazol, the module was inactivated by 
disrupting the gene, including the PKS modules 1 and 5 and the NRPS module, on the 
p15A-dis expression construct (Figure 1). A 1100 bp fragment conferring 
chloramphenicol resistance (cm) to the linker region between these modules was 
separately inserted into the p15A-dis construct by homologous recombination in E. 
coli. The modified deletion constructs pDisA, pDisB and pDisC were screened using 
low-salt LB plates plus chloramphenicol and then verified by restriction analysis 
(Table S1). The successfully modified constructs were then transformed into M. 
xanthus DK1622, and the production profile of positive recombinants was analyzed 
by HPLC-MS (Figure S6-I). 
The mutant strains no longer produced disorazols. The missing peaks indicate that 
all these modules and genes are vital for the disorazol biosynthetic pathway. Without 
any one of these genes, no disorazols are produced. It is, however, still possible that 
the significant changes in the cluster architecture that were caused by the gene 
inactivation may have affected the expression of the biosynthetic enzymes (Figure 
S6-II). 
  
Biological evaluation  
Cell lines were obtained from the German Collection of Microorganisms and Cell 
Cultures (Deutsche Sammlung für Mikroorganismen und Zellkulturen, DSMZ) or 
were part of our internal collection and were cultured under conditions recommended 
by the depositor. Half-inhibitory concentrations (IC50) in terms of growth inhibition 
were determined as described previously1. In brief, cells were treated in 96-well plates 
with serial dilutions of disorazol A1 and A2 for 5 d. Cell viability was assessed via 
tetrazolim salt reduction and average IC50 values were obtained in two independent 
experiments by sigmoidal curve fitting.  
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Room temperature 
electrocompetent bacterial cells 
improve DNA transformation and 
recombineering efficiency
Qiang Tu1,2,4,*, Jia Yin1,3,4,*, Jun Fu1,3, Jennifer Herrmann2, Yuezhong Li1, Yulong Yin4, 
A. Francis Stewart3, Rolf Müller2 & Youming Zhang1
Bacterial competent cells are essential for cloning, construction of DNA libraries, and mutagenesis in 
every molecular biology laboratory. Among various transformation methods, electroporation is found 
to own the best transformation efficiency. Previous electroporation methods are based on washing 
and electroporating the bacterial cells in ice-cold condition that make them fragile and prone to death. 
Here we present simple temperature shift based methods that improve DNA transformation and 
recombineering efficiency in E. coli and several other gram-negative bacteria thereby economizing time 
and cost. Increased transformation efficiency of large DNA molecules is a significant advantage that 
might facilitate the cloning of large fragments from genomic DNA preparations and metagenomics 
samples.
Usage of various competent cells in different molecular biology techniques such as cloning, amplification of plas-
mid DNA, construction of genomic libraries, gene expression, and mutagenesis are the routine procedures in each 
laboratory. Most commonly and extensively used bacterial strain is the Gram-negative bacterium Escherichia coli 1,2.
E. coli cells can be made competent by washing with divalent cations such as Ca2+ at 0 °C or under ice-cold 
conditions3,4. However, such metal ion liquids washed competent cells would have lower transformation effi-
ciency than using the electroporation method. In the electroshock methods (electroporation transformation), 
high-voltage pulse treated E. coli cells become exceptionally competent after washing with ice-cold 10% glycerol 
or water4–8. The high voltage causes the cellular membrane to be transiently permeabilized, allowing the foreign 
material to enter into the cells9. High efficient electrocompetent cells are mainly used in library construction, 
mutagenesis and recombineering10. Protocols for electroporating Gram-negative bacteria including E. coli have 
already been described by many researchers4–6,9,11,12. Generally, cells are grown up to a suitable density, harvested, 
and followed by a series of washes to remove culture medium. Several factors have been identified to cause poten-
tial impact on the efficiency of electroporation transformation process. These factors include the electrical field 
strength, pulse decay time, pulse shape, temperature, type of cell, type of suspension buffer, concentration and 
size of the nucleic acid to be transferred9,13. According to the methods reported earlier, electrocompetent cell 
preparation have to be performed at ice-cold temperature and the equipment and washing solutions have to be 
maintained at the same temperature as well14–16.
Recombineering is now an alternative technology for conventional recombinant DNA engineering, a unique 
tool for large size DNA engineering, as well as the most appealing method of choice for bacterial genome engi-
neering17,18. There are two main recombineering activities: one is based on linear plus circular homologous 
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recombination (LCHR) initiated by the Red operon from λ phage19, and the other is the linear plus linear homol-
ogous recombination (LLHR) which is initiated by RecE/RecT from Rac phage17. LCHR is mainly applied to 
engineer plasmids which includes Bacterial Artificial Chromosome (BAC) while LLHR is primarily applied to 
linear DNA cloning (PCR cloning)20 and direct cloning17. Direct cloning is a shortcut for cloning of a large DNA 
fragments from genomic DNA without library construction and screening. For accomplishing the direct cloning, 
the DNA segment of interest should meet the linear cloning vector in one cell and then recombine each other. 
Therefore, the transformation efficiency and homologous recombination efficiency in the RecET proficient cells 
become the major limitation.
Keeping the cells cold was the pivotal point in the most of the protocols for electroporating Gram-negative 
bacterial strains including E. coli but there was no detailed explanations why this is important16. However, an 
improved transformation efficacy in the pathogen Pseudomonas aeruginosa when cells were washed at room 
temperature (RT) had previously been reported21. We surprisingly discovered that electrocompetent cells could 
be prepared at room temperature so that the cooling steps would be omitted. This was really astonishing because 
the conventional preparation method of electrocompetent cells for Gram-negative bacteria must be performed 
at 4 °C or preferably at 0– 2 °C. Additionally, we found that the efficiency of direct cloning which was mediated by 
RecET recombineering would be dramatically improved by using the electrocompetent cells prepared at room 
temperature (named as room temperature competent cells). This astonishing discovery permitted the preparation 
and distribution of electrocompetent cells at a higher temperature. Here we present a novel DNA transforma-
tion method that is simplified, fast, efficient, convenient, and cost effective. This simple procedure does not only 
improves electroporation transformation efficiency in E. coli but also has implications for other bacterial hosts, 
e.g. Agrobacterium22, Burkholderia13, Photorhabdus23 and Xenorhabdus23.
Results
Effect of temperature shift on electrocompetent cells. It was inconvenient to maintain low tem-
perature conditions for preparation, storage and transport of the electrocompetent cells. We intended to test the 
transformation efficiency of the electrocompetent cells prepared at room temperature. A large plasmid pGB-amp-
Ptet-plu1880 (27.8 kb) was transformed into E. coli GB2005 strain17,24 at various temperature. The warm electro-
competent cells showed 10 times higher transformation efficiency than the cold electrocompetent cells (Fig. 1a). 
After placing the cold electrocompetent cells at room temperature for 15 minutes, the transformation efficiency 
increased by 5 folds (Fig. S1a). In contrast, after the room temperature electrocompetent cells were placed on ice 
for 15 minutes before electroporation, there was a significant decrease in transformation efficiency (Fig. S1b).
The room temperature in our laboratory was set at 24 °C. To determine the range of optimum temperature for 
the preparation of competent cells, we prepared the cells at different temperature ranges and revealed that the best 
temperature for electrocompetent cell preparation was in the range of 24°–28 °C (Fig. S2).
Effect of different plasmids on electrocompetent cells. Plasmids were varied in the size, selection 
marker and origins of replication. Initially we tested three plasmids with different sizes. Two of them were p15A 
origin plasmids with ampicillin (amp) or chloramphenicol (cm) resistance. Another one was a pBR322 origin 
based plasmid with ampicillin resistance. All the plasmids gained higher transformation efficiency with room 
temperature electrocompetent cells (Fig. 1b, column 1–3). We also tested BAC vectors with different size and 
selection markers. All BACs gained higher transformation efficiency when room temperature electrocompetent 
E. coli GB2005 cells were used (Fig. 1b, column 4–6). These results indicated that for electrocompetent transfor-
mation, room temperature electrocompetent cells were more efficient than cold electrocompetent cells irrespec-
tive of their size, selection marker and origins of replication. Therefore the room temperature electrocompetent 
cells could be a better candidate for gene cloning, construction of DNA libraries and mutagenesis than cold 
electrocompetent ones.
Effect of different strains on electrocompetent cells. The E. coli GB2005 was an optimized strain 
for plasmid transformation and propagation17,25. Along with this strain, several other commonly used E. coli 
strains were also tested for room temperature transformation as well. Results revealed that although different 
E. coli strains varied in their relative transformation efficiencies, all of them exhibited higher transformation 
efficiency when their electrocompetent cells were prepared at room temperature (Fig. 1c). We also tested the 
improving approach in a few of other Gram-negative bacterial strains. Burkholderia glumae PG1 was an industrial 
strain for detergent lipidase production26, which could also be the heterologous host used for PKS/NRPS gene 
clusters expression (unpublished data). An oriV origin plasmid pRK2-apra-kan based on plasmid pBC30127,28, 
was utilized for transformation. When PG1 competent cells were prepared at room temperature, the electropo-
ration efficiency of RK2 plasmid was around three times higher than the cells prepared on ice (Fig. S3a). Other 
Gram-negative bacterial strains, such as Agrobacterium22, Burkholderia13, Photorhabdus23 and Xenorhabdus23, 
were tested for RK2 plasmid transformation by using room temperature and cold temperature protocols. All the 
results indicated that room temperature competent cells had higher transformation efficiency than cold compe-
tent cells (Fig. S3b).
Improvement of recombineering by using room temperature electrocompetent cells. 
The plasmid transformation efficiency significantly increased by room temperature electrocompetent cells was 
not the destination. It was necessary to evaluate the improvement of the room temperature protocol on lambda 
Red or Rac RecET mediated recombineering. A simple assay using a PCR product of linear vector (p15A ori plus 
cm or pBR322 ori plus cm) and a PCR product with kanamycin (kan) was built to test LLHR efficiency17. E. coli 
strain GB05-dir with recET on its chromosome was used for LLHR test25. The results showed that LLHR in room 
temperature competent cells was 6–10 times more efficient than the cells prepared on ice. Both p15A origin and 
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pBR322 origin plasmids gained the same fold increase (Fig. 2a,b). A direct cloning experiment to fish out the 
thailandepsin gene cluster (~39 kb) from Burkholderia thailandensis had been performed, around 150 colonies 
were obtained by using cold electrocompetent cells, but by using room temperature electrocompetent cells more 
than 600 colonies were obtained. This improvement leads to a higher chance to clone large DNA fragments from 
genomic DNA pools directly.
PCR cloning is a routine exercise in every molecular biology laboratory20. It is thus our interest to find out an 
easy and inexpensive way to clone PCR products. Since the electrocompetent cells prepared at room tempera-
ture improves the LLHR efficiency around 10 folds, it is essential to find out the minimum homology sequences 
needed for LLHR. Previously, we identified 20 bp as the minimum length of sequence homology required for 
recombineering29,30. To test whether the minimal length could be further shortened, pBAD24 vector was digested 
with EcoR I/Hind III as linear recipient, and PCR product cassette (Tn5-neo) flanked with short homology arms 
to the ends of digested pBAD24 vector was used as linear donor fragment (Fig. S4). Seven PCR products with 
different sizes of homology arms (HA) were designed to test the LLHR efficiency. Results revealed that only 8 bp 
of terminal homology was sufficient via room temperature protocol (Fig. S5). When ice-cold cells were used, the 
minimum homology arms required for recombineering were found 12 bp. These data indicated that LLHR might 
be used to generate a kit for PCR product or small DNA fragment cloning by using homology arms as short as 8 bp.
In contrast to the LLHR experiment, LCHR efficiency was not increasing in the room temperature protocol 
when compared to the cold protocol (Fig. 2c). However, we discovered that LCHR efficiency would be signifi-
cantly raised when freshly prepared cold electrocompetent cells were placed at room temperature for 3 minutes 
(Fig. 2d), suggesting that transient swelling of the cells had a beneficial effect.
Figure 1. Transformation efficiency of competent cells. (a) Effect of temperature, E. coli GB2005 cells 
transformed by ~0.1 μg of pGB-amp-Ptet-plu1880 (27.8 kb) were plated on Amp plates. 1, the normal ice-
cold method for preparing electrocompetent cells; 2, as for 1 but the cells were kept on ice for 15 min before 
electroporation; 3, as for 1 but the cells were placed at room temperature (RT) for 15min before electroporation; 
all cuvettes were used at RT; 4, every step was done at RT; 5, no plasmid DNA. (b) RT prepared cells were 
transformed with different plasmids. 1, pBR322 origin with ampicillin resistance (27.8 kb); 2, p15A origin 
with chloramphenicol resistant (54.7 kb); 3, p15A origin with ampicillin resistance (54.7 kb); 4, BAC with 
chloramphenicol resistant (>120 kb); 5, BAC with kanamycin resistant (91.7 kb); 6, BAC with ampicillin 
resistant (91.7 kb). (c) Different E. coli strains tested for electroporation transformation. Cells were transformed 
by 0.1 μg of pGB-amp-Ptet-plu1880 and plated on Amp plates. Error bars, SD; n = 3.
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Stability of room temperature electrocompetent cells. Normally, after 2.5–3.0 hours cultivation at 
37 °C, E. coli GB2005 reached OD600 0.4–0.6 which was in the log phase, the period with the best transformation 
efficiency of the cells. When bacterial cells were overgrown, the transformation efficiency dropped down (Fig. S6a), 
and the transformation efficiency of the cold electrocompetent cells was completely lost after 4 hours or 6 hours 
(only 18 and 5 colonies respectively) (Fig. S6a). But room temperature electrocompetent cells still kept relatively 
high efficiency even after 4 or 6 hours cultivation. E. coli GB2005 cultured for 4 hours at 37 °C reached OD600 
1.0 ~ 1.2 and cultured for 6 hours reached OD600 > 1.8 which was at the plateau phase. It was noteworthy that 
over-grown or even overnight cultured bacterial cells could still be used for transformation when room tempera-
ture protocol was used for preparing competent cells.
To predigest the transformation process, we had tested whether the recovery step could be omitted. For simple 
plasmid transformation, the recovery step could be omitted when the electrocompetent cells were prepared by 
using room temperature protocol (Fig. S6b). Although the transformation efficiency in the un-recovery room 
temperature group was around 30% less than in the recovery room temperature group, it was still at least 5 times 
higher comparing to the cold temperature group, either recovery or not. Results suggested that plasmid or ligation 
transformation could be performed in a few minutes after electroporation by using room temperature competent 
cells. Previous results concluded that the room temperature electrocompetent cells had much better transforma-
tion efficiency than cold electrocompetent cells. Furthermore we wanted to know how long the competent cells 
could stay at room temperature without any significant loss of transformation efficiency. Results showed that 
room temperature competent cells lost around 30% efficiency after 1 hour storage at room temperature, around 
60% lost after 4 hours and around 80% lost after one day (Fig. S7). These results indicated that the room temper-
ature competent cells lost their transformation efficiency to the maximum when stored in room temperature 
more than one day. To avoid this efficiency loss, room temperature competent cells were prepared by using 10% 
glycerol11 and dried by vacuum and stored at 4 °C till three days. Result showed that dried room temperature com-
petent cells prepared in 10% glycerol lost their 55% efficiency as compared to the room temperature competent 
cells without dry (Table S2). But interestingly, the dried competent cells prepared in 10% glycerol could keep the 
LLHR efficiency up to 3 days without any further efficiency loss (Table S3). This ability gives us an opportunity in 
the future to deliver the competent cells in routine cooling pack, which is easier and cost effective.
Electron microscopy analysis of competent cells. To find the reasons of higher efficiency in room 
temperature protocol, electron microscopy was used for comparative analysis of the morphological shapes of cold 
competent cells and room temperature competent cells of E. coli. Their comparative analysis showed that cold 
competent cells appeared to shrink more than room temperature cells, and the surface of room temperature com-
petent cells was found smoother (Fig 3a–d). Shrunken cells might be more difficult to transform, and the bacterial 
cell membrane and wall could be more permeable for foreign DNA entry at a higher temperature. Additionally, it 
may be difficult for the shrunken cells to form pores that allow DNA transfer through the cell membrane under 
Figure 2. Recombineering using room temperature electrocompetent cells. (a) Colony number of a standard 
LLHR assay17 in GB05-dir from the normal and the cold method in E. coli. (b) As for A, but with pBR322 origin. 
(c) As for A, but with a standard LCHR assay in GB05-red. (d) The electrocompetent cells were prepared on ice 
first. After adding PCR product kan cassette into the ice-cold electrocompetent cells, the cells plus DNA mixture 
were shifted to RT for 3 minutes before electroporation (middle column). CT, Cold temperature; RT, Room 
temperature. Error bars, SD; n = 3.
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electroporation conditions, and after electroporation most of the cold competent cells were found to be lysed. 
(Fig. 3e,f). From this we assume that the bacterial cell membrane/cell wall might have better permeability for 
foreign material to enter into the cell.
Discussion
The ability to introduce exogenous DNA molecules into the cells plays key role in the development of molecu-
lar biology techniques, such as mutagenesis and genetic engineering of microorganisms. Several methods have 
been reported to introduce exogenous DNA molecules into the cells which includes chemical treatment, elec-
troporation, utilization of a biolistic gun, polyethylene glycol, ultrasound, microwave, and hydrogel31. In those 
methods, electroporation has been often demonstrated to be more efficient and convenient way to transform a 
large number of microorganisms used for genetic studies32, and many efforts have been performed to increase its 
efficiency33–36.
The phage-derived homologous recombination systems have been developed into very useful DNA engineer-
ing technologies, well known as recombineering which has also been performed in electrocompetent cells10,20. 
This suggests that a crucial step in recombineering is the transformation of E. coli by electroporation.
In conventional electroporation transformation, the electrocompetent cells were prepared on ice and the other 
supplies were also in cold environment, including pre-chilled cuvette, buffer, and centrifuge. The cells must be 
repeatedly washed before electroporation to remove conductive solutes. If the conductivity of a cell mixture is 
too high, then arcing will occur during electroporation, which will ruin the experiment. The washing process 
can elicit a stress response that can lead to decrease in transformation efficiency. If the cells are kept at 4 °C then 
they are inactive and this stress response is prevented. However, current studies reveals that the electroporation 
transformation efficiency is decreased at ice-cold temperature (Fig. 1). This decreased efficiency might be due to 
ice cold temperature which alters the cell membrane topology. The cell membrane mainly consists of phospho-
lipids and proteins37 and the phospholipid bilayer forms a stable barrier between two aqueous compartments. 
Embedded proteins of phospholipid bilayer carry out the specific functions of the plasma membrane, including 
the selective transportation of molecules across the membrane and cell-cell recognition38. At ice-cold tempera-
ture, the fatty acid tails of the phospholipids become more rigid. This affects the fluidity, permeability, and the 
cell’s ability to live39. Therefore, cold temperatures may be not favourable for the survival and thus decreases the 
transformation efficiency. Additionally, during electroporation process due to externally applied electric field 
there is a significant increase in the permeability of cell’s plasma membrane , which is used to introduce exog-
enous DNA into bacterial cell32. Previous reports revealed that if the environmental conditions were changed, 
including the temperature, the cell membranes undergoes a gross morphological changes40. These structural per-
turbations were associated with characteristic disturbances of functions such as loss of selective permeability. 
Similar results were observed in this study that cold competent cells were appeared to shrink more than room 
temperature cells, and additionally more cold competent cells were found lysed after electroporation (Fig. 3).
The temperature effects on electroporation transformation could be explained by thermal effects during elec-
tro pore formation41–43. According to the electroporation theory, hydrophobic pores in the cell membrane were 
formed spontaneously by lateral thermal fluctuations of the lipid molecules39, which suggested that hydrophobic 
pores formation would be enhanced by increased temperature conditions. To improve recombination efficiency 
many parameters had been described previously17,44,45 except the transformation efficiency. This study showed 
that LLHR efficiency in room temperature competent cells was higher than in the same cells prepared on ice 
(Fig. 2a,b), but the room temperature protocol did not increase LCHR efficiency when compared to the cold 
protocol (Fig. 2c). The Red recombinases (Red alpha and beta) might be not stable while preparing the competent 
cells at room temperature.
In conclusion, this study reports an unexpected finding, that is contrary to common assumption, that it is 
better to prepare bacterial cells at room temperature than on ice for electroporation. In addition, this study also 
Figure 3. Phenotypes of the cells by room temperature and cold protocols and also electroporated the cells 
for subsequent analysis by electron microscopy. (a–d): micrograph of the cells washed with cold and room 
temperature protocols with different magnications. (e–f): micrograph of the electroporated cells mixture with 
episomal insertion DNA.
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shows that this is not only efficient for E. coli but also for several other gram-negative and gram-positive hosts. 
However, further research will be essential to confirm the transfer and principle of membrane in competent cells.
Methods
Strains, plasmids and reagents. The bacterial strains and plasmids used in this study were listed in Table S1. 
The antibiotics were purchased from Invitrogen. E. coli, Agrobacterium, Photorhabdus and Xenorhabdus were 
cultured in Luria–Bertani (LB) broth or on LB agar plates (1.2% agar) with ampicillin [amp] (100 μg/mL), kana-
mycin [kan] (15 μg/mL) or chloramphenicol [cm] (15 μg/mL) as required. Burkholderia glumae PG1 was cultured 
in MME medium (5 g/L K2HPO4, 1.75 g/L Na(NH4)HPO4 × 4H2O, 1 g/L Citrate, 0.1 g/L MgSO4 × 7 H2O, 8 g/L 
Glucose, pH7.0). Burkholderia DSM7029 was cultured in CYCG medium (6g/L Casitone, 1.4 g/L CaCl2 × 2 H2O, 
2 g/L Yeast extract and 20 ml/L Glycerol).
Preparation of electrocompetent cell at cold and room temperature conditions. The elec-
trocompetent cells at cold temperature were prepared according to the protocol established previously in our 
lab46. For electrocompetent cells at room temperature, overnight culture were diluted into 1.4 mL LB medium 
and again cultured at 37 °C at 900 rpm in an Eppendorf ThermoMixer. After 2 hours of incubation when OD600 
was approximately reached up to 0.6, the bacterial cells were centrifuged at 9000 rpm at room temperature 
(24 °C). The supernatant was then discarded and the cells were resuspended in 1 mL of dH2O at room tempera-
ture, and washing step was repeated. The bacterial cells were again resuspended in about 30 μl of dH2O (24 °C) 
and the tubes were placed at room temperature. 300 ng of the each plasmid DNA or PCR products were added 
into the prepared cells. The DNA-cell mixture were then transferred into 1 mm-gap cuvette (24 °C) for electro-
poration at 1250 volts. The cuvette was then flushed with 1 ml fresh medium and the cells were recovered by 
the incubation at 37 °C for 1 hour. In the end, the culture was streaked on the LB plates containing appropriate 
antibiotics.
Preparation of electrocompetent cell to test the effect of different temperature range. E. coli 
GB2005 strain was cultured at 37 °C till OD600 was reached at 0.6. The cells were pelleted and washed by dH2O 
at different temperature range (2, 15, 20, 22, 24, 26, 28, 30, 32, 34 and 37 °C). The cuvettes were also kept at these 
temperatures. After electroporation with pGB-amp-Ptet-plu1880 plasmid, 1 ml LB was added into the cuvette 
to recover the transformed cells and then incubated at 37 °C. After 1 hour incubation 0.004 μl of cells (diluted by 
fresh LB) were streaked on LB plates containing ampicillin (100 μg/mL). The colonies were counted after 24 hours 
of cultivation.
Recombineering assays. In LCHR assay we used a 2 kb p15A-cm plasmid carrying the chloramphenicol 
resistance gene and a 2 kb kan-PCR product carrying the kanamycin resistance gene. Each end of the kan-PCR 
product had a 50-bp homology arm to the p15A-cm plasmid between the chloramphenicol gene (cm) and the 
p15A origin. The circular plasmid (200 ng) and the PCR product (200 ng) were co-electroporated into E. coli 
GB2005 expressing the lambda Red recombinase to generate the chloramphenicol plus kanamycin-resistant plas-
mid p15A-cm-kan (4 kb). The expression plasmid was pSC101-BAD-gbaA-tet. The recombinants were selected 
on LB plates with double antibiotic selection.
One of LLHR assays was just like above mentioned setup except the p15A-cm plasmid was linearized 
between the two 50-bp homology arms. The linear plasmid backbone (200 ng) and the kan-PCR product 
(200 ng) were co-electroporated into E. coli GB2005 expressing the recET recombinase to generate the plas-
mid p15A-cm-kan. Another LLHR assay used EcoR I and Hind III digested 4.5 kb pBAD24 plasmid (450 ng) 
and 1,7 kb Tn5-neo PCR (170 ng) to generate the ampicillin plus kanamycin-resistant plasmid pBAD24-neo 
(6.2 kb). The expression plasmid was pSC101-BAD-ETgA-tet. The recombinants were selected on LB plates 
with double antibiotic selection.
Both kan-PCR and Tn5-neo-PCR were amplified from suicide R6K plasmid to avoid the selection background 
from the carryover of the PCR template (any residual circular plasmid). The negative control with DNA elec-
troporation into uninduced cells was done to indicate the sufficient selection pressure. After colony counting, 
8 clones from each of the triplicate experiments were picked up for plasmid DNA preparation and restriction 
analysis to prove the successful accomplishment of the recombineering experiment.
Preparation of dried room temperature electrocompetent cell. The electrocompetent cells were 
washed twice with dH2O or 10% glycerol at room temperature, cells were pelleted once again and remaining 
dH2O or 10% glycerol was removed by pipetting. Cell pellet was dried under the vacuum for 30 min and stored at 
4 °C. For transformation, dried cells were resuspended in 25 μL dH2O (without glycerol) at room temperature and 
DNA was added into the cells. Cells and DNA were electroporated at 1250 v by using 1 mm-gap electroporation 
cuvette and Eppendorf electroporator as usual.
Cells preparations for Electron Microscope. E. coli cells were harvested by centrifugation and were 
fixed in 2% paraformaldehyde/1% glutaraldehyde for 20 min at room temperature. After repeated washing with 
ultrapure water the cell pellet was resuspended and a small aliquot of the samples in water was placed on a sili-
cium waver and was dried under ambient conditions. Next, the E. coli cells were investigated with secondary 
electrons under high-vacuum conditions in an ESEM type FEI Quanta400 FEG at 5 kV accelerating voltage.
References
1. Cohen, S. N., Chang, A. C. Y. & Hsu, L. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli 
by R-Factor DNA. Proc. Natl. Acad. Sci. USA 69, 2110–2114 (1972).
2. Cohen, S. N., Chang, A. C., Boyer, H. W. & Helling, R. B. Construction of biologically functional bacterial plasmids in vitro. Proc. 
Natl. Acad. Sci. USA 70, 3240–3244 (1973).
www.nature.com/scientificreports/
7Scientific RepoRts | 6:24648 | DOI: 10.1038/srep24648
3. Hanahan, D. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166, 557–580 (1983).
4. Hanahan, D., Jessee, J. & Bloom, R. B. Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol. 204, 63–113 
(1991).
5. Dower, W. J., Miller, J. F. & Ragsdale, C. W. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids 
Res. 16, 6127–6145 (1988).
6. Fiedler, S. & Wirth, R. Transformation of bacteria with plasmid DNA by electroporation. Anal. Biochem. 170, 38–44 (1988).
7. Taketo, A. DNA transfection of Escherichia coli by electroporation. Biochim. Biophys. Acta 949, 318–324 (1988).
8. Sambrook, J. & Rusell, D.W. Molecular Cloning: A Laboratory Manual. 3rd ed, Vol. 1 & 3 (Cold Spring Harbor Laboratory Press, New 
York, 2001).
9. Andreason, G. L. & Evans, G. A. Introduction and expression of DNA molecules in eukaryotic cells by electroporation. Biotechniques 
6, 650–660 (1988).
10. Zhang, Y., Buchholz, F., Muyrers, J. P. P. & Stewart, A. F. A new logic for DNA engineering using recombination in Escherichia coli. 
Nat. Genet. 20, 123–128 (1998).
11. Nikoloff, J.A. Animal cell electroporation and electrofusion protocols. Methods in molecular biology, Vol. 48 (Humana Press, Totowa, 
New Jersey, 1995).
12. Harlander, S.K. Transformation of Streptococcus lactis by electroporation. In: Ferretti J. J., Curtiss III R. (eds), Streptococcal Genetics, 
pp 229–233 (ASM Press, Washington DC, 1987).
13. Oka M. et al. Glidobactins A, B and C, new antitumor antibiotics. II. Structure elucidation. J. Antibiot. 41, 1338–1350 (1988).
14. Aune, T. E. V. & Aachmann, F. L. Methodologies to increase the transformation efficiencies and the range of bacteria that can be 
transformed. Appl. Microbiol. Biot. 85, 1301–1313 (2010).
15. Yoshida, N. & Sato, M. Plasmid uptake by bacteria: a comparison of methods and efficiencies. Appl. Microbiol. Biot. 83, 791–798 
(2009).
16. Chassy, B. M. & Flickinger, J. L. Transformation of Lactobacillus casei by electroporation. FEMS Microbiol. Lett. 44, 173–177 (1987).
17. Fu, J. et al. Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting. Nat. 
Biotechnol. 30, 440–446 (2012).
18. Thomason, L. et al. Recombineering: genetic engineering in bacteria using homologous recombination. Curr. Protoc. Mol. Biol. 
Section V. 1 16.1–1.16.24 (2007).
19. Maresca, M. et al. Single-stranded heteroduplex intermediates in lambda Red homologous recombination. BMC Mol. Biol. 29, 11–54 
(2010).
20. Zhang, Y., Muyrers, J. P. P., Testa, G. & Stewart, A. F. DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol. 
18, 1314–1317 (2000).
21. Liang, R. & Liu, J. Scarless and sequential gene modification in Pseudomonas using PCR product flanked by short homology regions. 
BMC Microbiol. 10, 209–209 (2010).
22. Hu, S. et al. Genome engineering of Agrobacterium tumefaciens using the lambda Red recombination system. Appl. Environ. 
Microbiol. 98, 2165–2172 (2014).
23. Yin, J. et al. A new recombineering system for Photorhabdus and Xenorhabdus. Nucleic Acids Res, 43 (6), e36 (2015).
24. Bian, X., Plaza, A., Zhang, Y. & Müller, R. Luminmycins A–C, cryptic natural products from Photorhabdus luminescens identified by 
heterologous expression in Escherichia coli. J. Nat. Prod. 75 (9), 1652–1655 (2012)
25. Bian, X. et al. Direct cloning, genetic engineering, and heterologous expression of the syringolin biosynthetic gene cluster in E. coli 
through Red/ET recombineering. ChemBioChem 13, 1946–1952 (2012).
26. Frenken, L. G. et al. Cloning of the Pseudomonas glumae lipase gene and determination of the active site residues. Appl. Environ. 
Microbiol. 58, 3787–3791 (1992).
27. Xiang, C., Han, P., Lutziger, I., Wang, K. & Oliver, D. A mini binary vector series for plant transformation. Plant Mol. Biol. 40, 
711–717 (1999).
28. Yang. Functional Modulation of the Geminivirus AL2 Transcription Factor and Silencing Suppressor by Self-Interaction. J. Virol. 81, 
11972–11981 (2007).
29. Erler, A. et al. Conformational adaptability of Redβ during DNA annealing and implications for its structural relationship with 
Rad52. J. Mol. Biol. 391, 586–598 (2009).
30. Yin, J. et al. Direct cloning and heterologous expression of the salinomycin biosynthetic gene cluster from Streptomyces albus 
DSM41398 in Streptomyces coelicolor A3(2). Sci. Rep. 5, 15081 (2015).
31. Singh, M., Yadav, A., Ma, X. & Amoah, E. Plasmid DNA Transformation in Escherichia Coli. Effect of Heat Shock Temperature, 
Duration, and Cold Incubation of CaCl2 Treated Cells. International Journal of Biotechnology and Biochemistry 6, 561–568 (2010).
32. Miller, J. F., Dowert, W. J. & Tompkins, L. S. High-voltage electroporation of bacteria: genetic transformation of Campylobacter 
jejuni with plasmid DNA. Proc. Natl. Acad. Sci. USA 85, 856–860 (1988).
33. Nováková, J., Izsáková, A., Grivalský, T., Ottmann, C. & Farkašovský, M. Improved method for high-efficiency electrotransformation 
of Escherichia coli with the large BAC plasmids. Folia Microbiol. 59, 53–61 (2014).
34. Cui, B., Smooker, P. M., Rouch, D. A. & Deighton, M. A. Enhancing DNA electro-transformation efficiency on a clinical 
Staphylococcus capitis isolate. J. Microbiol. Meth. 109, 25–30 (2015).
35. Welker, D. L., Hughes, J. E., Steele, J. L. & Broadbent, J. R. High efficiency electrotransformation of Lactobacillus casei. FEMS 
Microbiol. Lett. 362, 1–6 (2015).
36. Ma, Z., Liu, J., Shentu, X., Bian, Y. & Yu, X. Optimization of electroporation conditions for toyocamycin producer Streptomyces 
diastatochromogenes 1628. J. Basic Microb. 54, 278–284 (2014).
37. Singer, S. J. The structure and function of membranes—A personal memoir. J. Membrane Biol. 129, 3–12 (1992).
38. GM, C. Structure of the Plasma Membrane. 2 edn, ( Sinauer Associates, 2000).
39. Kandušer, M., Šentjurc, M. & Miklavčič, D. The temperature effect during pulse application on cell membrane fluidity and 
permeabilization. Bioelectrochemistry 74, 52–57 (2008).
40. Quinn. A lipid-phase separation model of low-temperature damage to biological membranes. Cryobiology 22, 128–146 (1985).
41. Weaver, J. C. & Chizmadzhev, Y. A. Theory of electroporation: A review. Bioelectrochem. Bioenerg. 41, 135–160 (1996).
42. Kotnik, T. & Miklavčič, D. Theoretical evaluation of the distributed power dissipation in biological cells exposed to electric fields. 
Bioelectromagnetics 21, 385–394 (2000).
43. Pavlin, M., Kotnik, T., Miklavčič, D., Kramar, P. & Maček Lebar, A. In Advances in Planar Lipid Bilayers and Liposomes Vol. 6 (ed 
Leitmannova Liu) 165–226 (Academic Press, 2008).
44. Gray, M. & Honigberg, S. M. Effect of chromosomal locus, GC content and length of homology on PCR-mediated targeted gene 
replacement in Saccharomyces. Nucleic Acids Res. 29, 5156–5162 (2001).
45. Cobb, R. E. & Zhao, H. Direct cloning of large genomic sequences. Nat. Biotechnol. 30, 405–406 (2012).
46. Fu, J., Teucher, M., Anastassiadis, K., Skarnes, W. & Stewart, A. F. In Methods in Enzymology Vol. 477 (eds M., Wassarman Paul & M., 
Soriano Philippe) 125–144 (Academic Press, 2010).
www.nature.com/scientificreports/
8Scientific RepoRts | 6:24648 | DOI: 10.1038/srep24648
Acknowledgements
This research was supported by the funding of Y. Z. from the Recruitment Program of Global Experts 
and Shandong Innovation and Transformation of Achievements Grant (2014ZZCX02601) and the 
Program of Introducing Talents of Discipline to Universities (B16030), funding of R.M. from the Deutsche 
Forschungsgemeinschaft (DFG) and the Bundesministerium für Bildung und Forschung (BMBF), funding of 
A. F. S. from the TUD Elite University Support the Best program, funding of J. F. from the International S&T 
Cooperation Program of China (ISTCP 2015DFE32850) and National Natural Science Foundation of China 
(31570094), funding of J. Y. from China/Shandong University International Postdoctoral Exchange Program and 
China Postdoctoral Science Foundation (2015M582081). The authors acknowledge Mr. Nazeer Abbasi’s help in 
proofreading this manuscript and Dr. Marcus Koch for ESEM scanning.
Author Contributions
Q.T. and J.Y. participated in the design of this study, performed data collection analysis, and drafted the 
manuscript; J.F, J.H, Y.L. and Y.Y. participated in interpretation data; A.F.S. and R.M. gave the advice for 
experimental design and discussed the data, also helped in the revision of the final manuscript. Y.Z. designed and 
oversaw the study, performed data interpretation and drafted the manuscript. All authors read and approved the 
final manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Tu, Q. et al. Room temperature electrocompetent bacterial cells improve DNA 
transformation and recombineering efficiency. Sci. Rep. 6, 24648; doi: 10.1038/srep24648 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 Supplemental Information 
Room temperature electrocompetent bacterial cells improve DNA transformation 
and recombineering efficiency 
Qiang Tu, Jia Yin, Jun Fu, Jennifer Herrmann, Yuezhong Li, Yulong Yin, A. Francis Stewart, Rolf 
Müller and Youming Zhang 
 
Inventory of Supplemental Information 
Supplemental data 
Figure S1. Temperature shift effect on the competent cells for transformation. On Page 5. 
Figure S2. Effect of different temperature on electrocompetent cells. On Page 5. 
Figure S3. Transformation efficiency comparison of warm and cold temperature in different 
gram-negative strains. On Page 6. 
Figure S4. Diagram of LLHR by using short homology arms. On Page 7. 
Figure S5. Effect of the length of homology arms on room temperature electrocompetent cells (warm 
cells). On Page 7. 
Figure S6. Effect of over-grown cells on transformation efficiency and electroporation without recovery 
step. On Page 8. 
Figure S7. Stability of room temperature electrocompetent cells stored at room temperature. On Page 8. 
 
Table S1 Strains and plasmids. 
Table S2 Transformation efficiency (colonies on plates with ampicillin (x104)) using cells prepared in 
dH2O or 10% glycerol. On Page 9. 
Table S3 LLHR efficiency (colonies on plates with ampicillin and kanamycin) using cells prepared in 
dH2O or 10% glycerol. On Page 9. 
Supplemental references 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. Temperature shift effect on the competent cells for transformation. (a) GB2005 cells 
transformed by ~0.1µg of pGB-Ptet-plu1880 (27.8kb) and plated on Amp plates. 1 -cells prepared at RT; 
2 -cells prepared on ice; 3 -cells prepared on ice first then left at RT for 2.5min before electroporation; 4 
-same as 3 but at RT for 4min; 5 -same as 4 but at RT for 10min; 6 -same as 3 but at RT for 15min. (b) 1 
-cells prepared at RT; 2 -cells prepared at RT, then placed on ice for 15min before electroporation. Error 
bars, SD; n = 3. 
 
  
 
 
Figure S2. Effect of different temperature on electrocompetent cells. GB2005 cells were transformed 
by ~0.1µg of pGB-Ptet-plu1880 (27.8kb) and plated on Amp plates. Ice to 37oC were used for preparing 
competent cells and electroporation. It shows the results in relative transformation efficiency using the 
transformants at 24°C (room temperature) as standard (100%). Transformants from different temperatures 
were divided by standard to give the relative transformation efficiency. It also shows that significant 
results were obtained by preparing competent cells between 24°C-28°C. This confirms that preparation of 
electrocompetent cells can be made as simple as possible. Error bars, SD; n = 3. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. Transformation efficiency comparison of warm and cold temperature in different 
gram-negative strains. (a) pRK2-apra-km plasmid was used to transform into Burkholderia PG1. The 
transformants were Km resistant. (b) A few bacterial strains: Agrobacterium (G-), Burkholderia 
DSM7029 (G-), Photorhabdus (G-), and Xenorhabdus (G-) were used to perform the transformation 
experiment. Error bars, SD; n = 3. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure S4. Diagram of LLHR by using short homology arms. pBAD24 circle vector digested by EcoR 
I plus Hind III was used as linear recipient vector. The homology sequences are exactly exposed at the 
ends. Tn5-neo PCR product flanked with short homology arms to the ends of digested pBAD24 vector is 
used as linear donor fragment. 
 
 
 
 
 
               
  
 
Figure S5. Effect of the length of homology arms on room temperature electrocompetent cells 
(warm cells). Seven PCR products with different homology arms (HA) were used for testing the LLHR 
efficiency. The homology arms can be as short as 8bp for LLHR to occur when cells were prepared at RT. 
When ice-cold cells used, the minimum homology arms are 12bp. Error bars, SD; n = 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6. Effect of over-grown cells on transformation efficiency and electroporation without 
recovery step. (a) 35µL overnight cultured GB2005 cells were diluted into 1.4mL LB medium and 
cultured at 37°C for different time courses. Electrocompetent cells were transformed by 0.1µg of 
pGB-Ptet-plu1880 and plated on LB plates plus amp. 1 -cells growing for 2.5 hours, OD600=0.4; 2 -cells 
growing for 4 hours, OD600=1.2; 3 -cells growing for 6 hours, OD600=1.8. (b) GB2005 cells 
transformed by 0.1µg of pGB-Ptet-plu1880 and plated on Amp plates. 1 -cells plated directly after 
electroporation; 2 - same as 1 but after 1 hour recovery at 37oC. Error bars, SD; n = 3. 
  
 
Figure S7. Stability of room temperature electrocompetent cells stored at room temperature. The 
room temperature competent cells lost around 30% of efficiency after 1 hour of storage at room 
temperature, 60% after 4 hours and approximately 80% after 1 day. Error bars, SD; n = 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table S1 Strains and plasmids. 
Strain or plasmid Characteristics References or sources 
Strains   
E. coli GB05 F-mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 
∆lacX74 recA1 endA1 araD139 ∆(ara, leu)7697 
galU galK λ rpsLnupGfhuA::IS2 recET redα, phage 
T1-resistent 
1 
E. coli GB05-dir GB2005, araC-BAD-ETγA 2 
E. coli GB05-red GB2005, araC-BAD-γβαA 1 
Burkholderia glumae PG1 lipidase -producing wild-type strain, host for 
heterologous expression of PKS/NRPS gene clusters 
3 
Agrobacterium tumenfaciens gram-positive strain 4 
Burkholderia DSM7029 gram-negative strain 3 
Photorhabdus luminescens gram-negative strain 5 
Xenorhabdus stockiae gram-negative strain 5 
Plasmid   
pGB-amp-Ptet-plu1880 pBR322 replicon, ampR 6 
pRK2-apra-km oriV origin, kmR This study 
pBC301 oriV origin 7,8 
pBeloBAC11-dis BAC, kmR This study 
p15A-cm p15A replicon, cmR 2 
p15A-cm-km p15A replicon, cmR, kmR 2 
pBAD24 pBR322 replicon, ampR 9 
pBAD24-neo pBR322 replicon, ampR, kmR This study 
 
  
Table S2 Transformation efficiency (colonies on plates with ampicillin (x104)) using cells prepared in 
dH2O or 10% glycerol. 
 Cells before dry Dried cells day 0 Dried cells day 1 Dried cells day 3 
dH2O 640 0 0 0 
10% glycerol 468 196 212 188 
 
Table S3 LLHR efficiency (colonies on plates with ampicillin and kanamycin) using cells prepared in 
dH2O or 10% glycerol. 
 Cells before dry Dried cells day 0 Dried cells day 1 Dried cells day 3 
dH2O 420 0 0 0 
10% glycerol 360 298 272 284 
 
References  
1 Fu, J., Teucher, M., Anastassiadis, K., Skarnes, W. & Stewart, A. F. in Methods in Enzymology 
Vol. 477 (eds M. Wassarman Paul & M. Soriano Philippe) 125-144 (Academic Press, 2010). 
2 Fu, J. et al. Full-length RecE enhances linear-linear homologous recombination and facilitates 
direct cloning for bioprospecting. Nat. Biotechnol. 30, 440-446 (2012). 
3 M, O. et al. Glidobactins A, B and C, new antitumor antibiotics. II. Structure elucidation. J. 
Antibiot. 41, 1338–1350 (1988). 
4 Hu, S. et al. Genome engineering of Agrobacterium tumefaciens using the lambda Red 
recombination system. Appl. Environ. Microbiol. 98, 2165-2172 (2014). 
5 Yin, J. et al. A new recombineering system for Photorhabdus and Xenorhabdus. Nucleic Acids Res. 
43 (6), e36 (2015). 
6 Bian, X. et al. Direct cloning, genetic engineering, and heterologous expression of the syringolin 
biosynthetic gene cluster in E. coli through Red/ET recombineering. ChemBioChem 13, 
1946-1952 (2012). 
7 Xiang. A mini binary vector series for plant transformation. Plant Mol. Biol. 40, 711-717 (1999). 
8 Yang. Functional modulation of the geminivirus AL2 transcription factor and silencing suppressor 
by self-interaction. J. Virol. 81, 11972–11981 (2007). 
9     Guzman, L.M., et al. Tight regulation, modulation, and high-level expression by vectors 
containing the arabinose pBAD promoter. J. Bacteriol. 177, 4121-4130 (1995). 
 
 

 
B. Publication 
III 
 
Biosynthesis of magnetic nanostructures in a foreign organism by 
transfer of bacterial magnetosome gene clusters. 
 
Isabel Kolinko1, Anna Lohße1, Sarah Borg1, Oliver Raschdorf1,2, Christian Jogler1, †, 
Qiang Tu3,4, Mihály Pósfai5, Éva Tompa5, Jürgen M. Plitzko2,6, Andreas Brachmann1, 
Gerhard Wanner1, Rolf Müller3, Youming Zhang4* and Dirk Schüler1* 
 
1Ludwig-Maximilians-Universität München, Department of Biology I, Großhaderner 
Straße 2-4, 82152 Martinsried, Germany. 
 
2Max Planck Institute of Biochemistry, Department of Molecular Structural Biology, 
Am Klopferspitz 18, 82152 Martinsried, Germany. 
 
3Helmholtz Institute for Pharmaceutical Research Saarland, Helmholtz Centre for 
Infection Research and Department of Pharmaceutical Biotechnology, Saarland 
University, PO Box 151150, 66041 Saarbrücken, Germany.  
 
4Shandong University – Helmholtz Joint Institute of Biotechnology, State Key 
Laboratory of Microbial Technology, Life Science College, Shandong University, 
Jinan 250100, China.  
 
5University of Pannonia, Department of Earth and Environmental Sciences, Veszprém, 
H-8200 Hungary. 
 
6Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The 
Netherlands. 
 
†Present address: Leibniz Institute DSMZ, Department of Microbial Cell Biology and 
Genetics, Inhoffenstraße 7B, 38124 Braunschweig, Germany.  
 
*e-mail: dirk.schueler@lmu.de; zhangyouming@sdu.edu.cn 
  
Biosynthesis of magnetic nanostructures in a
foreign organism by transfer of bacterial
magnetosome gene clusters
Isabel Kolinko1, Anna Lohße1, Sarah Borg1, Oliver Raschdorf1,2, Christian Jogler1†, Qiang Tu3,4,
Miha´ly Po´sfai5, E´va Tompa5, Ju¨rgen M. Plitzko2,6, Andreas Brachmann1, Gerhard Wanner1,
Rolf Mu¨ller3, Youming Zhang4* and Dirk Schu¨ler1*
The synthetic production of monodisperse single magnetic
domain nanoparticles at ambient temperature is challenging1,2.
In nature, magnetosomes—membrane-bound magnetic nano-
crystals with unprecedented magnetic properties—can be bio-
mineralized by magnetotactic bacteria3. However, these
microbes are difﬁcult to handle. Expression of the underlying
biosynthetic pathway from these fastidious microorganisms
within other organisms could therefore greatly expand their
nanotechnological and biomedical applications4,5. So far,
this has been hindered by the structural and genetic complexity
of the magnetosome organelle and insufﬁcient knowledge of
the biosynthetic functions involved. Here, we show that the
ability to biomineralize highly ordered magnetic nanostructures
can be transferred to a foreign recipient. Expression of a
minimal set of genes from the magnetotactic bacterium
Magnetospirillum gryphiswaldense resulted in magnetosome
biosynthesis within the photosynthetic model organism
Rhodospirillum rubrum. Our ﬁndings will enable the sustainable
production of tailored magnetic nanostructures in biotech-
nologically relevant hosts and represent a step towards
the endogenous magnetization of various organisms by
synthetic biology.
The alphaproteobacterium M. gryphiswaldense produces
uniform nanosized crystals of magnetite (Fe3O4), which can be
engineered by genetic6,7 and metabolic means8 and are inherently
biocompatible. The stepwise biogenesis of magnetosomes involves
the invagination of vesicles from the cytoplasmic membrane, mag-
netosomal uptake of iron, and redox-controlled biomineralization
of magnetite crystals, as well as their self-assembly into nanochains
along a dedicated cytoskeletal structure to achieve one of the highest
structural levels in a prokaryotic cell3,9.
We recently discovered genes controlling magnetosome synthesis
to be clustered within a larger (115 kb) genomic magnetosome
island, in which they are interspersed by numerous genes of unre-
lated or unknown functions6,10. Although the smaller mamGFDC,
mms6 and mamXY operons have accessory roles in the biominera-
lization of properly sized and shaped crystals6,11, only the large
mamAB operon encodes factors essential for iron transport, magne-
tosome membrane (MM) biogenesis, and crystallization of
magnetite particles, as well as their chain-like organization and
intracellular positioning6,10,12. However, it has been unknown
whether this gene set is sufﬁcient for autonomous expression of
magnetosome biosynthesis.
Using recombineering (recombinogenic engineering) based on
phage-derived Red/ET homologous recombination, we stitched
together several modular expression cassettes comprising all 29
genes (26 kb in total) of the four operons in various combinations
(Supplementary Fig. 1), but lacking the tubulin-like ftsZm. This
gene was omitted from its native mamXY operon because of its
known interference with cell division during cloning. Regions
200–400 bp upstream of all operons were retained to ensure tran-
scription from native promoters13. Transposable expression cas-
settes comprising the MycoMar (tps) or Tn5 transposase gene,
two corresponding inverted repeats, the origin of transfer oriT,
and an antibiotic resistance gene were utilized to enable transfer
and random chromosomal integration in single copy14,15
(Supplementary Tables 3 and 4). Chromosomal reintegration of
all cassettes into different non-magnetic single-gene and operon
deletion strains of M. gryphiswaldense resulted in stable wild type-
like restoration of magnetosome biomineralization, indicating that
transferred operons maintained functionality upon cloning and
transfer (Supplementary Fig. 2).
We next attempted the transfer of expression cassettes to a
foreign non-magnetic host organism (Fig. 1). We chose the
photosynthetic alphaproteobacterium R. rubrum as a ﬁrst model
because of its biotechnological relevance and relatively close
relationship to M. gryphiswaldense16–18 (16S rRNA similarity to
M. gryphiwaldense¼ 90%). Although the mamAB operon alone
has been shown to support some rudimentary biomineralization
in M. gryphiswaldense6, neither genomic insertion of the mamAB
operon alone (pTps_AB) nor in combination with the accessory
mamGFDC genes (pTps_ABG) had any detectable phenotypic
effect (Supplementary Table 1). We also failed to detect a magnetic
response (Cmag) in the classical light scattering assay
19 after insertion
of pTps_ABG6 (mamABþmamGFDCþmms6). However, the cel-
lular iron content of R. rubrum_ABG6 increased 2.4-fold compared
with the untransformed wild type (Supplementary Table 1).
Transmission electron microscopy (TEM) revealed a loose chain
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of small (12 nm) irregularly shaped electron-dense particles
(Fig. 2a,ii), identiﬁed as poorly crystalline hematite (Fe2O3) by
analysis of the lattice spacings in high-resolution TEM images
(Supplementary Fig. 3), much as in the hematite particles pre-
viously identiﬁed in M. gryphiswaldense mutants affected in
crystal formation11,20. To further enhance biomineralization, we
next transferred pTps_XYZ, an insertional plasmid harbouring
mamX, Y and Z from the mamXY operon, into
R. rubrum_ABG6 (Supplementary Fig. 1). The resulting strain
ABG6X encompassed all 29 relevant genes of the magnetosome
island except ftsZm. Intriguingly, cells of ABG6X exhibited a sig-
niﬁcant magnetic response (Supplementary Table 1) and were
‘magnetotactic’, that is, within several hours accumulated as a
visible pellet near a magnet at the edge of a culture ﬂask
(Fig. 2b). TEM micrographs revealed the presence of electron-
dense particles identiﬁed as magnetite (Fe3O4) (Fig. 2d,
Supplementary Fig. 8 and Table 1), which were aligned in short,
fragmented chains loosely dispersed within the cell (Fig. 2a,iii).
Despite their smaller sizes (average, 24 nm) the particles strongly
resembled the magnetosomes of the donor strain in terms of
their projected outlines and thickness contrast, suggestive of
cubooctahedral or octahedral crystal morphologies (Fig. 2d).
Additional insertion of the ftsZm gene under control of the indu-
cible lac promoter had no effect on the cellular iron content and
the number and size of magnetite crystals in the resulting
R. rubrum_ABG6X_ftsZm (Fig. 2a,iv, Supplementary Table 1).
Magnetite biomineralization occurred during microoxic chemo-
trophic as well anoxic photoheterotrophic cultivation. Medium
light intensity, 50 mM iron and 23 8C supported the highest mag-
netic response (Cmag) and robust growth of the metabolically ver-
satile R. rubrum_ABG6X, which was indistinguishable from the
untransformed wild type (Supplementary Figs 4 and 5). The mag-
netic phenotype remained stable for at least 40 generations under
non-selective conditions, with no obvious phenotypic changes.
To test whether known mutation phenotypes from M. gryphis-
waldense could be replicated in R. rubrum, we constructed variants
of expression cassettes in which single genes were omitted from the
mamAB operon by deletion within the cloning host Escherichia coli.
The small (77 amino acids) MamI protein was previously implicated
inMM vesicle formation and found to be essential for magnetosome
synthesis12. R. rubrum_ABG6X-dI failed to express magnetosome
particles (Supplementary Fig. 10), which phenocopied a mamI del-
etion in the related M. magneticum12. Another tested example was
MamJ, which is assumed to connect magnetosome particles to the
cytoskeletal magnetosome ﬁlament formed by the actin-like
MamK21. Much as in M. gryphiswaldense, deletion of mamJ
caused agglomeration of magnetosome crystals in 65% of
R. rubrum_ABG6X-dJ cells (Fig. 2a,v, Supplementary Fig. 10 and
Table 1). Together, these observations indicate that magnetosome
biogenesis and assembly within the foreign host are governed by
very similar mechanisms and structures as in the donor, which
are conferred by the transferred genes.
As magnetosomes in R. rubrum_ABG6X were still smaller than
those of M. gryphiswaldense, we wondered whether full expression
of biomineralization may depend on the presence of further auxili-
ary functions, possibly encoded outside the canonical magnetosome
operons. For instance, deletion of feoB1 encoding a constituent of a
ferrous iron transport system speciﬁc for magnetotactic bacteria
caused fewer and smaller magnetosomes in M. gryphiswaldense22.
Strikingly, insertion of feoAB1 into R. rubrum strain ABG6X
resulted in even larger, single-crystalline and twinned magneto-
somes and longer chains (440 nm) (Fig. 2a,vi, Supplementary
Table 1). The size (37 nm) of the crystals approached that of the
donor, and cellular iron content was substantially increased (0.28%
of dry weight) compared with R. rubrum_ABG6X (0.18%), although
still lower than in M. gryphiswaldense (3.5%), partly because of the
considerably larger volume of R. rubrum cells (Fig. 2c).
Magnetosome particles could be puriﬁed from disrupted cells
by magnetic separation and centrifugation23 and formed stable
suspensions (Fig. 3). Isolated crystals were clearly enclosed by
a layer of organic material resembling the MM attached to
magnetosomes of M. gryphiswaldense. Smaller, immature crystals
were surrounded by partially empty vesicles (Fig. 3c, inset), which
were also seen in thin-sectioned cells (Supplementary Fig. 8) and
on average were smaller (66+6 nm) than the abundant photo-
synthetic intracytoplasmic membranes (ICMs) (93+34 nm;
Fig. 3a, Supplementary Fig. 8).
Organic material of the putative MM could be solubilized from
isolated magnetite crystals of R. rubrum_ABG6X by various deter-
gents (Fig. 3d), in a similar manner to that reported for MM of
mamABmms6mamGFDC
apR
kmRcmR J
mamXYZ
ftsZm
HIEKLMNOPAQRBSTU
mmsF
GFDC mms6
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tcRAB
tcRZ X Y gmR
1 kb
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PmmsPmamDC Pcm
PmamH Pkm
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Figure 1 | Schematic representation of molecular organization of gene cassettes inserted into the chromosome of R. rubrum in a stepwise manner. Broad
arrows indicate the extensions and transcriptional directions of individual genes. Different colours illustrate the cassettes inserted into the chromosome (oval
shape, not to scale) as indicated by their gene names in the ﬁgure. Shown in yellow are antibiotic resistance genes (kmR, kanamycin resistance; tcR,
tetracycline resistance; apR, ampicillin resistance; gmR, gentamicin resistance). Thin red arrows indicate different promoters (P) driving transcription of
inserted genes (Pkm, Pgm, Ptc, promoters of antibiotic resistance cassettes; PlacI, promoter lac repressor; Pmms , PmamDC, PmamH, PmamXY, native promoters of
the respective gene clusters from M. gryphiswaldense; Plac, lac promoter). Crossed lines indicate sites of gene deletions of mamI and mamJ in strains
R. rubrum_ABG6X_dI and R. rubrum_ABG6X_dJ, respectively. IR, inverted repeat deﬁning the boundaries of the sequence inserted by the transposase.
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M. gryphiswaldense23. Proteomic analysis of the SDS-solubilized
MM revealed a complex composition (Supplementary Fig. 6), and
several genuine magnetosome proteins (MamKCJAFDMBYOE,
Mms6, MmsF) were detected among the most abundant polypep-
tides (Supplementary Table 2). An antibody against MamC, the
most abundant protein in the MM of M. gryphiswaldense23, also
recognized a prominent band with the expected mass (12.4 kDa)
in the MM of R. rubrum_ABG6X (Supplementary Fig. 6).
The subcellular localization of selected magnetosome proteins in
R. rubrum depended on the presence of further determinants
encoded by the transferred genes. For example, MamC tagged
with a green ﬂuorescent protein, which is commonly used as
magnetosome chain marker in M. gryphiswaldense24 displayed a
punctuate pattern in the R. rubrum wild type background. In con-
trast, a ﬁlamentous ﬂuorescent signal became apparent in the
majority of cells (79%) of the R. rubrum_ABG6X background, in
which the full complement of magnetosome genes is present
(Supplementary Fig. 7), reminiscent of the magnetosome-chain
localization of these proteins in M. gryphiswaldense24.
Our ﬁndings demonstrate that one of the most complex prokar-
yotic structures can be functionally reconstituted within a foreign,
hitherto non-magnetic host by balanced expression of a multitude
of structural and catalytic membrane-associated factors. This also
provides the ﬁrst experimental evidence that the magnetotactic
trait can be disseminated to different species by only a single
event, or a few events, of transfer, which are likely to occur also
under natural conditions by horizontal gene transfer as speculated
before18,25,26.
The precise functions of many of the transferred genes have
remained elusive in native magnetotactic bacteria, but our results
will now enable the dissection and engineering of the entire
pathway in genetically more amenable hosts. The approximately
30 transferred magnetosome genes constitute an autonomous
expression unit that is sufﬁcient to transplant controlled synthesis
of magnetite nanocrystals and their self-assembly within a foreign
organism. However, further auxiliary functions encoded outside
the mam and mms operons are necessary for biomineralization of
donor-like magnetosomes. Nevertheless, this minimal gene set is
likely to shrink further as a result of systematic reduction
approaches in different hosts.
Importantly, the results are promising for the sustainable pro-
duction of magnetic nanoparticles in biotechnologically relevant
photosynthetic hosts. Previous attempts to magnetize both prokar-
yotic and eukaryotic cells by genetic and metabolic means (for
example, refs 27,28) resulted in only irregular and poorly crystalline
iron deposits. This prompted ideas to borrow genetic parts of the
bacterial magnetosome pathway for the synthesis of magnetic nano-
particles within cells of other organisms4,29. Our results now set the
stage for synthetic biology approaches to genetically endow both
uni- and multicellular organisms with magnetization by biominer-
alization of tailored magnetic nanostructures. This might be
exploited for instance in nanomagnetic actuators or in situ heat
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Figure 2 | Phenotypes of R. rubrum strains expressing different magnetosome gene clusters and auxiliary genes. a, TEM images: R. rubrum wild type (i),
containing a larger phosphate inclusion (P) and some small, non-crystalline, electron-dense particles; R. rubrum_ABG6 (ii); R. rubrum_ABG6X (iii);
R. rubrum_ABG6X_ftsZm (iv); R. rubrum_ABG6X_dJ (v); R. rubrum_ABG6X_feo (vi). Insets: Magniﬁcations of non-crystalline electron-dense particles (i) or
heterologously expressed nanocrystals (ii–vi). All insets are of the same particles/crystals as in their respective main images, except for (v). For further TEM
micrographs see Supplementary Fig. 10. b, Unlike the untransformed R. rubrum wild type, cells of R. rubrum_ABG6X accumulated as a visible red spot near
the pole of a permanent magnet at the edge of a culture ﬂask. c, TEM micrograph of a mixed culture of the donor M. gryphiswaldense and the recipient
R. rubrum_ABG6X_feo, illustrating characteristic cell properties and magnetosome organization. Insets: Magniﬁcations of magnetosomes from
M. gryphiswaldense and R. rubrum_ABG6X_feo. d, High-resolution TEM lattice image of a twinned crystal from R. rubrum_ABG6X, with Fourier transforms (i)
and (ii) showing intensity maxima consistent with the structure of magnetite.
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generators in the emerging ﬁeld of magnetogenetics30, or for
endogenous expression of magnetic reporters for bioimaging31.
Methods
Bacterial strains, media and cultivation. The bacterial strains are described in
Supplementary Table 4. E. coli strains were cultivated as previously described32.
A volume of 1 mM DL-a,e-diaminopimelic acid was added for the growth of
auxotrophic strains BW29427 and WM3064. M. gryphiswaldense strains were
cultivated in ﬂask standard medium (FSM), in liquid or on plates solidiﬁed by 1.5%
agar, and incubated at 30 8C under microoxic (1% O2) conditions
33. Cultures of
R. rubrum strains were grown as speciﬁed (Supplementary Fig. 3).
Construction of magnetosome gene cluster plasmids and conjugative transfer.
The oligonucleotides and plasmids used in this study are listed in Supplementary
Tables 4 and 5. Red/ET (Lambda red and RecET) recombination was performed as
described previously14. Brieﬂy, a cloning cassette was ampliﬁed by polymerase chain
reaction (PCR) and transferred into electrocompetent E. coli cells (DH10b)
expressing phage-derived recombinases from a circular plasmid (pSC101-BAD-
gbaA). After transfer of the cassette, recombination occurred between homologous
regions on the linear fragment and the plasmid.
To stitch the magnetosome gene clusters together into a transposon plasmid
(Supplementary Fig. 1) we used triple recombination14 and co-transformed two
linear fragments, which recombined with a circular plasmid. Recombinants
harbouring the correct plasmids were selected by restriction analysis32.
Conjugations into M. gryphiswaldense were performed as described before33.
For conjugation of R. rubrum, cultures were incubated in ATCC medium 112.
Approximately 2× 109 cells were mixed with 1× 109 E. coli cells, spotted on
American Type Culture Collection (ATCC) 112 agar medium and incubated for
15 h. Cells were ﬂushed from the plates and incubated on ATCC 112 agar medium
supplemented with appropriate antibiotics for 7–10 days (Tc¼ 10 mg ml21;
Km¼ 20 mg ml21; Gm¼ 10 mg ml21, where Tc, tetracycline; Km, kanamycin;
Gm, gentamicin). Sequential transfer of the plasmids resulted in 1× 1026 to
1× 1028 antibiotic-resistant insertants per recipient, respectively. Two clones from
each conjugation experiments were chosen for further analyses. Characterized
insertants were indistinguishable from wild type with respect to motility, cell
morphology or growth (Supplementary Fig. 5).
Analytical methods. The optical density of M. gryphiswaldense cultures was
measured turbidimetrically at 565 nm as described previously19. The optical density
of R. rubrum cultures was measured at 660 nm and 880 nm. The ratio of
880/660 nm was used to determine yields of chromatophores within intact cells
(Supplementary Fig. 4). Furthermore, bacteriochlorophyll a was extracted from
cultures with methanol. Absorption spectra (measured in an Ultrospec 3000
photometer, GE Healthcare) of photoheterotrophically cultivated
R. rubrum_ABG6X cells were indistinguishable from that of the wild type
(Supplementary Fig. 4). The average magnetic orientation of cell suspensions (Cmag)
was assayed with a light scattering assay as described previously19. Brieﬂy, cells were
aligned at different angles to a light beam by application of an external
magnetic ﬁeld.
Microscopy. For TEM of whole cells and isolated magnetosomes, specimens were
directly deposited onto carbon-coated copper grids. Magnetosomes were stained
with 1% phosphotungstic acid or 2% uranyl acetate. Samples were viewed and
recorded with a Morgagni 268 microscope. Sizes of crystals and vesicles were
measured with ImageJ software.
Chemical ﬁxation, high-pressure freezing and thin sectioning of cells were
performed as described previously17. Processed samples were viewed with an EM
912 electron microscope (Zeiss) equipped with an integrated OMEGA energy ﬁlter
operated at 80 kV in the zero loss mode. Vesicle sizes were measured with ImageJ
software. High-resolution TEM was performed with a JEOL 3010 microscope,
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Figure 3 | Ultrastructural analysis of R. rubrum_ABG6X and isolated crystals. a, Cryo-ﬁxed, thin-sectioned R. rubrum_ABG6X contained intracytoplasmic
membranes (ICMs) (93+34 nm, n¼ 95) and magnetic particles (MP). Inset: Magniﬁcation of the magnetite crystals. b, Cryo-electron tomography of
isolated magnetic particles of R. rubrum_ABG6X: x–y slice of a reconstructed tomogram (i) and surface-rendered three-dimensional representation (ii).
A membrane-like structure (yellow, thickness 3.4+1.0 nm, n¼ 6) surrounds the magnetic particles (red). (Blue, empty vesicle.) c,d, TEM images of isolated
magnetosomes from R. rubrum_ABG6X (c and d,ii, iii, iv) and M. gryphiswaldense (d,i) negatively stained by uranyl acetate (c) or phosphotungstic acid (d).
Insets: Higher-magniﬁcation images of magnetic particles; these are of different particles to those shown in the main images, except for (iv). Scale bars,
100 nm. Arrows indicate the magnetosome membrane, which encloses magnetic crystals of M. gryphiswaldense (thickness 3.2+1.0 nm, n¼ 103) and
R. rubrum_ABG6X (thickness 3.6+1.2 nm, n¼ 100). Organic material could be solubilized from magnetite crystals of R. rubrum_ABG6X with SDS
(sodium dodecyl sulfate, iv) and less effectively also with Triton X-100 (iii).
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operated at 297 kV and equipped with a Gatan Imaging Filter for the acquisition of
energy-ﬁltered compositional maps. For TEM data processing and interpretation,
DigitalMicrograph and SingleCrystal software were used20. Cryo-electron
tomography was performed as described previously21. Fluorescence microscopy was
performed with an Olympus IX81 microscope equipped with a Hamamatsu Orca
AG camera using exposure times of 0.12–0.25 s. Image rescaling and cropping were
performed with Photoshop 9.0 software.
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Biosynthesis of magnetic nanostructures in 
a foreign organism by transfer of bacterial 
magnetosome gene clusters
1 
 
Genetic transfer of bacterial magnetosome biosynthesis to a 1 
foreign organism 2 
 3 
Supplementary methods 4 
 5 
Construction of Tn5 transposon plasmids  6 
For construction of translational (C-terminal) gene fusions, the mamDC promoter 7 
(XbaI, BamHI restriction sites added) was cloned in front of either the mamGFDC 8 
operon or the mamJ gene (NdeI, KpnI), which were followed by the egfp gene (KpnI, 9 
EcoRI). The resulting construct was cloned into pBAM11 modified by a tetracycline 10 
resistance cassette (exchange of kmR against tcR with SanDI and AatII). The 11 
replicative plasmid pFM211 (Frank Müller, unpublished) harboring ftsZm with a 12 
mCherry fusion under control of an inducible lac promoter was recombined with 13 
pBAM1 to construct pBAM-ftsZm_mcherry. The resident kmR was replaced by tcR 14 
using ET-recombination. For construction of pBAM_feoAB1, a fragment with PmamH 15 
and feoAB1 was amplified by PCR from pRU1feoAB (XbaI, EcoRI) and cloned into 16 
Tet-pBAM1.  17 
 18 
Intracellular iron measurements 19 
Cellular iron contents were determined after incubation under photoheterotrophic 20 
conditions in 10 ml Hungate tubes using a modified version of the ferrozine assay2. 21 
To this end, 4 ml cultures were centrifuged for 1 min at 11.000 rpm, resuspended in 22 
90 µl HNO3 (65%) and incubated for 3 h at 99 °C. 23 
 24 
Sequencing 25 
For whole genome sequencing of strain R. rubrum_ABG6X a genomic DNA library 26 
was generated with the Nextera Kit (Illumina). Sequencing (1.25 Mio clusters, 2x 250 27 
bp) was performed with a MiSeq sequencer (Illumina). Data analysis with CLC 28 
Genomics Workbench (CLCbio) confirmed single-site integration of both expression 29 
cassettes without mutations, except for a spontaneous deletion (aa 169-247) within 30 
the hypervariable non-essential CAR domain of mamJ which was shown to be 31 
irrelevant for protein function3. 32 
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Magnetosome isolation, electrophoresis and immuno-chemical detection 33 
For magnetosome isolation and expression analysis, cultures of R. rubrum were 34 
grown photoheterotrophically in sealed 5 liter flasks illuminated by white light, 1000 35 
lux intensity. Cells were harvested, washed and resuspended into HEPES buffer4. 36 
Cell suspensions were lysed by sonication and cellular debris was removed by low-37 
speed centrifugation. Magnetic separation of magnetosome particles, solubilization of 38 
the enclosing organic layer and fractionation of non-magnetic membrane fraction and 39 
soluble proteins were performed as previously described5,6. Polyacrylamide gels 40 
were prepared according to the procedure of Laemmli7. Protein samples from 41 
different cellular fractions (magnetosome membrane, soluble fraction, non-magnetic 42 
membrane fraction) were resuspended in electrophoresis sample buffer and 43 
denatured at 98 °C for 5 min8. 10 µg of protein extracts were separated on a 15% 44 
SDS-polyacrylamide gel. Protein bands were visualized by Coomassie brilliant blue 45 
staining. Western blot analysis for detection of MamC was performed as previously 46 
described6. 47 
 48 
Mass spectrometry 49 
For mass spectrometry 25 µg solubilised proteins were tryptically in-gel digested as 50 
described previously9. The resulting fragments were separated on a C18 reversed-51 
phase column and analyzed by nano-electrospray ionization-LC tandem MS (ESI-LC-52 
MS/MS), recorded on an Orbitrap mass spectrometer9. Spectra were analyzed via 53 
MascotTM software using the NCBI nr Protein Database and a database from 54 
M. gryphiswaldense10.  55 
56 
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Fig. S1: Construction scheme of insertion cassettes for modular expression of 
the mam and mms operons. (a) Recombineering of a BAC containing the mamAB 
operon (blue) and a vector backbone (Km-p15A-Tps-oriT-Km, orange) harboring a 
MycoMar transposase gene (tps), inverted repeats (IR), origin of transfer (oriT), p15A 
origin of replication (p15A) and a kanamycinR cassette (kmR, orange). (b) Insertion of 
a spectinomycinR cassette (specR, pink) and the mamGFDC operon (green) into 
pTps_AB by triple recombination. (c & d) Stitching of pTps_ABG by insertion of the 
mms6 operon and a chloramphenicolR cassette. (e) pTps_XYZ consisting of a Tps 
vector backbone (orange), mamXYZ (pale blue) and a gentamicinR gene (gmR, 
purple) was constructed. (f) Plasmids were transferred by conjugation into R. rubrum. 
Transposition of the DNA-fragments within the IR sequences occurred at random 
positions at TA dinucleotide insertion sites by a “cut and paste” mechanism1. (g) 
Chromosomal insertion sites of the transposed constructs in R. rubrum_ABG6X are 
shown with adjacent genes (red) as revealed by whole genome sequencing 
performed with a MiSeq sequencer (Illumina) (accession number of R. rubrum 
ATCC 11170: NC_007643). pTps_ABG6 inserted within a gene encoding a putative 
aldehyd dehydrogenase (YP_426002), and pTps_XYZ inserted within rru_A2927, 
encoding a putative acriflavin resistance protein (protein accession number 
YP_428011). Sequences of inserted magnetosome operons matched those of the 
donor (M. gryphiswaldense) with no detectable mutations, except for a deletion (aa 
169-247) within the hypervariable non-essential CAR domain of mamJ, which was 
shown to be irrelevant for protein function2. 
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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Fig. S2: Transmission electron micrographs of MSR mutants expressing 
various insertional transposon constructs. The plasmids pTps_AB, pTps_ABG 
and pTps_ABG6 were transferred into the non-magnetic M. gryphiswaldense 
mutants ΔmamAB3 and MSR-1B, the latter lacking most of the magnetosome genes 
except of the mamXY operon3,4. After transfer of pTps_AB, a wt-like phenotype was 
restored in ΔmamAB_AB as revealed by Cmag (1.2 ± 0.2) and measured crystal sizes 
(37 ± 10 nm) in comparison with M. gryphiswaldense wt (36 ± 9 nm, Cmag=1.4 ± 0.2) 
(see also Table S1). Mutant MSR-1B was only partly complemented after insertion of 
pTps_AB and pTps_ABG, that is, Cmag and crystal sizes were still lower than in the wt 
(Table S1). Transfer of pTps_ABG6 restored nearly wt-like magnetosome formation 
in MSR-1B (35 ± 8 nm, Cmag=0.9± 0.1). ±= s.d. Scale bar: 1 μm, insets: 0.2 µm. 
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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Fig. S3: HRTEM image of a poorly crystalline iron oxide particle from 
R. rubrum_ABG6 with the corresponding Fourier transform (i) that shows 
diffuse, faint intensity maxima consistent with the structure of hematite. 
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Fig. S4: Growth, magnetic response and ICM/Bchl a production of 
R. rubrum_AGB6X. (a & b) Cells were grown in ATCC 112 (chemotrophic, 20% O2), 
Sistrom A (phototrophic, anoxygenic) and M2SF (chemotrophic, 1%O2) medium for 3 
(30 °C), 4 (23 °C) or 10 (18 °C) days. Optical density at 660 nm (minimal Bchl a 
absorption, black diamonds), 880 nm (maximal Bchl a absorption) and magnetic 
response (grey diamonds) were measured. The ratio OD880/OD660 (white diamonds) 
correlates with the amount of chromatophores produced in the cells5 (median values 
n=3, error bars indicate s.d.). No Cmag was detectable under aerobic and 
microaerobic conditions at 30 °C. (c & d) Absorption spectra of extracted 
bacteriochlorophylls from R. rubrum wt (c) and R. rubrum_ABG6X (d) (phototrophic 
growth, 30 °C).  
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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Fig. S5: Growth of R. rubrum wt and R. rubrum_ABG6X (OD660). Cells of 
R. rubrum (Sistrom A medium, 1000 lux) were incubated in Sistrom A medium (1000 
lux) for 3 days at 23 °C under anaerobic conditions. No major growth differences 
between wt (n=3) and mutant strain ABG6X (median values n=3, error bars indicate 
s.d.) were detectable .  
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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Fig. S6: Proteomic analysis of magnetosomes from R. rubrum_ABG6X. (a) 1D 
SDS-PAGE of Coomassie blue stained proteins solubilized from isolated 
magnetosome particles of M. gryphiswaldense and R. rubrum_ABG6X. Bands of the 
same size are indicated (arrowheads). (b) Immunodetection of MamC (12.4 kDa) in 
blotted fractions of M. gryphiswaldense and R. rubrum_ABG6X using an anti-MamC 
antibody6. A signal for MamC was detectable in the magnetic membrane fraction of 
R. rubrum_ABG6X (6), which was absent from the soluble fraction, but faintly present 
also in the non-magnetic membrane fraction (5), possibly originating from empty 
membrane vesicles or incomplete magnetic separation during isolation. Protein 
extracts from M. gryphiswaldense: 1. soluble fraction, 2. non-magnetic membrane 
fraction, 3. magnetosome membrane. Protein extracts from R. rubrum_ABG6X: 4. 
soluble fraction, 5. non-magnetic membrane fraction, 6. magnetic (“magnetosome”) 
membrane fraction. M: Marker. 
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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Fig. S7: Fluorescence microscopy of R. rubrum wt and R. rubrum_ABG6X cells 
expressing different EGFP-tagged magnetosome proteins. For localization 
studies of fluorescently labeled magnetosome proteins, strains were cultivated in 
ATCC medium overnight at 30 °C with appropriate antibiotics (Table S3). (a & b) 
MamGFDC with a C-terminal MamC-EGFP fusion expressed in R. rubrum wt (n=151) 
(a), and R. rubrum_ABG6X (n=112) (b). In the transformed strain, a filamentous 
structure is visible for 79% of the cells (n=89). c & d, MamJ-EGFP expressed in 
R. rubrum wt (n=109) (c), and in R. rubrum_ABG6X (n=89) displaying a chain-like 
fluorescence signal in 63% of the cells (n=56) (d). Scale bar: 2 µm. 
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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Fig. S8: TEM of cryo- or chemically fixed, thin sectioned R. rubrum strains. 
Cells were cultivated under photo-heterotrophic conditions. ICM sizes of cryo-fixed 
R. rubrum wt (93 ± 34 nm, n=95) and vesicles surrounding immature magnetosomes 
of cryo-fixed R. rubrum_ABG6X (66 ± 6 nm, n=6) were measured.  
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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Fig. S9: Size distribution of magnetosome crystals in M. gryphiswaldense and 
different R. rubrum strains. Whereas crystals of R. rubrum_ABG6 (n=303) and 
R. rubrum_ABG6X (n=306) were smaller than those of the donor M. gryphiswaldense 
(n=310), crystal sizes of R. rubrum_ABG6X_feo (n=301) were significantly larger, 
approaching those of the donor strain (see also Supplementary Table 1).  
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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Figure S10: Transmission electron micrographs of whole cells of different 
R. rubrum strains expressing magnetosome gene clusters. Scale bar: 1 µm, 
inset: 0.2 µm. 
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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Table S1: Summary of magnetic responses (“Cmag”), intracellular iron content and crystal 
size and number of various strains (median values, ± = standard deviation). If not 
indicated otherwise, cells were grown in the presence of 50 µM ferric citrate. Magnetic response 
and total iron content measurements were performed with (n) biological replicates under 
identical conditions (see also material & methods). For determination of crystal size and number 
per cell, cells of one clone were analyzed by TEM (n=sample size). The Mann-Whitney test 
(http://elegans.som.vcu.edu/~leon/stats/utest.html) was performed for crystal size comparison 
of R. rubrum_ABG6X and R. rubrum_ABG6X_feo: the difference was highly significant 
(p<0.001, two tailed test). Crystal size comparison of R. rubrum_ABG6X_feo and 
M. gryphiswaldense revealed no significant difference (p≥0.05, two tailed test).  
Strain 
Magnetic 
response  
(“Cmag”) 
Iron content 
(% dry weight) 
Crystal size (nm) 
Crystal number per 
cell 
M. gryphiswaldense MSR-1 
1.4 ± 0.2 
(n=3) 
3.5  
(n=3) 
36 ± 9 
(n=310) 
24 ± 8 
(n=52) 
M. gryphiswaldense 
∆mamAB_AB 
1.2 ± 0.2 
(n=3) 
n.d. 
37 ± 10  
 (n=112) 
23 ± 7 
(n=24) 
M. gryphiswaldense MSR-
1B_AB 
0.2 
(n=3) 
n.d. 
17 ± 6  
(n=112) 
16 ± 6 
(n=20) 
M. gryphiswaldense MSR-
1B_ABG 
0.6 ± 0.1, 
(n=3) 
n.d. 
25 ± 6  
(n=104) 
13 ± 6 
(n=20) 
M. gryphiswaldense MSR-
1B_ABG6 
0.9± 0.2 
(n=3) 
n.d. 
35 ± 8  
(n=103) 
18 ± 8 
(n=22) 
R. rubrum ATCC 11170 - 
0.07 ± 0.04 
(n=3) 
- - 
R. rubrum_AB - 
0.08 
(n=3) 
- - 
R. rubrum_ABG - 
0.10 ± 0.01 
(n=3) 
- - 
R. rubrum_ABG6 - 
0.17 
(n=4) 
12 ± 6 
(n=304) 
26 ± 10 
(n=50) 
R. rubrum_ABG6X 
0.3 ± 0.2 
(n=3) 
0.17 ± 0.02 
(n=4) 
24 ± 7 
(n=307) 
10 ± 4 
(n=50) 
R. rubrum_ABG6X 500 µM 
ferric citrate 
0.3 
(n=4) 
n. d. 
25 ± 7 
(n=301) 
11 ± 5 
(n=51) 
R. rubrum_ABG6X  
100 µM ferrous sulfate 
0.2 
(n=4) 
n.d. 
24 ± 8 
(n=312) 
10 ± 5 
(n=52) 
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R. rubrum_ABG6X_ftsZm 
0.6 ± 0.1* 
(n=3) 
0.18 ± 0.03 
(n=3) 
26 ± 9 
(n=300) 
11 ± 4 
(n=51) 
R. rubrum_ABG6X_dJ 
0.2 
(n=3) 
0.18 ± 0.01 
(n=3) 
27 ± 9 
(n=300) 
9 ± 4 
(n=50)** 
R. rubrum_ABG6X_dI - 
0.09 ± 0.07 
(n=3) 
- - 
R. rubrum_ABG6X_feo 
0.8 ± 0.1 
(n=3) 
0.28 ± 0.07 
(n=3) 
37 ± 10 
(n=300) 
10 ± 4 
(n=52) 
*The slightly increased Cmag is likely due to effects of the genuine cell division protein FtsZm on 
cell morphology, as no difference in iron content and crystal size or number per cell was 
detectable. 
**64% of mutant cells (n=32) harbored clustered magnetosomes, whereas 36% still showed a 
chain-like alignment of magnetosomes (n=18). 
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Table S2: Magnetosome proteins identified in the MM of strain R. rubrum_ABG6X by nano-electrospray ionization-LC tandem MS (ESI-
LC-MS/MS). Spectra were analyzed via MascotTM software using the NCBI nr Protein Database and a database from M. gryphiswaldense1 
(asterisks). Proteins are listed in the order of their exponentially modified protein abundance index (emPAI). The data have been deposited to 
ProteomeXchange with identifier PXD000348 (DOI 10.6019/PXD000348). 
Protein 
Accession 
number 
Coverage 
(%) 
No. of 
spectrum 
matches 
No. of 
sequence 
peptides 
Molecular 
weight 
(kDa) 
Calculated 
pI 
emPAI Putative function 
MamK MGR_4093 57 9 9 39.6 5.4 1.51 
Magnetosome chain 
assembly/positioning 
2,3
 
MamC MGR_4078 32 4 3 12.4 5.1 1.01 
Crystal size and shape 
control 
4
 
MamJ MGR_4092 32 10 6 48.6 4.0 0.76 
Magnetosome chain 
assembly 
5
 
MamA MGR_4099 37 1 1 23.9 5.7 0.65 
TPR-like protein 
associated with the 
magnetosome membrane 
6,7
 
MamF MGR_4076 17 1 1 12.4 9.1 0.60 
Magnetosome size and 
shape control 
4
 
Mms6 MGR_4073 19 1 1 12.7 9.5 0.58 
Magnetosome 
crystallization 
8,9
 
MamD MGR_4077 20 3 3 30.2 9.8 0.49 
Crystal size and shape 
control 
4
 
MamM* MGR_4095 15 3 3 34.7 5.8 0.42 
Iron transport/MM 
assembly 
10
 
MmsF* MGR_4072 8 2 1 13.9 9.3 0.23 
Crystal size and shape 
control 
11
 
MamB* MGR_4102 7 1 1 32.1 5.4 0.21 
Iron transport/MM 
assembly 
10
 
MamY* MGR_4150 18 2 2 40.9 4.8 0.16 
Tubulation and 
magnetosome membrane 
formation 
12
 
MamO* MGR_4097 6 3 3 65.3 6.5 0.15 
Magnetosome 
crystallization 
13,14
 
MamE MGR_4091 4 2 2 78.3 8.1 0.08 
Magnetosome 
crystallization 
13,14
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Table S3: Strains and plasmids used in this study. KmR= kanamycin resistance, TcR= 
tetracycline resistance, ApR= ampicillin resistance, BSDR= blasticidin S resistance, CmR= 
chloramphenicol resistance, GmR= gentamicin resistance, SpecR= spectinomycin resistance. 
Strain or plasmid Characteristics Reference(s) or source 
Magnetospirillum gryphiswaldense strains  
 
M. gryphiswaldense MSR-1 
 
Wild-type (wt) DSM-6361,
15
 
M. gryphiswaldense MSR-1B 
spontaneous unmagnetic 
mutant lacking parts of the 
MAI 
16
 
M. gryphiswaldense ∆mamAB mamAB deletion mutant 17 
M. gryphiswaldense ∆mamAB _AB 
Km
R
, transposon mutant with 
inserted mamAB operon 
This study 
M. gryphiswaldense MSR-1B_AB 
Km
R
, transposon mutant with 
inserted mamAB operon 
This study 
M. gryphiswaldense MSR-1B_ABG 
Km
R
, Spec
R
, transposon 
mutant with inserted mamAB 
and mamGFDC operon 
This study 
M. gryphiswaldense MSR-1B_ABG6 
Km
R
, Cm
R
, transposon mutant 
with inserted mamAB, 
mamGFDC and mms6 operon 
This study 
Rhodospirillum rubrum strains  
R. rubrum ATCC 11170 wt 
18
 
(kindly provided by H. 
Grammel, Magdeburg) 
R. rubrum_AB 
Km
R
, transposon mutant with 
inserted mamAB operon 
This study 
R. rubrum_ABG 
Km
R
, Spec
R
, transposon 
mutant with inserted mamAB 
and mamGFDC operon 
This study 
R. rubrum _ABG6 
Km
R
, Cm
R
, transposon mutant 
with inserted mamAB, 
mamGFDC and mms6 operon 
This study 
R. rubrum_ABG6X 
Km
R
, Cm
R
, Gm
R
 transposon 
mutant with inserted mamAB, 
mamGFDC, mms6 and 
mamXY operon (without 
ftsZm) 
This study 
R. rubrum_ABG6X_dJ 
Km
R
, Cm
R
, Gm
R
, Ap
R 
transposon mutant with 
inserted mamAB (mamJ 
deletion), mamGFDC, mms6 
and mamXY operon (without 
ftsZm) 
This study 
R. rubrum_ABG6X_dI 
Km
R
, Cm
R
, Gm
R
, Ap
R 
transposon mutant with 
inserted mamAB (mamI 
deletion), mamGFDC, mms6 
and mamXY operon (without 
ftsZm) 
This study 
R. rubrum_ABG6X_ftsZm 
Km
R
, Cm
R
, Gm
R
, Tc
R 
transposon mutant with 
inserted mamAB, mamGFDC, 
mms6 and mamXY operon 
(without ftsZm) and ftsZm 
This study 
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under control of an inducible 
lac promoter 
R. rubrum_ABG6X_feo 
Km
R
, Cm
R
, Gm
R
, Tc
R 
transposon mutant with 
inserted with inserted 
mamAB, mamGFDC, mms6, 
mamXY and feoAB1 operon 
This study 
R.rubrum_GFDC-EGFP 
Tc
R
 transposon mutant with 
inserted mamGFDC-EGFP 
This study 
R.rubrum_ABG6X_GFDC-EGFP 
Km
R
, Cm
R
, Gm
R
, Tc
R 
transposon mutant with 
inserted mamAB, mamGFDC, 
mms6 and mamXY operon 
(without ftsZm) and 
mamGFDC-EGFP 
This study 
R. rubrum_J-EGFP 
Tc
R
 transposon mutant with 
inserted mamGFDC-EGFP 
This study 
R. rubrum_ABG6X_J-EGFP 
Km
R
, Cm
R
, Gm
R
, Tc
R 
transposon mutant with 
inserted mamAB, mamGFDC, 
mms6 and mamXY operon 
(without ftsZm) and mamJ-
EGFP 
This study 
Escherichia coli strains  
DH10b 
F– mcrA Δ(mrr-hsdRMS-
mcrBC) Φ80lacZΔM15 
ΔlacX74 recA1 endA1 
araD139 Δ(ara leu) 7697 galU 
galK rpsL nupG λ– 
Invitrogen 
BW29427 
dap auxotroph derivative of E. 
coli strain B2155 
K. Datsenko and B. L. 
Wanner, unpublished 
WM3064 
thrB1004 pro thi rpsL hsdS 
lacZΔM15 RP4-1360 
Δ(araBAD)567 
ΔdapA1341::[erm pir] 
W. Metcalf, kindly provided 
by J. Gescher, KIT Karlsruhe 
Plasmids  
pSC101-BAD-gbaA 
Tc
R
, replicative plasmid 
containing redα/redβ 
recombinases under the 
control of a L-Arabinose 
inducible promoter, 
temperature sensitive origin of 
replication 
19
  
p15A-Tps-oriT-Km 
Km
R
, BSD
R
, oriT, p15A origin 
of replication, mariner tps, 
cloning cassette 
20
 
pSSK18 (BAC_mamAB) 
BAC containing the mamAB 
operon from M. 
gryphiswaldense 
16
 
pTps_AB 
Km
R
, BSD
R
, mariner tps 
vector containing mamAB 
operon 
This study 
pTps_ABG 
Spec
R
, Km
R
, BSD
R
, mariner 
tps vector with mamAB and 
mamGFDC operon 
This study 
pTps_ABG6 
Cm
R
, Km
R
, BSD
R
, mariner tps 
vector with mamAB, 
mamGFDC, and mms6 
operon 
This study 
pTps_XYZ 
Gm
R
, BSD
R
, mariner Tps 
vector with mamY, mamX and 
mamZ 
This study 
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pTps_ABG6_dJ 
Cm
R
, Km
R
, BSD
R
, Ap
R
, 
mariner tps vector with 
mamAB, mamGFDC, and 
mms6 operon, (mamJ 
deletion) 
This study 
pTps_ABG6_dI 
Cm
R
, Km
R
, BSD
R
, Ap
R
, 
mariner tps vector with 
mamAB, mamGFDC, and 
mms6 operon, (mamI 
deletion) 
This study 
pBAM1 
Km
R
, Ap
R, γR6K origin of 
replication, oriT, Tn5 vector 
21
 
Tet-pBAM1 
Tc
R
, Ap
R, γR6K origin of 
replication, oriT, Tn5 vector 
This study 
Tet-pBam_mamGFDC-EGFP 
Tc
R
, Ap
R
, mamGFDC operon 
under control of PmamDCwith a 
C-terminal EGFP fusion, Tn5 
vector 
This study 
Tet-pBam_MamJ-EGFP 
Tc
R
, Ap
R
, mamJ under control 
of PmamDC with a C-terminal 
EGFP fusion, Tn5 vector 
This study 
pRU-1feoAB 
Km
R
, broad host range 
pBBRMCS2, feoAB1 operon 
under the control of PmamH 
R. Uebe, unpublished 
Tet-pBam_feoAB1 
Tc
R
, Ap
R
, feoAB1 operon 
under the control of PmamH, 
Tn5 vector 
This study 
Tet-pBam-ftsZm_mCherry 
Tc
R
, Ap
R
, ftsZm, lacI with a C-
terminal mCherry fusion 
under control of inducible Plac, 
Tn5 vector 
This study 
pFM211 
Km
R
, broad host range 
pBBRMCS2, lacI, ftsZm with 
C-terminal mCherry fusion, 
mamK with N-terminal EGFP 
fusion 
F. Müller, unpublished 
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Table S4: Oligonucleotides used in this study. 
Primer Nucleotide sequence (5'-3')
a
 Product 
Mam-tps5 
AATTCGCACGGACTATAGCAACGAATCGAGGTCGGTTGAC
AAGCCATAAATCAGAAGAACTCGTCAAGAAGGC 
p15A-Tps-oriT-Km, 
ET-recombination 
with BAC_mamAB, 
pTps_AB 
Mam-tps3 
GAACGAAGATGAGACAGAAATCCGTGGCGCCGAGCGTAA
GCATCCGGTGAGAACCTCATTCCCTCATGATACAG 
mamGFC3 
TATCATGAGGGAATGAGGTTCTCACCGGATGCTTACGCTC
GGCGCCAGAGCACATCGGGGTGAATGACGAC 
mamGFDC operon, 
ET-recombination 
with pTps_AB mamGFC5 CGCTAGCTGCGGGTTATTCGCATTTGC 
spectMam3 
TCAAAACCCGCGCAGAGGCAAATGCGAATAACCCGCAGCT
AGCGTTATAATTTTTTTAATCTGTTATT 
Spectinomycin 
resistance cassette, 
ET-recombination 
with pTps_AB 
spectMam5 
TGATCCGCTATGGTAAGCGCATCATGTCCGGATCCCATGG
CGTTCCGCTCGTAACGTGACTGGCAAGAGATATT 
mms6cm5 
TACTGCGATGAGTGGCAGGGCGGGGCGTAAGCTTACAATT
TCCATTCGCCATTC 
mms6 operon, ET-
recombination with 
pTps_ABG mms6mam3 GTGCTTCGCTGTGTCCACAAGAACC 
cm-mms6-3 
TGGCGAATGGAAATTGTAAGCTTACGCCCCGCCCTGCCAC
TC 
Chloramphenicol 
resistance cassette, 
ET-recombination 
with pTps_ABG 
cm-mms6-5 
TGATCCGCTATGGTAAGCGCATCATGTCCGGATCCCATGG
CGTTCCGCTCGTCCTGGTGTCCCTGTTGATACC 
IK097 
TCTAGAGGGCCCCAACTTTTTCGCTTTACTAGCTCTTAGTT
CTCCAATAAATTCCCTGCGTCGA 
PmamDC in pBAM1 
IK098 
CATATGCTGATCTCCGGCAAGTGTATGCACGATTCCCTCTC
TGCCCCTTAAAATCGACGCAGGGAAT 
IK107 CATATGATCAAGGGCATCGCGGG mamGFDC operon 
in pBAM1 IK101 GGTACCGGCCAATTCTTCCCTCAGAA 
IK102 GGTACCGGAGGCGGAGGCGGT 
egfp in pBAM1 
IK103 GAATTCTTACTTGTACAGCTCGTCCATG 
IK163 GAATTCTTAGCCGATTCGCAG mamXY-operon 
(without ftsZm), ET-
recombination with 
p15A-Tps-oriT-Gm 
IK164 GAGCTCGGCAGCCTCATTTAAA 
IK173 
CCGGAATTGCCAGCTGGGGCGCCCTCTGGTAAGGTTGGG
AAGCCCTGCAACGTATAATATTTGCCCATG 
Gentamicin 
resistance cassette, 
ET-Recombination 
with p15A-Tps-oriT-
Km 
IK174 
AGGCGATAGAAGGCGATGCGCTGCGAATCGGGAGCGGCG
ATACCGTAAAGCGATCTCGGCTTGAA 
IK208 
CCCGGTACCCAGCTTTTGTTCCCTTTAGTGAGGGTTAATTG
CGCGCTTGGCCTCATTCCCTCATGATACAGAGAC 
p15A-Tps-oriT-Gm, 
ET-recombination 
with mamXY IK209 
GGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTT
CGCCAGCTGTCTCGGCTTGAACGAATTG 
IK213 GACGTCGAGCCACGGCGG Tetracycline 
resistance cassette 
in pBAM1 
IK214 GGGTCCCTCAGGTCGAGGTGGC 
IK215 TCTAGACTACAAGAATGTCCCGC feoAB1 
operon+PmamH in 
pBAM1 IK216 
GAATTCGGCATCCTGATCGGT 
IK217 CATATGATGGCAAAAAACCGG 
mamJ in pBAM1 
IK218 GGCGGTACCTTTATTCTTATCTTCAGCATCAC 
IK235 GGGTGGAGCGGGATAATGGCAAAAAACCGGCGTGATCGC
GGCACGGCTAAATACATTCAAATATGTATCC 
Ampicillin resistance 
cassette insertion 
into mamJ of 
pTps_ABG6 
IK236 
CTATTTATTCTTATCTTCAGCATCACATTTCGGCGATGAACA
ACTACCTTACCAATGCTTAATCAGTG 
IK239 
CGCCGCTTGTGTTCTGTATCAAGACTGGAGAACGTTTATG
CCAACTAAATACATTCAAATATGTATCC 
Ampicillin resistance 
cassette Insertion 
into mamI of 
pTps_ABG6 
IK240 
TCAACCATCGATGTTAGGGTCTGAGTTCGCCCTCTTACCG
GCAGGTTACCAATGCTTAATCAGTG 
IK251 
AAACCGCCCAGTCTAGCTATCGCCATGTAAGCCCACTGCA
AGCTACCTGCCCTCATTCCCTCATGATACA 
Tet-pBAM1, ET- 
recombination with 
© 2014 Macmillan Publishers Limited.  All rights reserved. 
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IK252 
CAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGA
GGCCCGCACCGGATTTTGAGACACAAGACGTC 
recombination with 
pFM211 
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Direct cloning and heterologous 
expression of the salinomycin 
biosynthetic gene cluster from 
Streptomyces albus DSM41398 in 
Streptomyces coelicolor A3(2)
Jia Yin1,2,3,4, Michael Hoffmann3, Xiaoying Bian1, Qiang Tu1,3, Fu Yan3, Liqiu Xia4, 
Xuezhi Ding4, A. Francis Stewart2, Rolf Müller3, Jun Fu1,2 & Youming Zhang1
Linear plus linear homologous recombination-mediated recombineering (LLHR) is ideal for obtaining 
natural product biosynthetic gene clusters from pre-digested bacterial genomic DNA in one or two 
steps of recombineering. The natural product salinomycin has a potent and selective activity against 
cancer stem cells and is therefore a potential anti-cancer drug. Herein, we separately isolated three 
fragments of the salinomycin gene cluster (salO-orf18) from Streptomyces albus (S. albus) DSM41398 
using LLHR and assembled them into intact gene cluster (106 kb) by Red/ET and expressed it in 
the heterologous host Streptomyces coelicolor (S. coelicolor) A3(2). We are the first to report a 
large genomic region from a Gram-positive strain has been cloned using LLHR. The successful 
reconstitution and heterologous expression of the salinomycin gene cluster offer an attractive system 
for studying the function of the individual genes and identifying novel and potential analogues of 
complex natural products in the recipient strain.
Red/ET recombineering in E. coli1,2, is a powerful technique for the genetic engineering of natural prod-
uct biosynthetic pathways, especially for large polyketide synthetase (PKS) as well as nonribosomal 
peptide-synthetase (NRPS)3–6. Recently, this technique was used to clone large biosynthetic gene clusters 
from a complex DNA source into a vector by linear plus linear homologous recombination (LLHR)7. 
LLHR is mediated by the full-length Rac prophage protein RecE, an exonuclease, its partner RecT, a 
single-strand DNA-binding protein, and Redγ , an inhibitor of the major exonuclease. RecA, a repair 
protein, is also included8. Fu et al., 2012 cloned ten hidden biosynthetic pathways from digested genomic 
DNA of Gram-negative P. luminescens using LLHR, and two of these have been successfully expressed in 
E. coli7,9. Many gene clusters have also been cloned by this method, including the syringolin, glidobactin, 
and colibactin gene clusters10–12, and all are from Gram-negative strains.
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An emerging idea in cancer biology is that tumors harbor a group of cells, known as cancer stem 
cells (CSCs), which have the unique ability to regenerate cancers13,14. In addition to promoting tumor 
growth, growing evidence indicates that CSCs may be responsible for cancer recurrence, resistance to 
conventional treatments and metastasis15–18. Recently, Lander et al., 2009 showed that salinomycin can 
selectively kill breast CSCs after screening 16,000 compounds19. Further studies revealed that salinomy-
cin has potent and selective activity against other cancer cell lines20,21. In vitro data revealed that salin-
omycin pre-treatment reduced the tumor-seeding ability of cancer cell lines greater than 100-fold over 
the chemotherapy drug paclitaxel. Furhtermore, salinomycin reduced mammary tumor size in mice to 
a greater extent than paclitaxel19.
Salinomycin is produced by Streptomyces albus22 and has been used to prevent Coccidioidomycosis in 
poultry and alter gut flora to improve nutrient absorption in ruminants23. The compound interferes with 
potassium transport across mitochondrial membranes, thus reducing intracellular energy production. 
It may also disrupt Na+/Ca2+ exchange in skeletal and, in some cases, cardiac muscle, allowing a fatal 
accumulation of intracellular calcium24.
Earlier results revealed that the polyketide chain of salinomycin is synthesized by an assembly line of 
nine PKS multienzymes (salAI–IX). The nine PKS genes are collinearly arranged in the cluster. Four of 
these multienzymes (salAIV, salAVI, salAVII, and salAIX) each catalyze a single extension module, while 
the other five (salAI, salAII, salAIII, salAV, and salAVIII) encode two extension modules. In addition to 
the nine PKS genes, some other genes play vital roles in salinomycin biosynthesis25,26. Upstream of the 
PKS genes, the adjacent orf1, orf2, and orf3 do not belong to the salinomycin cluster, but salN and salO 
encode putative regulatory proteins. SalP and SalQ are involved in the formation of the butyrate extender 
unit for salinomycin biosynthesis, and inactivation of salP and salQ reduced the yields of salinomycin 
by 10% and 36%, respectively when compared to wild-type26. Downstream of the PKS genes, orf18 is 
predicted to encode a peptidyl carrier protein, and targeted inactivation of orf18 results in a 50–60% 
reduction in salinomycin production compared to wild-type25.
Herein, we report the cloning of the 106-kb salinomycin gene cluster (salO-orf18) from the genomic 
DNA of Streptomyces albus DSM41398 by three rounds of direct cloning followed by assembling. All 
of the genes are oriented in the same direction and under the original promoters. The gene cluster was 
introduced into S. coelicolor A3(2) for successful heterologous production of salinomycin.
Results
Constructing a BAC vector for direct cloning of the salinomycin gene cluster by quadruple 
recombineering. In order to construct a vector for direct cloning of the salinomycin gene cluster, 
the four fragments (backbone of pBeloBAC11, amp-ccdB, salO, and orf18) each had a 50-bp overlapping 
sequence, as illustrated in Fig. 1, and were co-electroporated into GB05dir-gyrA4625, a CcdB-resistant E. 
Figure 1. Quadruple recombineering of the BAC vector for direct cloning of the salinomycin gene 
cluster. pBeloBAC11 was linearized by BamHI, and three fragments (salO, amp-ccdB, and orf18) were 
obtained by PCR. An ampicillin resistance gene and ccdB were co-expression under the same promoter.
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coli strain containing the mutation GyrA R462M27,28 and LLHR-proficient recombinase (RecET, Redγ , 
and RecA), to form the BAC vector by quadruple recombineering.
The BAC vector contained a homology arm to salO (292 bp) and orf18 (238 bp) and a cassette of the 
counterselection marker CcdB, which can be used to delete the background from the original BAC vector 
for direct cloning. A CcdB function test was performed as described previously5.
Direct cloning of the salinomycin gene cluster. As mentioned above, salO encodes putative reg-
ulatory protein and orf18 is an essential factor for salinomycin production. Additionally, the restriction 
site (EcoRV), which can be utilized for direct cloning, is located in salO and orf18. Thus, we attempted 
to directly clone the 106-kb fragment (salO-orf18) using one and two-step recombination reactions7 with 
the BAC vector but were unsuccessful.
Hence, we divided the gene cluster into three fragments for direct cloning (Fig.  2a). We directly 
cloned the fragments of salO-salAIV (F1) and salAIX-orf18 (F3) using one step of LLHR7 with an effi-
ciency of 4/24 and 1/24, respectively (Fig. S1a,c). We directly cloned the fragment of salAIV-salAVIII 
(F2) by a two-step recombination with an efficiency of 8/24 (Fig. S1b). Due to the repeated sequence in 
salAIV-salAVIII (Fig. S2), we were unable to directly clone this fragment by one step of LLHR. Therefore, 
this fragment was isolated using a neomycin selection marker flanked by lox71-lox66, which could be 
utilized to delete the selection marker conveniently in the assembling procedure. The three desired 
fragments were inserted in plasmids p15A-amp-F1, p15A-amp-F2-lox71-neo-lox66, and p15A-amp-F3, 
respectively.
Assembling of the salinomycin gene cluster and engineering for conjugation and integra-
tion. Figure  2b show the assembling procedure to reconstitute the entire cluster. F2 and F3 were 
ligated using the original restriction site of AsiSI/EcoRV in the gene cluster, which did not cause 
any open reading frame shift. The neomycin selection marker was deleted by Cre from the plasmid 
Figure 2. Diagram of direct cloning and assembling of the salinomycin gene cluster and engineering 
for conjugation and integration. (a) Genomic DNA was digested by restriction enzymes to produced three 
fragments, which were recombined with p15A-amp after direct cloning. Fragment F2 was isolated using the 
neomycin selection marker. (b) Three fragments were assembled. Fragments F2 and F3 were assembled by a 
ligation reaction. F1 and F2&3 were assembled together by triple recombineering to produce pBeloBAC11-
sal-lox71-neo-lox66. (c) The neomycin selection marker was deleted by Cre from the pBeloBAC11-sal-lox71-
neo-lox66 plasmid, and the integrase-attP-oriT-apramycin cassette was inserted into the noncoding sequence 
to generate the final construct, pBeloBAC-sal-int-attP-oriT-apr. hyg, hygromycin resistance gene; amp, 
ampicillin resistance gene; neo, neomycin resistance gene.
www.nature.com/scientificreports/
4Scientific RepoRts | 5:15081 | DOi: 10.1038/srep15081
p15A-amp-F2-lox71-neo-lox66 to produce p15A-amp-F2. Modifications were made to p15A-amp-F3 
with two steps of recombineering. The neomycin selection marker flanked by lox71-lox66 was inserted 
into the non-coding sequence of F3 in the first recombineering step. The second recombineering step 
replaced the ampicillin selection marker with the hyg-ccdB cassette to produce p15A-hyg-ccdB-F3-lox
71-neo-lox66. F3 was excised by AsiSI/EcoRV and inserted into the AsiSI/EcoRV site in p15A-amp-F2 
by ligation to produce p15A-amp-F2&3-lox71-neo-lox66.
The ampicillin selection marker of the previous ligation product was replaced by the hyg-ccdB cas-
sette to produce the plasmid p15A-hyg-ccdB-F2&3-lox71-neo-lox66. The plasmid p15A-amp-F1 was 
digested by EcoRV to release the fragment F1, and p15A-hyg-ccdB-F2&3-lox71-neo-lox66 was digested 
by EcoRV/MseI to excise F2&3-lox71-neo-lox66. The two fragments overlapped by 592 bp, and each 
fragment had a homologous arm with previously constructed BAC vector. The BAC vector was trans-
formed into GB05 cells harboring the plasmid pSC101-ccdA-gbaA. As CcdB is toxic, we induced 
CcdA, that inactivates the CcdB toxin, by rhamnose in the liquid medium or culture plates. The two 
previous linearize fragments were co-transformed into GB05 cells containing the BAC vector and the 
expression plasmid (pSC101-ccdA-gbaA) to produce pBeloBAC11-sal-lox71-neo-lox66. We verified 
pBeloBAC11-sal-lox71-neo-lox66 using three restriction enzymes, the results (Fig. S3) showed that the 
pBeloBAC11-sal-lox71-neo-lox66 was correct.
To introduce the gene cluster into a heterologous expression host, few necessary elements were engi-
neered before conjugation. The two step engineering procedure for conjugation and integration is dia-
grammed in Fig. 2c. Finally, the gene cluster was introduced into S. coelicolor A3(2) by conjugation and 
integrated into its chromosome.
Heterologous production of salinomycin in S. coelicolor A3(2). The genetic organization and 
promoters of the obtained salinomycin gene cluster are identical to those of the original producer S. albus 
DSM41398. After conjugation, the exconjugant colonies were confirmed by PCR and subsequently ana-
lyzed for heterologous salinomycin production. The salinomycin gene cluster was successfully inserted 
into the attB site of S. coelicolor A3(2) (Fig. S4).
The metabolite profiles of the wild-type S. coelicolor and the mutant strains S. coelicolor::sal were 
analyzed by HPLC-MS and compared with the salinomycin standard (Fig. 3a (Ref)). Thus, we were able 
to identify Salinomycin in extracts of the mutant strains S. coelicolor::sal via HPLC-MS (Fig. 3a,b) and 
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Figure 3. Heterologous salinomycin production. (a) HPLC-MS analysis (base peak chromatograms (BPC) 
m/z 200–2000+ All MS) of the salinomycin standard (Ref), the wild-type S. coelicolor A3(2) and mutant S. 
coelicolor::sal. Salinomycin is indicated by an asterisk. (b) MS2 fragmentation patterns of precursor m/z 733.5 
[M–H2O+ H]+ in standard salinomycin and in S. coelicolor::sal mutant.
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heterologous expression could be unambiguously confirmed by comparing MS2 fragmentation pattern 
(Fig. 3c).
Discussion
Over the past several decades, numerous multifunctional megasynthases have been identified, cloned, 
sequenced, engineered, and heterologously expressed in suitable hosts. Traditionally, natural product 
biosynthetic gene clusters were retrieved from a single cosmid or reconstructed from several cosmids 
within a genomic library of the natural producer stain, which was time consuming due to subsequent 
cloning steps following the screening process from a genomic library4,29.
LLHR-mediated recombineering was ideal for direct cloning of the salinomycin gene cluster from 
pre-digested genomic DNA after one or two steps of recombineering7. Red/ET recombineering has tra-
ditionally been applied for heterologous expression of biosynthetic pathways to modify the biosynthetic 
pathways30.
The failure to directly clone the 106-kb fragment with the BAC vector may have resulted from several 
considerations. First, the recombineering efficiency is very low for large fragments. Although the devel-
oped method of direct cloning is efficient for cloning up to ~52-kb fragments from a bacterial genome7, it 
is limited by inefficient co-transformation of two linear molecules, especially for long fragments (106 kb). 
Moreover, the gene cluster contains GC-rich sequences. We studied the impact of the GC content on the 
recombineering efficiency and found that it was decreased for sequences with high GC content (data not 
shown). Second, enrichment of the target DNA is difficult after extracting the genomic DNA. Genomic 
DNA is susceptible to shearing forces associated with mechanical destruction and degradation by nucle-
ase activity. Therefore, it is difficult to obtain the intact salinomycin biosynthesis gene cluster, especially 
for S. albus DSM 41398, the gram-positive strain. Third, previous data revealed that the Redβ monomer 
anneals ~11 bp of DNA, and the smallest stable annealing intermediate requires only 20 bp of DNA and 
two Redβ monomers31. In this study, we found that most of the colonies resulted from self-circularization 
of the vector used for direct cloning after recombineering although there were no obvious homologous 
regions in the backbone of the vector. As a result, it is difficult to screen the correct clone from thousands 
of self-circularized vectors.
In parallel to our LLHR-mediated direct cloning, the other DNA cloning methods for bioprospecting 
have their distinct merits. LLHR-mediated RecET direct cloning was not accessible to metagenomic 
DNA. Bioprospecting of metagenomics needs DNA synthesis and assembly method. Streptomyces phage 
φ BT1 integrase-mediated in vitro site-specific recombination could assembly the 56 kb epothilone bio-
synthetic gene cluster using modules as units. The authors didn’t prove that the complete gene cluster 
with att site scars could be expressed in a heterologous host32. The incorrect linker between modules 
might affect the biosynthesis33. An intact DNA sequence can be obtained by the Gibson assembly34,35, 
which is the most efficient ‘chew back and anneal’ method36–38. The Gibson assembly was also proved to 
be capable of direct cloning of a 41 kb conglobatin biosynthetic gene cluster39. Much larger DNA frag-
ment can be directly cloned by transformation-associated recombination (TAR) in yeast Saccharomyces 
cerevisiae40,41. However unregulated yeast homologous recombinase might cause rearrangement of repet-
itive PKS/NRPS biosynthetic DNA sequences. The oriT-directed cloning for Gram-negative bacteria 
relies on available genetic tools to insert conjugation elements on the genome by two elaborated vectors. 
Although it is not straight forward, it has a capacity of cloning regions up to 140 kb from the genome 
of Burkholderia pseudomallei42. The phage φ BT1 integrase-mediated direct cloning was developed for 
Gram-positive bacteria Streptomyces. It has the similar logic to oriT-directed cloning, which starts with 
integration of a capture vector by genome engineering at two spots, but both excision and circulariza-
tion happen in the original bacteria43. If Bacillus subtilis is justified as a suitable heterologous host for a 
biosynthetic gene cluster, its genome can be used as a vector for direct cloning of giant DNA, which has 
the potential to overcome the capacity limit of the BAC vector44.
Compare to above methods our LLHR-mediated direct cloning has a significant feature. It is a genetic 
tool in E coli, which is simple, convenient and cost-effective. The important improvement in this study is 
to combine RecET mediated direct cloning and lambda Red mediated plasmids stitching to hierarchically 
clone the intact 106kb salinomycin gene cluster. The reliability of the cloning method has been proved 
by subsequently successful heterologous expression in S. coelicolor A3(2). Our results represent a potent 
approach to mine the function of the individual genes and identify novel and potentially useful analogues 
of the complex natural products through module exchange in the recipient.
Methods
Strains, plasmids and culture conditions. The bacterial strains and plasmids used in this study are 
shown in Table S1. All primers were synthesized by Sigma-Genosys (Germany) (Table S2). All restriction 
enzymes, Taq polymerase, and DNA markers were purchased from New England Biolabs (UK).
E. coli cells were cultured in Luria-Bertani (LB) liquid media or on LB agar (1.2% agar). Ampicillin 
(amp, 100 μ g mL−1), kanamycin (km, 15 μ g mL−1), chloramphenicol (cm, 15 μ g mL ), hygromycin (hyg, 
30 μ g mL−1), apramycin (apr, 15 μ g mL−1), and tetracycline (tet, 5 μ g mL−1) were added to the media as 
required.
For sporulation and conjugation, S. coelicolor A3(2) was grown on mannitol salt (MS) agar plates for 
10 days. If necessary for conjugation, apr (50 μ g mL−1) and nalidixic acid (NA, 50 μ g mL−1) were added.
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S. albus DSM41398, S. coelicolor A3(2), and mutant strains were cultivated in M1 medium (10 g L−1 
starch, 4 g L−1 yeast extract, 2 g L−1 peptone) at 30 °C with constant agitation at 180 rpm.
Bacterial genomic DNA isolation. S. albus DSM41398 was cultured in 30 mL medium (4 g L−1 
glucose, 4 g L−1 yeast extract, 10 g L−1 malt extract, pH 7.2) at 30 °C for two days. After centrifugation, 
the cells were resuspended in 5 mL SET buffer (75 mM NaCl, 25 mM EDTA, 20 mM Tris, pH 7.5). After 
adding lysozyme to a final concentration of 1 mg mL−1 and incubating at 37 °C for 0.5–1 h, 500 μ L 10% 
SDS and 125 μ L 20 mg mL−1 proteinase K were added, and the mixture was incubated at 55 °C with occa-
sional inversion for 2 h until the solution became clear. The solution was combined with 2 mL 5 M NaCl 
and 8 mL phenol:chloroform:isoamyl alcohol (25:24:1) and incubated at room temperature for 0.5 h with 
frequent inversion. After centrifuging at 4500 × g for 15 min, the aqueous phase was transferred to a new 
tube using a blunt-ended pipette tip, and the DNA was precipitated by adding one volume of isopropanol 
and gently inverting the tube. DNA was transferred to a microfuge tube, rinsed with 75% ethanol, dried 
under vacuum, and dissolved in ddH2O.
Preparation of electrocompetent cells for recombineering. Recombineering and direct cloning 
were performed as described previously7 with several small modifications. The linear cloning vector 
p15A-amp, flanked with homology arms to target genes, was amplified by PCR using p15A-amp-ccdB5 as 
a template. Digested genomic DNA (10 μ g) was mixed with 2 μ g linear cloning vector and co-transformed 
into competent cells by electroporation.
Conjugation. Conjugation between E. coli and S. coelicolor A3(2) was performed as described pre-
viously with minor modifications45. The plasmid containing the salinomycin gene cluster and elements 
for conjugation and integration was transformed into the donor strain E. coli ET12567 (pUZ8002). The 
donor strain was prepared by growth overnight at 37 °C in LB supplemented with antibiotics. The over-
night culture was diluted 100-fold in 15 mL fresh LB plus antibiotic and grown at 30 °C to an OD600 of 
0.3. The E. coli cells were washed twice with an equal volume of LB and resuspended in 0.1 volume LB. 
S. coelicolor A3(2) mycelia fragments were harvested from a four-day-old culture in TSB medium and 
served as the recipient strain. The donor strain and recipient strain were mixed with equal volumes, 
the mixture was centrifuged, and the supernatant was discarded. Finally, the pellet was resuspended in 
the residual liquid. The mating mixture was spread on MS plates and incubated at 30 °C. After 24 h, the 
cells were collected and spread on MS plates with NA (50 μ g mL−1) and apr (50 μ g mL−1) and further 
incubated at 30 °C until exconjugant colonies appeared.
Extraction and analysis of the compound. S. coelicolor::sal gene cluster cells were cultivated in 
300-mL flasks containing 30 mL M1 medium supplemented with apr (25 μ g mL−1). The culture was 
grown at 30 °C with constant agitation at 180 rpm. After 13 days, the biomass was harvested by centrif-
ugation, and 2% resin Amberlite XAD-16 was added to the supernatant before the resin was extracted 
with methanol. The received extracts were evaporated and dissolved in methanol and used for HPLC-MS 
analysis. The HPLC-MS measurement was performed on a Dionex Ultimate 3000 LC system utilizing 
a Waters Acquity BEHC-18 column (50 × 2 mm, 1.7-μ m particle size). Separation of 2 μ L sample was 
obtained using a linear gradient of A (water and 0.1% formic acid) and B (acetonitrile and 0.1% formic 
acid) at a flow rate of 600 μ L min−1 at 45 °C. The gradient was initiated by a 0.5-min isocratic step at 5% B 
followed by an increase to 95% B over 9 min and a final 1.5-min step at 95% B before reequilibration with 
initial conditions. UV spectra were recorded by a DAD from 200–600 nm. MS measurement was carried 
on an amaZon speed mass spectrometer (Bruker Daltonics, Bremen, Germany) using the standard ESI 
source. Mass spectra were acquired in centroid mode ranging from 200–2000 m/z in positive ionization 
mode with auto MS2 fragmentation.
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Table S1 Strains and plasmids 25 
Strain or plasmid Characteristics References or sources 
E. coli   
GB05 F-mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 endA1 araD139 ∆(ara, leu)7697 galU galK λ rpsL 
nupGfhuA::IS2 recET redα, phage T1-resistent 
1
 
GB06 endA1glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ Δ(lac-proAB) e14- [F' traD36 proAB+ lacIq lacZΔM15] hsdR17(rK-mK+) 
rpsLrecET phage T1-resistent 
 
GB05-dir GB2005, araC-BAD-ETγA 
2
 
GB05-red GB2005, araC-BAD-γA 
1
 
GB05dir-gyrA462 GB05dir, gyrA462 (ccdB resistant) 
3
 
GB05red-gyrA462 GB05red, gyrA462 (ccdB resistant) 
3
 
ET12567(pUZ8002) recF, dam-, dcm-, CmR, KmR 
4
 
Streptomyces   
S. albus DSM41398 Salinomycin-producing wild-type strain DSMZ 
S. coelicolor A3(2) Recipient strain of gene cluster 
5
 
S. coelicolor::sal Salinomycin gene cluster in the chromosome, aprR This study 
Plasmid   
pSC101-BAD-Cre-tet Cre under BAD promoter, tetR 
6
 
pSC101-rha-ETgA-tet RecET, redγ and RecA under rha promoter, tetR This study 
pBeloBAC11-amp-ccdB-4Sal pBeloBAC11, the vector for direct cloing, ampR This study 
p15A-amp-F1 p15A replicon, contained the fragment of salO-salAIV, ampR This study 
p15A-amp-F2-lox71-neo-lox66 p15A replicon, contained the fragment of salAIV-salAVIII and the cassette of lox71-neo-lox66, ampR, kmR This study 
p15A-amp-F3 p15A replicon, contained the fragment of salAIX-orf18, ampR This study 
p15A-amp-F2 p15A replicon, the neo selection marker was deleted by Cre from the p15A-amp-F2-lox71-neo-lox66, ampR This study 
p15A-hyg-ccdB-F3-lox71-neo-lox66 p15A replicon, two cassettes of hyg-ccdB and lox71-neo-lox66 was integrated into the p15A-amp-salAIX-orf18, hygR, kmR This study 
p15A-amp-F2&3-lox71-neo-lox66 p15A replicon, contained the fragment of salAIV-orf18 and the cassette of lox71-neo-lox66, ampR, kmR This study 
pBeloBAC11-sal-lox71-neo-lox66 pBeloBAC11, contained the whole salinomycin PKS and the cassette of lox71-neo-lox66, kmR This study 
pBeloBAC-sal-int-attP-oriT-apr pBeloBAC11, contained the whole salinomycin PKS, an origin of transfer(oriT), attP sequence and integrase gene, aprR This study 
   
 26 
 27 
 28 
 29 
 30 
 31 
 32 
 33 
 34 
 35 
 36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
Table S2. Oligonucleotides 44 
Gene  
Primer 
name 
Primer sequence 5’-3’ 
Restriction 
enzymes sites 
application 
salO salO-5 AGTGAATTGTAATACGACTCACTATAGGGCGAATTCGAGCTCGGTACCCGGTGGACGAGACCCGACCGCG  BAC vector 
 salO-3 GGCCCGCCAGCGGTCCATCA  BAC vector 
orf18 Orf18-5 CTAATGAGCGGGCTTTTTTTTGAACAAAACAACTTATATCGTATGGGGCTGGATCCttATGACCCGCCCCGCCCCCTG BamHI BAC vector 
 Orf18-3 GTGACACTATAGAATACTCAAGCTTGCATGCCTGCAGGTCGACTCTAGAGaTCACCACGGCCACCCCTCGG  BAC vector 
Amp-ccdB 
 
Amp-ccdB-5 ATGCAGAGCGAACTGGCCACCCTGATGGACCGCTGGCGGGCCCGCCGCGCCGGGAGTTGAGGATCCTTTGTTTA
TTTTTCTAAATA 
BamHI BAC vector 
 Amp-ccdB-3 AGCCCCATACGATATAAGTT  BAC vector 
salO-salAIV salO-salAIV-
3 
CGCTCGCGCCGGGAGCCGGGTTCGCGCTCCCGGCCGACCATGTGGATCTGCGAGAGGTAGCGGACCGCGCCG
GATATCTTACCAATGCTTAATCAGTG 
EcoRV 
 
Direct cloning 
 
salO-salAIV-
5 
CCAGCTGGAGGCGGACCTGCTGTCCGTCGCCCTGGACAAGGACGAACGCAAGAACCTCACCCGGCGCCTCGAA
GGATATCACAACTTATATCGTATGGGG 
EcoRV 
 
 
salAIV-salAVIII salAIV-salAV
III-3 
TCCGAGAGCAGCGGGGCGGGTCGCGCGGAGGTGAACAGCGGCCAGAACCGCTCCCAGTCCACGTCCGCGACG
GCGATTAATACAACTTATATCGTATGGGG 
MseI 
 
Direct cloning 
 salAIV-salAV
III-5 
CGACGCGCTCCTCGAGCTCGGCGCCGCCCCGGTCGGCGAGACGGCCGCGCAGCAACCGCAGCAG 
GCCGCGGCGATCGCACTGTAGATATCTTACCAATGCTTAATCAGTG 
AsiSI&EcoRV  
salAIX-orf18 
 
salAIX-orf18
-3 
TCCGCTCCACGGGCGCGTCAGGAGTTGCTGTTGTCGAGGGCCAGCGAGACGAGGGCGTCGACGTC 
CATCTCGGCGATCGCACAACTTATATCGTATGGGG 
AsiSI 
 
Direct cloning 
 salAIX-orf18
-5 
TCGAGGACGACTTCGGCCTCGCCGTCGACCCCCGCCTCGCCCGCGAACTCCCCACCGTGACCGCCCTCGCCGG
ATATCTTACCAATGCTTAATCAGTG 
EcoRV  
lox71-neo-lox66 sal-km-5 CCTGCTCGACGACGAACTCGAAACGAAATAACCCATGAACGGCGCCGCTTTACCGTTCGTATAATGTATGCTATACG
AAGTTATTCAGAAGAACTCGTCAAGAAG 
 Direct cloning 
 sal-km-3 AACTCAGTCACCTACCGGAAACAGGACCGGGCACGGGAAGCGGAAGGCCGTACCGTTCGTATAGCATACATTATAC
GAAGTTATGCTTGCAGTGGGCTTACAT 
  
Hyg-ccdB hygccdb-5 TTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCCCTAGGTTATATTCCCCAGAACATCA  Assembling 
 
hygccdb-3 ATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAGGAGGCCTAGGTATGAAAAAGCCTGAA
CTCAC 
  
lox71-neo-lox66 kan-5 GTAGAGCGCCACCATCAGATGCGCGTGGAACTCCTCGCGCAGCGGGAACTTACCGTTCGTATAGCATACATTATAC  Assembling 
GAAGTTATGCTTGCAGTGGGCTTACAT 
 kan-3 GACGAGGAGGATGTTCTCGGCGGGCACCTCGAACTCCTCGGCGATCAGCATACCGTTCGTATAATGTATGCTATAC
GAAGTTATTCAGAAGAACTCGTCAAGAAG 
  
Integrase-attP-o
riT-Apramycin 
intApSal5 TAGAGCGCCACCATCAGATGCGCGTGGAACTCCTCGCGCAGCGGGAACTTAGATCAGGCTTCCCGGGTGTC  Engineering 
 intApSal3 CGCGGGCCGTGTCCCTCAAGTCCAGCAGGTCCGCGCGCAGTTGGCGGGTCTGACGCTCAGTGGAACG   
 attB-L CAGGTTCACCCACAGCTG  Verification 
 attB-R CTCAACTAAAGTGGGGCG  Verification 
 attP-dn AAATGCCCGACGAACCTGAA  Verification 
 attP-up TCGCTATAATGACCCCGAAGCAG  Verification 
Underlined sequences indicate homology arms. 45 
Bold letters represent restriction enzyme sites. 46 
 47 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1 Digestion of the direct cloning products. (a) Products of fragment F1 were 
digested by NcoI. M, 1-kb NEB ladder. 1–24, clones obtained from direct cloning. (b) 
Products of fragments F2 and (c) F3 digested by PvuII. M, 1-kb NEB ladder. 1–24, 
clones obtained from direct cloning. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2 Alignment analysis of the F2 fragment and itself. The repetitive sequences 
were marked as same numbers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3 Digestion of pBeloBAC11-sal-lox71-neo-lox66. The three fragments were 
stitched into pBeloBAC11, and the correct clone was confirmed by three restriction 
enzymes: AscI (1), ApaLI (2), and (BgIII (3). M: Marker (NEB 1-kb DNA ladder). 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4 PCR verification of salinomycin gene cluster integration into the attB site 
in S. coelicolor A3(2). (a, b) Diagram of the PCR procedure in the wild-type (a) and 
mutant (b) strains using the indicated primers. Primers attB-L and attB-R were 
dependent on the sequence of S. coelicolor A3(2). Primers attP-down and attP-up 
were based on the BAC sequence. (c) PCR products and primer pairs. (d) Agarose gel 
containing PCR-amplified DNA fragments using to the primer pairs in (c). M, Marker; 
N, wild-type S. coelicolor A3(2); 1, exconjugant colonies. 
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1. Development of a novel improved Red/ET recombination method 
Introduction of foreign DNA into E. coli (transformation) is a basic and essential step 
for mutagenesis and genetic engineering of microorganisms. In order to enhance 
transformation efficacy, several methods have been reported in the literature to 
introduce exogenous DNA into the cells, including chemical treatment (using divalent 
cations like Ca2+), electroporation, polyethylene glycol, utilization of a biolistic gun, 
ultrasound, hydrogel, and microwave techniques.202 Among these methods, 
electroporation has been proven to be most useful and convenient to genetically 
transform a number of microorganisms used for genetic studies.203  
The phage-derived homologous recombination systems, well known as 
recombineering, have been developed into very helpful DNA engineering 
technologies performing in electrocompetent cells,83,204 and it is very important to 
increase the transformation efficiency which means the number of cells transformed 
out of one microgram DNA. 
The novel transformation of electrocompetent cells presented here, prepared at room 
temperature (named as room temperature competent cells), showed almost 10 times 
higher transformation efficiency than the conventional ice-cold electrocompetent cells 
in our research (Figure 3-1). As is well known, the electrocompetent cells were 
always prepared on ice in the conventional electroporation transformation, including 
other supplies, such as cold pre-chilled cuvette, buffer, and centrifuge. At such low 
temperatures, cell membrane topology would be modified for electrocompetent cells, 
and the fatty acid tails of the phospholipids in the cell membrane become more rigid, 
which that impacts membrane fluidity and permeability, and in turn, cell survival.205 
In addition, a remarkable raise occurred in the permeability of cell’s plasma 
membrane, which was used to introduce exogenous DNA into bacterial cell during 
electroporation process due to externally applied electric field.203 These structural 
perturbations were associated with characteristic disturbances of function such as loss 
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of selective permeability. Afterwards, according to the electroporation theory, 
hydrophobic pores in the cell membrane were formed spontaneously by lateral 
thermal fluctuations of the lipid molecules,205 which suggested that hydrophobic pores 
formation would be enhanced at higher temperatures. Moreover, previous research 
found that the cell membranes underwent major morphological changes with respect 
to constantly changing environmental conditions, including temperature.206  
 
Figure 3-1. Transformation efficiency of competent cells with temperature shift, E. coli 
GB2005 cells transformed by plasmid pGB-amp-Ptet-plu1880 (27.8 kb) were plated on Amp 
plates. 1, the normal ice-cold method for preparing electrocompetent cells; 2, every step was 
done at RT; 5, no plasmid DNA. Error bars, s.d.; n = 3. 237 
 
Recombineering is now a central technology for recombinant DNA engineering, as 
well as the method of choice for bacterial genome engineering.116 In order to improve 
recombination efficiency, many parameters had been described previously.116,207,208 
For our Red/ET recombineering, whether LLHR by RecET or LCHR by Redαβ, the 
recombineering efficiency tests were also performed at room temperature. 
Interestingly, the situation in these two types of recombineering were not as good as 
we expected and the result was different. The reason was attributed to the instability 
of the Red recombinases (Red alpha and beta), which are related to LCHR 
recombineering while preparing the competent cells at room temperature. In a word, 
no one protocol was best for all the DNA manipulation. 
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Using improved Red/ET recombineering with room temperature competent cells, the 
secondary metabolite pathways can be more easily and rapidly performed in E. coli. 
We can take the appropriate procedure in the complex different cases, whether using 
room temperature competent cells in transformation, LLHR or cold temperature 
competent cells in LCHR. Additionally, in some cases, it is more deliberate in the 
construction of metabolite biosynthetic gene clusters because of knowing the 
minimum homology arms for recombineering. DNA transformation and 
recombineering are very critical steps in the study of synthetic biology in the recent 
revolution for discovering thousands of biosynthetic gene clusters and novel natural 
compounds. The transformation of exogenous DNA by room temperature competent 
cells in several other Gram-negative bacteria (Agrobacterium, Burkholderia, 
Photorhabdus and Xenorhabdus) have also been accomplished by our group, which 
demonstrates the powerful capability and wide adaptability of room temperature 
competent cells for potential bioprospecting. The improved approach will be a new 
guide and standard for our Red/ET recombineering in the future. 
 
2. Several applications in mining microbial genomes via Red/ET technology, 
including disorazol, salinomycin and magnetosome product 
Next, we used this developed transformation technique combined with direct cloning 
and other Red/ET methods for cloning and engineering of known disorazol gene 
cluster from Sorangium cellulosum So ce12 and salinomycin gene cluster from S. 
albus DSM41398, and for the challenging magnetosome gene clusters from M. 
gryphiswaldense. 
2.1 Disorazol 
Disorazol, initially isolated from the fermentation broth of the myxobacterium 
Sorangium cellulosum So ce12 in 1994,196 represents a class of antibiotics exhibiting 
inhibitory activity on cancer cell proliferation at low picomolar 
concentrations.197,198,209 Disorazols are the third group of myxobacterial secondary 
metabolites that interfere with tubulin polymerization following behind epothilones238 
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and tubulysins.239 Because of this extraordinary potency, disorazols were fostered for 
development as peptide-conjugates for cancer therapy in drug discovery.210,211 Later 
on, the dis biosynthetic gene cluster was identified in 2005 by two independent groups 
through transposon mutagenesis.212,213 The whole disorazol gene cluster was larger 
than 60 kb with four main genes which were named disA-D.212 After comparison with 
databases, the anticipated disA-C genes encoded hybrid trans-AT type I PKS/NRPS 
megaenzymes, and the last gene disD encoded an additional acyl transferase protein. 
Our findings are in agreement with these results. 
In this work, we reconstituted the 58-kb dis core gene cluster from BACs212 into a 
p15A replication origin (p15A ori) via Red/ET recombineering and expressed in M. 
xanthus DK1622. Gene clusters with moderate sequence complexity are usually stable 
in the p15A plasmid.155 Additionally, disorazol was highly toxic to the host cell due to 
its biological activity. All the E. coli strains harboring the core dis gene cluster with 
native promoter were found to carry mutations after recombineering. Therefore, to 
solve the issue, an inducible promoter Ptet was used to regulate gene expression 
because of its achievements in enabling several mixed PKS/NRPS natural products in 
many diverse hosts unrelated to the native producing organisms, including E. coli, M. 
xanthus and P. putida116,129,168,214,215. 
The dis gene cluster was randomly transposed into the chromosome of the 
heterologous host M. xanthus DK1622 by electroporation and several recombinants 
were verified by PCR126 to confirm that the dis gene cluster had been integrated into 
the M. xanthus chromosome in each case. After fermentation of mutants M. 
xanthus::p15A-dis, we demonstrated that the main compound disorazol A2 was 
produced at 5-fold higher levels than described in the native producer strain So 
ce12.196,216 The reason for this enhancement could be the effect of promoter Ptet which 
could raise transcription rate of the dis gene cluster. 
Disorazol was characterized to be a typical trans-AT type PKSs. Based on the 
successful heterologous expression model, more research had been focused on the 
special AT domain (disD gene) of this trans-AT type PKS. According to the results of 
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overexpression the discrete disD gene, the yield of disorazol increased approximately 
2.5-fold when compared to the ones without overexpression. The event obviously 
indicated and confirmed the crucial position of the special AT domain in disorazol 
biosynthetic pathway. Enough supplementation of DisD could boost metabolite 
quantities to a modest extent. It was worth mentioning that the production of disorazol 
was currently limiting further progress of the compounds as neither synthetic nor 
fermentative methods had resulted in sufficient production strategies. Notably, 
abundant substrates consisting of sufficient ATs would facilitate the PKS module 
efficiency for polyketide chain extension of disorazol biosynthesis leading to elevated 
production.  
Furthermore, successful heterologous expression of known full-length disorazol gene 
cluster in M. xanthus DK1622 is another considerable mirror for Red/ET 
recombineering application in engineering metabolites biosynthetic gene clusters in 
the myxobacteria which own an ample source of natural products with biological 
activity. Disorazol, a novel macrocyclic compound with two oxazol rings, has almost 
highest inhibitory effects on mammalian cells ever recorded for a natural product. 
Clearly, it seems that disorazol has great potential development and market value. 
However, the first limitation of disorazol promotion is the drug production. The native 
natural product producer So ce12 grow poor and slowly even in optimized laboratory 
conditions. In this case, in order to increase the yields and industrialize development 
of disorazols, a surrogate heterologous host must be invested for the reconstitution 
and genetic manipulation of dis biosynthetic pathways. A multitude of shared 
heterologous hosts are chosen to express such potential clinic compound because of 
theirs fast growth rate and the ease of achieving genetic manipulations, including M. 
xanthus DK1622 here. All sorts of trials are provided towards a total synthesis of 
disorazol and to expand a natural derivative as an anticancer drug. 
2.2 Salinomycin 
Salinomycin, an antibiotic potassium ionophore with an unique tricyclic spiroketal 
ring system and an unsaturated six-membered ring isolated from Streptomyces 
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albus,201 has been described to exhibit high antimicrobial activity against 
Gram-positive bacteria and murder breast cancer stem cells in mice at least 100 times 
higher effectively than paclitaxel.217-219 Previous studies have stated that the 
polyketide chain of salinomycin was synthesized by an assembly line of nine PKS 
multienzymes (named salAI, salAII, salAIII, salAIV, salAV, salAVI, salAVII, 
salAVIII and salAIX).220,221 Here, the 106 kb salinomycin gene cluster (salO-orf18) 
was cloned from the genomic DNA of Streptomyces albus DSM41398 by three 
rounds of direct cloning (LLHR) followed by assembly and successfully expression in 
a heterologous host S. coelicolor A3 (2), which resulted in the identification of 
salinomycin and its derivatives. All of the genes are oriented in the same direction and 
under the original promoters.  
At the beginning, we attempted to directly clone the 106 kb sal biosynthetic gene 
cluster (salO-orf18) using one and two-step recombination reactions116 with the BAC 
vector but were unsuccessful. The failure to this case might have resulted from several 
issues. Firstly, the direct cloning efficiency, both in transformation and 
recombineering, was quite low for large DNA fragments, especially with high GC 
content. Co-transformation of two large linear molecules inside the cell was difficult 
as well as the recombineering efficiency would also drop for sequences with GC-rich 
content (data not shown). Secondly, it was arduous to enrich the target DNA after 
extracting the genomic DNA whose stability could be damaged under the mechanical 
destruction and degradation by nuclease activity. Consequently, it was challenging to 
gain the intact sal biosynthesis gene cluster from S. albus DSM 41398 straight. 
Streptomyces is the largest genus of Actinobacteria who produce the large majority of 
characterized natural products.8 Over 500 species of Streptomyces bacteria have been 
described. With the purpose to analyze the known natural products biosynthetic gene 
clusters and discover the silent biosynthetic gene clusters in these precious resources, 
lots of genetic tools and approaches are developed for Streptomyces strains. Target 
secondary metabolite genes from Streptomyces were constructed and manipulated into 
bifunctional vectors in traditional E. coli species by the management of the λ Red 
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recombination system. Afterwards, the vectors were transformed into Streptomyces by 
conjugation and site-specific integrated into bacteriophage attachment (attB) sites for 
stable maintenance of the points. Consequently, target genes were expressed in model 
heterologous hosts for natural product production in modern biotechnology.      
In summary, our work represents a powerful approach to mine the function of the 
individual genes and identify novel and potentially valuable analogues of the complex 
natural products through module exchange in the recipient. 
2.3 Magnetosome products 
Magnetotactic bacteria (MTB), well known to synthesize magnetic nanocrystals with 
uniform shapes and sizes at physiological conditions, serve as a source of multiple 
biological macromolecules taken for the biomimetic synthesis of a whole host of 
magnetic nanomaterials.76 Only a limited number of MTB have been isolated in pure 
culture so far, including our target M. gryphiswaldense strain.222 According to the 4.3 
Mb genome draft sequence of M. gryphiswaldense,223 magnetosome-related mam and 
mms genes are organized as clusters in close proximity to each other.76,224 
These clusters are organized as a larger unit, the so-called genomic magnetosome 
island (MAI), in some species. However, although the gene clusters within the 
magnetosome island that are required for biomineralization have already been 
identified in 2010,228 successfully transferring these specific gene clusters or indeed 
the whole island to a different bacterium has remained an elusive aim till now. 
In our work, a minimal set of genes from the magnetotactic bacterium M. 
gryphiswaldense linked to magnetosome biosynthesis has been successfully expressed 
in the photosynthetic model organism Rhodospirillum rubrum (very close biological 
relationship to M. gryphiswaldense, whose 16S rRNA similarity to M. gryphiwaldense 
is 90%) using powerful Red/ET recombineering technology. These cassettes consist of 
four chief gene clusters on the magnetosome island that play either vital (mamAB 
gene, for magnetite biomineralization225) or regulatory (mamGFDC gene, for 
involving in controlling the size of magnetite crystals,226 mms6 gene, for the 
magnetosome membrane protein227 and mamXY gene) roles in magnetosome 
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formation. These expression cassettes were transformed into R. rubrum and cultivated 
under the same conditions (iron ions in solution, microaerobic or anaerobic 
environment) as M. gryphiswaldense. The host cells R. rubrum_ABG6 were found to 
be able to produce iron oxide particles of varying quality depending on which gene 
clusters were transferred. Consequently, the successful synthesis of magnetosomes 
within another organism expands the feasibility of commercialization of modified 
magnetosome production within bacteria which breaks the inexorable laws of 
nanomagnets under the strict control of magnetotactic bacterial genes. Similarly, 
depending on the use of Red/ET technology, a crucial following procedure would be 
integrated magnetosome biosynthetic gene clusters in E. coli and other easy-to-grow 
model bacterium. If fast-growing microbes could be utilized in the future to 
manufacture nanomagnets in a satisfied yield, higher value-added and greener 
industries for nanomagnets might emerge. Accompanied by a mass production of 
nanomagnets in a well-known model organism which is with the advantage of 
easy-control and stabilization, it could be widely used in development of targeted 
drugs, kits of early-diagnosis disease, heat treatment for tumor magnetic, molecular 
environment monitoring, and even the sealing materials for aviation helmet seals. 
In a word, the Red/ET recombineering art mediated activation and expression of 
complex biosynthetic gene clusters in various heterologous hosts is exhibited to be a 
cogent tool for synthetic biology, not only for antibiotic in PKS/NRPS but also for 
other type natural products. 
 
3. New molecular technologies are required for construction and modification 
of large gene clusters in microbial genomes 
It is well known that the development of recombinant DNA technology in E. coli 
occurred in the early 1970s while natural products was playing an increasing 
important part in its progress as all vectors used for cloning depended on the use of 
genes that conferred resistance to antibiotics (such as penicillin, aureomycin, 
streptomycin, etc.).100 Subsequently, multifunctional plasmids, such as P1 vectors, 
BACs, harboring the specialized secondary metabolite genes were constructed and 
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engineered in E. coli under the use of λ Red recombination genetic engineering 
methods.229-231 Afterwards, the modified target constructs would be transformed and 
expressed in a host that was closely associated to its native producer. In addition, all 
analytical means were in a state of rapid advance with the developing of determining 
gene expression (transcriptomics, RNA-Seq), enzyme levels (proteomics), precursor 
supply (metabolomics) in E. coli and other well-characterized heterologous hosts.  
Cloning, engineering and expression of long microbial genomic sequences in the 
chosen heterologous host is an effective approach in synthetic biology and genome 
engineering for natural products discovery and optimization, especially if the genomic 
sequences are derived from slow-growing bacteria or such one for which genetics are 
only poorly or not at all established. However, such large sequences (invariably more 
than 20 kb) are often arduous to acquire directly by traditional PCR or restriction 
enzyme digestion, and therefore the cloning of these sequences has remained a 
technical obstacle in molecular biology. 
Much of the research in the last two decades has reported several synthetic biology 
tools which have already been developed to directly capture entire biosynthetic gene 
clusters from complex genomic DNA sources, circumventing the laborious 
construction and screening of genomic libraries.163 RecET-mediated linear–linear 
homologous recombination (LLHR)116 or transformation-associated recombination 
(TAR),175 CRISPR/Cas9-mediated TAR,233 Cas9-assisted targeting of chromosome 
segments (CATCH),234 and ϕBT1 integrase-mediated site-specific recombination235 
are the present popular and powerful methods for direct capture of large DNA 
fragments from bacteria chromosome. Based on these advanced technologies, now 
gene cloning is not limiting genome mining anymore. Furthermore, with the 
continued technological and conceptual advances in bioinformatics, mass 
spectrometry, proteomics, transcriptomics, metabolomics and gene expression, the 
new field of microbial genome mining for applications in natural product discovery 
and development are gradually opening to scientists. Therefore, we predict a second 
“Golden Age for Antibiotics” and natural products discovery is coming. 
39 
 
 
D. References 
D. References 
 
1 Cragg, G. M. & Newman, D. J. Natural products: a continuing source of novel drug 
leads. Biochim. Biophys. Acta 1830, 3670-3695 (2013). 
2 Chin, Y. W., Balunas,M.J., Chai,H.B., & Kinghorn,A.D. Drug discovery from natural 
sources. AAPS Journal 8, E239-E253 (2006). 
3 Firn, R. D. J., C.G. Natural products - a simple model to explain chemical diversity. 
Nat. Prod. Rep. 20, 382-391 (2003). 
4 Ganesan, A. The impact of natural products upon modern drug discovery. Curr. Opin. 
Chem. Biol. 12, 306-317 (2008). 
5 Cantrell, C. L., Dayan, F.E., & Duke, S.O. Natural products as sources for new 
pesticides. J. Nat. Prod. 75, 1231-1242 (2012). 
6 Florey, H. W. Penicillin: A Survey. British Medical Journal 2, 169-171. (1944). 
7 D. J. Newman, G. M. C., K. M. Snader. The influence of natural products upon drug 
discovery. Nat. Prod. Rep. 17, 215-234 (2000). 
8 Katz, L. & Batlz, R. H. Natural product discovery: past, present, and future. J. Ind. 
Microbiol. Biotechnol. 43, 1-22 (2016). 
9 Luo, Y., Cobb, R. E., & Zhao H. Recent advances in natural product discovery. Curr. 
Opin. Biotechnol. 30, 230-237 (2014). 
10 Agarval, V. & Nair, S. K. Antibiotics for Emerging Pathogens. Science 325, 
1089-1093 (2009). 
11 Demain, A. L. From natural products discovery to commercialization: a success story. 
J. Ind. Microbiol. Biotechnol. 33, 486-495 (2006). 
12 H. Gross, V. O. S., M. D. Henkels, B. Nowak-Thompson, J. E. Loper, & W. H. 
Gerwick. The Genomisotopic Approach: A Systematic Method to Isolate Products of 
Orphan Biosynthetic Gene Clusters. Chem. Biol. 14, 53-63 (2007). 
13 T. A. Gulder, & B. S. Moore. Salinosporamide natural products: Potent 20S 
proteasome inhibitors as promising cancer chemotherapeutics. Angew. Chem. Ed. 
Engl. 49, 9346-9367 (2010). 
14 Li, J. W. V., J.C. Drug discovery and natural products: end of an era or an endless 
frontier? Science 325, 161-165 (2009). 
15 Bode, H. B. & Müller., R. The impact of bacterial genomics on natural product 
research. Angew. Chem. Int. Ed. Engl. 44, 6828-6846 (2005). 
16 Cordier C., M. D., Murrison S., Nelson A., & O'Leary-Steele C. Natural products as 
an inspiration in the diversity-oriented synthesis of bioactive compound libraries. Nat. 
Prod. Rep. 25, 719-737 (2008). 
17 Winter, J. M. & Tang, Y. Synthetic biological approaches to natural product 
biosynthesis. Curr. Opin. Bioltech. 23, 736-743 (2012). 
18 Hertweck, C. The biosynthetic logic of polyketide diversity. Angew. Chem. Ed. Engl. 
48, 4688-4716 (2009). 
19 Fischbach, M. A. & Walsh, C. T. Assembly-line enzymology for polyketide and 
nonribosomal Peptide antibiotics: logic, machinery, and mechanisms. Chemical 
reviews 106, 3468-3496 (2006). 
40 
 
 
D. References 
20 Marahiel, M. A. Working outside the protein-synthesis rules: insights into 
non-ribosomal peptide synthesis. Journal of peptide science : an official publication 
of the European Peptide Society 15, 799-807 (2009). 
21 Knaggs, A. R. The biosynthesis of shikimate metabolites. Nat. Prod. Rep. 18, 
334-355 (2001). 
22 Knaggs, A. R. The biosynthesis of shikimate metabolites. Nat. Prod. Rep. 20, 119-136 
(2003). 
23 Dewick, P. M. The biosynthesis of C5-C25 terpenoid compounds. Nat. Prod. Rep. 19, 
181-222 (2002). 
24 Schwarzer, D. & Marahiel, M. A. Multimodular biocatalysts for natural product 
assembly. Naturwissenschaften 88, 93-101 (2001). 
25 Walsh, C. T. Polyketide and nonribosomal peptide antibiotics: modularity and 
versatility. Science 303, 1805-1810 (2004). 
26 Moore, B. S. & Hertweck, C. Biosynthesis and attachment of novel bacterial 
polyketide synthase starter units. Nat. Prod. Rep. 19, 70-99 (2002). 
27 Schwarzer, D., Finking, R. & Marahiel, M. A. Nonribosomal peptides: from genes to 
products. Nat. Prod. Rep. 20, 275 (2003). 
28 Du, L., Sanchez, C., Chen, M., Edwards, D. J. & Shen, B. The biosynthetic gene 
cluster for the antitumor drug bleomycin from Streptomyces verticillus ATCC15003 
supporting functional interactions between nonribosomal peptide synthetases and a 
polyketide synthase. Chem. Biol. 7, 623-642 (2000). 
29 Miao V., C.-L. M., Brian P., Brost R., Penn J., Whiting A., et al., Daptomycin 
biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster 
and revision of peptide stereochemistry. Microbiology 151, 1507–1523 (2005). 
30 Sattely, E. S., Fischbach, M. A. & Walsh, C. T. Total biosynthesis: in vitro 
reconstitution of polyketide and nonribosomal peptide pathways. Nat. Prod. Rep. 25, 
757-793 (2008). 
31 Staunton, J. & Weissman, K. J. Polyketide biosynthesis: a millennium review. Nat. 
Prod. Rep. 18, 380-416 (2001). 
32 Hopwood, D. A. Genetic Contributions to Understanding Polyketide Synthases. Chem. 
Rev. 97, 2465-2497 (1997). 
33 Kopp, F. & Marahiel, M. A. Macrocyclization strategies in polyketide and 
nonribosomal peptide biosynthesis. Nat. Prod. Rep. 24, 735-749 (2007). 
34 Wenzel, S. C. & Müller., R. The impact of genomics on the exploitation of the 
myxobacterial secondary metabolome. Nat. Prod. Rep. 26, 1385-1407 (2009). 
35 Schäberle, T. F., Lohr, F., Schmitz, A., & König, G.M. Antibiotics from 
myxobacteria. . Nat. Prod. Rep. 31, 953-972 (2014). 
36 Ralph H Lambalot, A. M. G., Roger S Flugel, Peter Zuber, Michael LaCelle, 
Mohamed A Marahiel, Ralph Reid, Chaitan Khosia, Christopher T Walsh. A new 
enzyme superfamily - the phosphopantetheinyl transferases. Chem. Biol. 3, 923-936 
(1996). 
37 Mercer, A. C. & Burkart, M. D. The ubiquitous carrier protein--a window to 
metabolite biosynthesis. Nat. Prod. Rep. 24, 750-773 (2007). 
38 Chan, Y. A., Boyne, M.T., Podevels, A.M., Klimowicz, A.K., Handelsman, J., 
41 
 
 
D. References 
Kelleher, N.L., and Thomas, M.G. Hydroxymalonyl-acyl carrier protein (ACP) and 
aminomalonyl-ACP are two additional type I polyketide synthase extender units. . 
Proc. Natl. Acad. Sci. USA 103, 14349-14354 (2006). 
39 Caboche, S., Pupin, M., Leclère, V., Fontaine, A., Jacques, P., Kucherov, G. . 
NORINE: a database of nonribosomal peptides. Nucleic Acids Res. 36, D326–D331 
(2008). 
40 Das, A., and Khosla, C. Biosynthesis of aromatic polyketides in bacteria. Accounts of 
chemical research 42, 631-639 (2009). 
41 Shen, B. Polyketide biosynthesis beyond the type I, II and III polyketide synthase 
paradigms. Curr. Opin. Chem. Biol. 7, 285-295 (2003). 
42 Yu, D., Xu, F., Zeng, J., & Zhan, J. Type III polyketide synthases in natural product 
biosynthesis. IUBMB Life 64, 285-295 (2012). 
43 Yuzaw, S., Kim, W., Katz, L., & Keasling, J. D. Heterologous production of 
polyketides by modular type I polyketide synthases in Escherichia coli. Curr. Opin. 
Biotechnol. 23, 727-735 (2012). 
44 Zhang, W., and Tang, Y. In vitro analysis of type II polyketide synthase. Methods in 
Enzymology 459, 367-393 (2009). 
45 Masschelein, J., Mattheus, W., Gao, L.-J., Moons, P., Houdt, R.V., Uytterhoeven, B., 
Lamberigts, C., Lescrinier, E., Rozenski, J., Herdewijn, P., et al. A PKS/NRPS/FAS 
hybrid gene cluster from Serratia plymuthica RVH1 encoding the biosynthesis of 
three broad spectrum, zeamine-related antibiotics. PLoS One 8, e54143 (2013). 
46 Mcdaniel, R., Ebert-Khosla, S., A.Hopwood, D., & Khosla, C. Rational design of 
aromatic polyketide natural products by recombinant assembly of enzymatic subunits. 
Nature 375, 549-554 (1995). 
47 Fu, H., Hopwood, D.A., & Khosla, C. Engineered biosynthesis of novel polyketides: 
evidence for temporal, but not regiospecific, control of cyclization of an aromatic 
polyketide precursor. Chem. Biol. 1, 205-210 (1994). 
48 Abe, I., & Morita, H. . Structure and function of the chalcone synthase superfamily of 
plant type III polyketide synthases. Nat. Prod. Rep. 27, 809-838 (2010). 
49 Austin, M. B., & Noel, J.P. The chalcone synthase superfamily of type III polyketide 
synthases. Nat. Prod. Rep. 20, 79-110 (2003). 
50 Schow, S. G., Buchholz, T.J., Seufert, W., Dordick, J.S., & Sherman, D.H. Substrate 
profile analysis and ACP-mediated acyl transfer in Streptomyces coelicolor Type III 
polyketide synthases. Chembiochem 8, 863-868 (2007). 
51 Li, Y. Y. & Müller, R. Non-modular polyketide synthases in myxobacteria. 
Phytochemistry 70, 1850-1857 (2009). 
52 Albertini, A.M., Scoffone, F., Scotti, C., & Galizzi, A. Sequence around the 
159-degrees region of the Bacillus subtilis genome - the PKS-X locus spans 33.6 kb. 
Microbiology 141, 299–309 (1995). 
53 Piel, J. A polyketide synthase-peptide synthetase gene cluster from an uncultured 
bacterial symbiont of Paederus beetles. Proc. Natl. Acad. Sci. USA 99, 14002-14007 
(2002). 
54 Cheng, Y. Q, & Shen, B. Type I polyketide synthase requiring a discrete 
acyltransferase for polyketide biosynthesis. Proc. Natl. Acad. Sci. USA 100, 3149–
42 
 
 
D. References 
3154 (2003). 
55 El-Sayed, A.K., Cooper, S.M., Stephens, E., Simpson, T.J., & Thomas, C.M. 
Characterization of the mupirocin biosynthesis gene cluster from Pseudomonas 
fluorescens NCIMB 10586. Chem. Biol. 10, 419–430 (2003). 
56 Piel, J. Biosynthesis of polyketides by trans-AT polyketide synthases. Nat. Prod. Rep. 
27, 996-1047 (2010). 
57 Helfrich, E. J. & Piel, J. Biosynthesis of polyketides by trans-AT polyketide synthases. 
Nat. Prod. Rep. (2015). 
58 Nguyen T, I. K., Jenke-Kodama H, Dittmann E, Gurgui C, Hochmuth T, Taudien S, 
Platzer M, Hertweck C, & Piel J. Exploiting the mosaic structure of 
trans-acyltransferase polyketide synthases for natural product discovery and pathway 
dissection. Nat. Biotechnol. 26, 225–233 (2008). 
59 Olano, C., Méndez, C., and Salas, J.A. Molecular insights on the biosynthesis of 
antitumour compounds by actinomycetes. Microbial Biotechnology 4, 144-164 
(2011). 
60 Brakhage, A. Molecular Regulation of β-Lactam Biosynthesis in Filamentous Fungi. 
Microbiology and Molecular Biology Reviews 62, 547–585 (1998). 
61 T. J. Wolpert, V. M., W. Acklin, B. Jaun, J. Seibl, J. Meiliand & D. Arigoni. Structure 
of victorin C, the major host-selective toxin from Cochliobolus victoriae. Experientia. 
41, 1524-1529 (1985). 
62 Brachmanna, A. O., Kirchnera, F., Keglera, C., Kinskia, S.C., Schmittb, I., & Bode, 
H.B. Triggering the production of the cryptic blue pigment indigoidine from 
Photorhabdus luminescens. Journal of Biotechnology 157, 96-99 (2012). 
63 Carroll, P. A., Calderwood, S.B., Butterton, J.R., Choi, M.H., & Watnick, P.I. . Vibrio 
cholerae VibF Is Required for Vibriobactin Synthesis and Is a Member of the Family 
of Nonribosomal Peptide Synthetases. Journal of Bacteriology 182, 1731–1738 
(2000). 
64 W.W. Carmichael, S. M. F. O. A., J. S. An, et al.,. Human Fatalities from 
Cyanobacteria: Chemical and Biological Evidence for Cyanotoxins. Environmental 
Health Perspectives 109, 663-668 (2001). 
65 Cane, D. E. & Walsh, C. T. The parallel and convergent universes of polyketide 
synthases and nonribosomal peptide synthetases. Chem. Biol. 6, R319-325 (1999). 
66 Eustáquio, A. S. et al. Biosynthesis of the salinosporamide A polyketide synthase 
substrate chloroethylmalonyl-coenzyme A from S-adenosyl-L-methionine. Proc. Natl. 
Acad. Sci. USA 106, 12295–12300 (2009). 
67 B. Silakowski, H. U. S., H. Ehret, B. Kunze, S. Weinig, G. Nordsiek, P. Brandt, H. 
Blöcker, G. Höfle, S. Beyer, & R. Müller. New Lessons for Combinatorial 
Biosynthesis from Myxobacteria. J. Biol. Chem. 274, 37391-37399 (1999). 
68 S. Weinig, H. J. H., T. Mahmud, R. Müller. Melithiazol biosynthesis: further insights 
into myxobacterial PKS/NRPS systems and evidence for a new subclass of methyl 
transferases. Chem. Biol. 10, 939-952 (2003). 
69 Y. Paitan, G. A., E. Orr, E. Z. Ron, E. Rosenberg. The first gene in the biosynthesis of 
the polyketide antibiotic TA of Myxococcus xanthus codes for a unique PKS module 
coupled to a peptide synthetase. J. Mol. Biol. 286, 465-474 (1999). 
43 
 
 
D. References 
70 B. Silakowski, G. N., B. Kunze, H. Blöcker, & R. Müller. Novel features in a 
combined polyketide synthase/non-ribosomal peptide synthetase: the myxalamid 
biosynthetic gene cluster of the myxobacterium Stigmatella aurantiaca Sga15. Chem. 
Biol. 8, 59-69 (2001). 
71 Shen, B. et al. The biosynthetic gene cluster for the anticancer drug bleomycin from 
Streptomyces verticillus ATCC15003 as a model for hybrid peptide-polyketide 
natural product biosynthesis. J. Ind. Microbiol. Biotechnol. 27, 378-385 (2001). 
72 Huang, T., Wang, Y., Yin, J., Du, Y., Tao, M., Xu, J., Chen, W., Lin, S., & Deng, Z. 
Identification and characterization of the pyridomycin biosynthetic gene cluster of 
Streptomyces pyridomyceticus NRRL B-2517. J. Biol. Chem. 286, 20648-20657 
(2011). 
73 N. Gaitatzis, A. H., R. Müller, & S. Beyer. The mtaA gene of the myxothiazol 
biosynthetic gene cluster from Stigmatella aurantiaca DW4/3-1 encodes a 
phosphopantetheinyl transferase that activates polyketide synthases and polypeptide 
synthetases. J. Biochem. 129, 119-124 (2001). 
74 L. E. Quadri, P. H. W., M. Lei, M. M. Nakano, P. Zuber, & C. T. Walsh. 
Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for 
peptidyl carrier protein domains in peptide synthetases. Biochemistry 37, 1585-1595 
(1998). 
75 Sanchez, C., Du, L., Edwards, D. J., Toney, M. D. & Shen, B. Cloning and 
characterization of a phosphopantetheinyl transferase from Streptomyces verticillus 
ATCC15003, the producer of the hybrid peptide-polyketide antitumor drug bleomycin. 
Chem. Biol. 8, 725-738 (2001). 
76 Prozorov, T., Bazylinski, D. A., Mallapragada, S. K. & Prozorov, R. Novel magnetic 
nanomaterials inspired by magnetotactic bacteria: topical review. Mater. Sci. Eng. R. 
74, 133–172 (2013). 
77 Blakemore, R. P. Magnetotactic bacteria. Science 190, 377-379 (1982). 
78 Komeili, A., Zhuo Li & D. K. Newman. Magnetosomes Are Cell Membrane 
Invaginations Organized by the Actin-Like Protein MamK. Science 311, p. 242-245 
(2006). 
79 Pollithy, A. et al. Magnetosome expression of functional camelid antibody fragments 
(nanobodies) in Magnetospirillum gryphiswaldense. Appl. Environ. Microbiol. 77, 
6165–6171 (2011). 
80 Ullrich, S., Kube, M., Schu¨bbe, S., Reinhardt, R. & Schu¨ler, D. A hypervariable 
130-kilobase genomic region of Magnetospirillum gryphiswaldense comprises a 
magnetosome island which undergoes frequent rearrangements during stationary 
growth. J. Bacteriol. 187, 7176–7184 (2005). 
81 Muyrers, J.P., Zhang, Y., Testa, G., & Stewart, A.F. Rapid modification of bacterial 
artificial chromosomes by ET-recombination. Nucleic Acids Res. 27, 1555-1557 
(1999). 
82 Youming Zhang, J. P. P. Muyrers, Giuseppe Testa, & A. Francis Stewart. DNA 
cloning by homologous recombination in Escherichia coli. Nature biotechnol. 18, 
1314-1317 (2000). 
83 Zhang Y., Muyrers J.P. and Stewart A.F. A new logic for DNA engineering using 
44 
 
 
D. References 
recombination in Escherichia coli. Nature Genetics. 20, 123-128 (1998). 
84 Yu, D. et al. An efficient recombination system for chromosome engineering in 
Escherichia coli. Proc. Natl. Acad. Sci. USA 97, 5978-5983 (2000). 
85 Junping Wang, M. S., Jeanette Rientjes, Jun Fu, Heike Hollak, Harald Kranz, Wei Xie, 
A. Francis Stewart & Youming Zhang. An improved recombineering approach by 
adding RecA to lambda Red recombination. BMC Mol. Biotechnolo.32, 43-54 (2006). 
86 Copeland, N. G., Jenkins, N. A. & Court, D. L. Recombineering: a powerful new tool 
for mouse functional genomics. Nature reviews. Genetics 2, 769-779 (2001). 
87 Sharan, S. K., Thomason, L. C., Kuznetsov, S. G. & Court, D. L. Recombineering: a 
homologous recombination-based method of genetic engineering. Nature protocols 4, 
206-223 (2009). 
88 Muyrers, J.P., Zhang, Y., Buchholz, F., & Stewart A.F. RecE/RecT and Reda/Redb 
initiate double stranded break repair by specifically interacting with their respective 
partners. Genes & Dev. 14, 1971-1982 (2000). 
89 Zhang Y. M., J., Rientjes, J. and Stewart, A.F. Phage annealing proteins promote 
oligonucleotide-directed mutagenesis in Escherichia coli and mouse ES cells. BMC 
molecular biology 4, 1-14 (2003). 
90 Kovall, R. & Matthews, B. W. Toroidal structure of lambda-exonuclease. Science 277, 
1824-1827 (1997). 
91 Erler, A. et al. Conformational adaptability of Redbeta during DNA annealing and 
implications for its structural relationship with Rad52. J. Mol. Biol. 391, 586-598 
(2009). 
92 Iyer, L. M., Koonin, E. V. & Aravind, L. Classification and evolutionary history of the 
single-strand annealing proteins, RecT, Redbeta, ERF and RAD52. BMC Genomics 3, 
8 (2002). 
93 Muniyappa, K. & M., E. Phage λβ protein, a component of general recombination, is 
associated with host ribosomal S1 protein. Biochem. Mol. Biol. Int. 31, 1-11 (1993). 
94 Venkatesh, T. V. & R., C.M. Ribosomal protein S1 and NusA protein complexed to 
recombination protein β of phage λ. J. Bacteriol. 175, 1844-1846 (1993). 
95 Shulman, M. J., Hallick, L.M., Echols, H. & Signer, E.R. Properties of 
recombination-deficient mutants of bacteriophage lambda. J. Mol. Biol. 52, 501-520 
(1970). 
96 Zagursky, R. J. & H., J.B. Expression of the phage λ recombination genes exo and bet 
under lacPO control on a multi-copy plasmid. Gene 23, 277-292 (1983). 
97 Hall, S. D. & K., R.D. Homologous pairing and strand exchange promoted by the 
Escherichia coli RecT protein. Proc. Natl. Acad. Sci. USA 91, 3205-3209 (1994). 
98 Muniyappa, K. & R., C.M. The homologous recombination system of phage λ. 
Pairing activities of β protein. J. Biol. Chem. 261, 7472-7478 (1986). 
99 Kmiec, E. & H., W. K. Beta protein of bacteriophage lambda promotes renaturation 
of DNA. J. Biol. Chem. 256, 12636-12639 (1981). 
100 STANLEY N. COHEN, A. C. Y. C., HERBERT W. BOYER, AND ROBERT B. 
HELLING. Construction of Biologically Functional Bacterial Plasmids In Vitro. Proc. 
Nat. Acad. Sci. USA 70, 3240-3244 (1973). 
101 Mullis, K. et al. Specific enzymatic amplification of DNA in vitro: the polymerase 
45 
 
 
D. References 
chain reaction. Cold Spring Harbor symposia on quantitative biology 51 Pt 1, 
263-273 (1986). 
102 Collins, J. & Hohn, B. Cosmids: a type of plasmid gene-cloning vector that is 
packageable in vitro in bacteriophage lambda heads. Proc. Nat. Acad. Sci. USA 75, 
4242-4246 (1978). 
103 Pierce, J. C., Sauer, B. & Sternberg, N. A positive selection vector for cloning high 
molecular weight DNA by the bacteriophage P1 system: improved cloning efficacy. 
Proc. Nat. Acad. Sci. USA 89, 2056-2060 (1992). 
104 Shizuya, H. et al. Cloning and stable maintenance of 300-kilobase-pair fragments of 
human DNA in Escherichia coli using an F-factor-based vector. Proc. Nat. Acad. Sci. 
USA 89, 8794-8797 (1992). 
105 O'Connor, M., Peifer, M. & Bender, W. Construction of large DNA segments in 
Escherichia coli. Science 244, 1307-1312 (1989). 
106 Kim, U. J., Shizuya, H., de Jong, P. J., Birren, B. & Simon, M. I. Stable propagation 
of cosmid sized human DNA inserts in an F factor based vector. Nucleic Acids Res. 
20, 1083-1085 (1992). 
107 Orr-Weaver, T. L., Szostak, J. W. & Rothstein, R. J. Genetic applications of yeast 
transformation with linear and gapped plasmids. Methods Enzymol. 101, 228-245 
(1983). 
108 Szostak, J. W., Orr-Weaver, T. L., Rothstein, R. J. & Stahl, F. W. The 
double-strand-break repair model for recombination. Cell 33, 25-35 (1983). 
109 Moerschell, R. P., Tsunasawa, S. & Sherman, F. Transformation of yeast with 
synthetic oligonucleotides. Proc. Nat. Acad. Sci. USA 85, 524-528 (1988). 
110 Hamilton, C. M., Aldea, M., Washburn, B. K., Babitzke, P. & Kushner, S. R. New 
method for generating deletions and gene replacements in Escherichia coli. J. 
Bacteriol. 171, 4617-4622 (1989). 
111 Ellis, H. M., Yu, D., DiTizio, T. & Court, D. L. High efficiency mutagenesis, repair, 
and engineering of chromosomal DNA using single-stranded oligonucleotides. Proc. 
Nat. Acad. Sci. USA 98, 6742-6746 (2001). 
112 Joep P.P. Muyrers, Y. Zhang, Vladimir Benes, Giuseppe Testa,Wilhelm Ansorge & A. 
Francis Stewart. Point mutation of bacterial artificial chromosomes by ET 
recombination. EMBO reports. 1, 239-243 (2000). 
113 Warming, S., Costantino, N., Court, D. L., Jenkins, N. A. & Copeland, N. G. Simple 
and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33, 
e36 (2005). 
114 Wong, Q. N. et al. Efficient and seamless DNA recombineering using a thymidylate 
synthase A selection system in Escherichia coli. Nucleic Acids Res. 33, e59 (2005). 
115 DeVito, J. A. Recombineering with tolC as a selectable/counter-selectable marker: 
remodeling the rRNA operons of Escherichia coli. Nucleic Acids Res. 36, e4 (2008). 
116 Fu, J. et al. Full-length RecE enhances linear-linear homologous recombination and 
facilitates direct cloning for bioprospecting. Nature Biotechnol. 30, 440-446 (2012). 
117 Hu, S. et al. Genome engineering of Agrobacterium tumefaciens using the lambda 
Red recombination system. Appl. Microbiol. Biotechnol. 98, 2165-2172 (2014). 
118 van Kessel, J. C. & Hatfull, G. F. Recombineering in Mycobacterium tuberculosis. 
46 
 
 
D. References 
Nat. methods 4, 147-152 (2007). 
119 van Kessel, J. C. & Hatfull, G. F. Mycobacterial recombineering. Methods Mol. Biol. 
435, 203-215 (2008). 
120 Yin, J. et al. A new recombineering system for Photorhabdus and Xenorhabdus. 
Nucleic Acids Res. 43, e36 (2015). 
121 Bunny, K., Liu, J. & Roth, J. Phenotypes of lexA mutations in Salmonella enterica: 
evidence for a lethal lexA null phenotype due to the Fels-2 prophage. J. Bacteriol. 
184, 6235-6249 (2002). 
122 Derbise, A., Lesic, B., Dacheux, D., Ghigo, J. M. & Carniel, E. A rapid and simple 
method for inactivating chromosomal genes inYersinia. FEMS Immunology & 
Medical Microbiology 38, 113-116 (2003). 
123 Kang, Y. et al. Knockout and pullout recombineering for naturally transformable 
Burkholderia thailandensis and Burkholderia pseudomallei. Nat. protocols 6, 
1085-1104 (2011). 
124 Lynn Thomason, D. L. C., Mikail Bubunenko, Nina Costantino, & HelenWilson, S. 
D., & Amos Oppenheim. Recombineering,genetic engineering in bacteria using 
homologous recombination. Current Protocols in Molecular Biology, 
1.16.11-11.16.24 (2007). 
125 Maresca, M. et al. Single-stranded heteroduplex intermediates in lambda Red 
homologous recombination. BMC molecular biology 11, 54 (2010). 
126 Fu, J. et al. Efficient transfer of two large secondary metabolite pathway gene clusters 
into heterologous hosts by transposition. Nucleic Acids Res. 36, e113 (2008). 
127 Wenzel, S. C. et al. Heterologous expression of a myxobacterial natural products 
assembly line in pseudomonads via red/ET recombineering. Chem. Biol. 12, 349-356 
(2005). 
128 Ongley, S. E., Bian, X., Neilan, B. A. & Müller, R. Recent advances in the 
heterologous expression of microbial natural product biosynthetic pathways. Nat. 
Prod. Rep. 30, 1121-1138 (2013). 
129 Bian, X., Plaza, A., Zhang, Y. & Müller, R. Luminmycins A-C, cryptic natural 
products from Photorhabdus luminescens identified by heterologous expression in 
Escherichia coli. J. Nat. Prod. 75, 1652-1655 (2012). 
130 Bian, X. et al. Heterologous production of glidobactins/luminmycins in Escherichia 
coli Nissle containing the glidobactin biosynthetic gene cluster from Burkholderia 
DSM7029. Chembiochem 15, 2221-2224 (2014). 
131 Hanahan, D., Jessee, J. & Bloom, F. R. Plasmid transformation of Escherichia coli 
and other bacteria. Methods Enzymol. 204, 63-113 (1991). 
132 Dower, W. J., Miller, J. F. & Ragsdale, C. W. High efficiency transformation of E. 
coli by high voltage electroporation. Nucleic Acids Res. 16, 6127-6145 (1988). 
133 Fiedler, S. & Wirth, R. Transformation of bacteria with plasmid DNA by 
electroporation. Anal Biochem. 170, 38-44 (1988). 
134 Taketo, A. DNA transfection of Escherichia coli by electroporation. Biochim. Biophys. 
Acta 949, 318-324 (1988). 
135 Sambrook, J. R., D.W. Molecular Cloning: A Laboratory Manual. 3rd ed. Vol. Vol. 1 
& 3 (Cold Spring Harbor Laboratory Press, 2001). 
47 
 
 
D. References 
136 Andreason, G. L. & Evans, G. A. Introduction and expression of DNA molecules in 
eukaryotic cells by electroporation. BioTechniques 6, 650-660 (1988). 
137 Chassy, B. M. F., J. L. Transformation of Lactobacillus casei by electroporation. 
FEMS Microbiol. Lett. 44, 173-177 (1987). 
138 Yoshida, N. & Sato, M. Plasmid uptake by bacteria: a comparison of methods and 
efficiencies. Appl. Microbiol. Biotechnol. 83, 791-798 (2009). 
139 Aune, T. E. & Aachmann, F. L. Methodologies to increase the transformation 
efficiencies and the range of bacteria that can be transformed. Appl. Microbiol. 
Biotechnol. 85, 1301-1313 (2010). 
140 Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 
339, 819-823 (2013). 
141 Wiedenheft, B., Sternberg, S. H. & Doudna, J. A. RNA-guided genetic silencing 
systems in bacteria and archaea. Nature 482, 331-338 (2012). 
142 Horvath, P. & Barrangou, R. CRISPR/Cas, the immune system of bacteria and 
archaea. Science 327, 167-170 (2010). 
143 Deltcheva, E. et al. CRISPR RNA maturation by trans-encoded small RNA and host 
factor RNase III. Nature 471, 602-607 (2011). 
144 Jiang, Y. et al. Multigene editing in the Escherichia coli genome via the 
CRISPR-Cas9 system. Appl. Environ. Microbiol. 81, 2506-2514 (2015). 
145 Pyne, M. E., Moo-Young, M., Chung, D. A. & Chou, C. P. Coupling the 
CRISPR/Cas9 System with Lambda Red Recombineering Enables Simplified 
Chromosomal Gene Replacement in Escherichia coli. Appl. Environ. Microbiol. 81, 
5103-5114 (2015). 
146 Wenzel, S. C. & Müller, R. Recent developments towards the heterologous 
expression of complex bacterial natural product biosynthetic pathways. Curr. Opin. 
Biotechnol. 16, 594-606 (2005). 
147 Wenzel, S. C. & Müller, R. Myxobacterial natural product assembly lines: fascinating 
examples of curious biochemistry. Nat. Prod. Rep. 24, 1211-1224 (2007). 
148 Bode, H. B. & Müller, R. Analysis of myxobacterial secondary metabolism goes 
molecular. J. Ind. Microbiol. Biotechnol. 33, 577-588 (2006). 
149 Gross, F. et al. Bacterial type III polyketide synthases: phylogenetic analysis and 
potential for the production of novel secondary metabolites by heterologous 
expression in pseudomonads. Archives of microbiology 185, 28-38 (2006). 
150 Schmidt, E. W. et al. Patellamide A and C biosynthesis by a microcin-like pathway in 
Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella. Proc. Natl. 
Acad. Sci. USA 102, 7315-7320 (2005). 
151 Kodumal, S. J. et al. Total synthesis of long DNA sequences: synthesis of a 
contiguous 32-kb polyketide synthase gene cluster. Proc. Natl. Acad. Sci. USA 101, 
15573-15578 (2004). 
152 Bode, H. B. & Muller, R. The impact of bacterial genomics on natural product 
research. Angew. Chem. Int. Ed. Engl. 44, 6828-6846 (2005). 
153 Sorensen, H. P. & Mortensen, K. K. Advanced genetic strategies for recombinant 
protein expression in Escherichia coli. J. Biotechnol. 115, 113-128 (2005). 
154 Li, Y. et al. Directed natural product biosynthesis gene cluster capture and expression 
48 
 
 
D. References 
in the model bacterium Bacillus subtilis. Sci. Rep. 5, 9383 (2015). 
155 Hailong Wang, Z. L., Ruonan Jia, Jia Yin, Xiaoying Bian, Aiying Li, Rolf Müller, A 
Francis Stewart, Jun Fu & Youming Zhang. A concerted pipeline for direct cloning of 
biosynthetic gene clusters and engineering for heterologous expression. Nature 
protocols accepted (2016). 
156 Tu, Q. et al. Genetic engineering and heterologous expression of the disorazol 
biosynthetic gene cluster via Red/ET recombineering. Sci. Rep. 6, 21066 (2016). 
157 Homburg, S., Oswald, E., Hacker, J. & Dobrindt, U. Expression analysis of the 
colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS 
Microbiol. Lett. 275, 255-262 (2007). 
158 Watanabe, K. et al. Total biosynthesis of antitumor nonribosomal peptides in 
Escherichia coli. Nat. Chem. Biol. 2, 423-428 (2006). 
159 Fong, R. et al. Characterization of a large, stable, high-copy-number Streptomyces 
plasmid that requires stability and transfer functions for heterologous polyketide 
overproduction. Appl. Environ. Microbiol. 73, 1296-1307 (2007). 
160 Kakirde, K. S. et al. Gram negative shuttle BAC vector for heterologous expression 
of metagenomic libraries. Gene 475, 57-62 (2011). 
161 Aakvik, T. et al. A plasmid RK2-based broad-host-range cloning vector useful for 
transfer of metagenomic libraries to a variety of bacterial species. FEMS Microbiol. 
Lett. 296, 149-158 (2009). 
162 Ganusov, V. V. & Brilkov, A. V. Estimating the instability parameters of 
plasmid-bearing cells. I. Chemostat culture. J. Theoretical Biology 219, 193-205 
(2002). 
163 Zhang, M. M., Wang, Y., Ang, E. L. & Zhao, H. Engineering microbial hosts for 
production of bacterial natural products. Nat. Prod. Rep. (2016). 
164 Dahod, S. K. Dissolved carbon dioxide measurement and its correlation with 
operating parameters in fermentation processes. Biotechnology progress 9, 655-660 
(1993). 
165 Gross, F. et al. Metabolic engineering of Pseudomonas putida for 
methylmalonyl-CoA biosynthesis to enable complex heterologous secondary 
metabolite formation. Chem. Biol. 13, 1253-1264 (2006). 
166 Wang, A. et al. High level expression and purification of bioactive human 
alpha-defensin 5 mature peptide in Pichia pastoris. Appl. Microbiol. Biotechnol. 84, 
877-884 (2009). 
167 Liao, G. et al. Cloning, reassembling and integration of the entire nikkomycin 
biosynthetic gene cluster into Streptomyces ansochromogenes lead to an improved 
nikkomycin production. Microbial cell factories 9, 6 (2010). 
168 Chai, Y. et al. Heterologous expression and genetic engineering of the tubulysin 
biosynthetic gene cluster using Red/ET recombineering and inactivation mutagenesis. 
Chem. Biol. 19, 361-371 (2012). 
169 Perlova, O. et al. Reconstitution of the myxothiazol biosynthetic gene cluster by 
Red/ET recombination and heterologous expression in Myxococcus xanthus. Appl. 
Environ. Microbiol. 72, 7485-7494 (2006). 
170 Yin, J. et al. Direct cloning and heterologous expression of the salinomycin 
49 
 
 
D. References 
biosynthetic gene cluster from Streptomyces albus DSM41398 in Streptomyces 
coelicolor A3(2). Sci. Rep. 5, 15081 (2015). 
171 Kolinko, I. et al. Biosynthesis of magnetic nanostructures in a foreign organism by 
transfer of bacterial magnetosome gene clusters. Nature nanotechnology 9, 193-197 
(2014). 
172 Vladimir Larionov, N. K., & Michael, A. R. Direct isolation of human BRCA2 gene 
by transformation- associated recombination in yeast. Proc. Natl. Acad. Sci. USA 94, 
7384–7387 (1997). 
173 Natalay, L. A., Joan, G., & Vladimir Larionov. Functional copies of a human gene can 
be directly isolated by transformation-associated recombination cloning with a small 
3' end target sequence. Proc. Natl. Acad. Sci. USA 95, 4469–4474 (1998). 
174 Kouprina, N. & Larionov, V. Selective isolation of genomic loci from complex 
genomes by transformation-associated recombination cloning in the yeast 
Saccharomyces cerevisiae. Nature protocols 3, 371-377 (2008). 
175 Kouprina, N. & Larionov, V. TAR cloning insights into gene function, long-range 
haplotypes and genome structure and evolution. Nature Reviews Genetics 7, 805-812 
(2006). 
176 Noskov, V. N. et al. A general cloning system to selectively isolate any eukaryotic or 
prokaryotic genomic region in yeast. BMC Genomics 4, 16 (2003). 
177 Kim, J. H. et al. Cloning large natural product gene clusters from the environment: 
piecing environmental DNA gene clusters back together with TAR. Biopolymers 93, 
833-844 (2010). 
178 Kouprina, N. et al. Dynamic structure of the SPANX gene cluster mapped to the 
prostate cancer susceptibility locus HPCX at Xq27. Genome research 15, 1477-1486 
(2005). 
179 Kouprina, N. et al. The SPANX gene family of cancer/testis-specific antigens: rapid 
evolution and amplification in African great apes and hominids. Proc. Natl. Acad. Sci. 
USA 101, 3077-3082 (2004). 
180 Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred 
kilobases. Nat. methods 6, 343-345 (2009). 
181 Shao, Z., Zhao, H. & Zhao, H. DNA assembler, an in vivo genetic method for rapid 
construction of biochemical pathways. Nucleic Acids Res. 37, e16 (2009). 
182 Shao, Z., Luo, Y. & Zhao, H. Rapid characterization and engineering of natural 
product biosynthetic pathways via DNA assembler. Mol. Biosyst. 7, 1056-1059 
(2011). 
183 Baltz, R. H. Molecular engineering approaches to peptide, polyketide and other 
antibiotics. Nat. Biotechnol. 24, 1533-1540 (2006). 
184 Galm, U. & Shen, B. Expression of biosynthetic gene clusters in heterologous hosts 
for natural product production and combinatorial biosynthesis. Expert Opin. Drug 
Discov. 1, 409-437 (2006). 
185 Ikeda, H. et al. Complete genome sequence and comparative analysis of the industrial 
microorganism Streptomyces avermitilis. Nat. Biotechnol. 21, 526-531 (2003). 
186 Onaka, H., Taniguchi, S., Igarashi, Y. & Furumai, T. Cloning of the staurosporine 
biosynthetic gene cluster from Streptomyces sp. TP-A0274 and its heterologous 
50 
 
 
D. References 
expression in Streptomyces lividans. J. Antibiot. (Tokyo) 55, 1063-1071 (2002). 
187 Bentley, S. D. et al. Complete genome sequence of the model actinomycete 
Streptomyces coelicolor A3(2). Nature 417, 141-147 (2002). 
188 Pope, M. R., Murrell, S. A. & Ludden, P. W. Covalent modification of the iron protein 
of nitrogenase from Rhodospirillum rubrum by adenosine diphosphoribosylation of a 
specific arginine residue. Proc. Natl. Acad. Sci. USA 82, 3173-3177 (1985). 
189 Mutka, S. C., Carney, J. R., Liu, Y. & Kennedy, J. Heterologous production of 
epothilone C and D in Escherichia coli. Biochemistry 45, 1321-1330 (2006). 
190 Krug, D. et al. Discovering the hidden secondary metabolome of Myxococcus 
xanthus: a study of intraspecific diversity. Appl. Environ. Microbiol. 74, 3058-3068 
(2008). 
191 Stevens, D. C., Henry, M. R., Murphy, K. A. & Boddy, C. N. Heterologous expression 
of the oxytetracycline biosynthetic pathway in Myxococcus xanthus. Appl. Environ. 
Microbiol. 76, 2681-2683 (2010). 
192 Oliynyk, M. et al. Complete genome sequence of the erythromycin-producing 
bacterium Saccharopolyspora erythraea NRRL23338. Nat. Biotechnol. 25, 447-453 
(2007). 
193 Baltz, R. H. Streptomyces and Saccharopolyspora hosts for heterologous expression 
of secondary metabolite gene clusters. J. Ind. Microbiol. Biotechnol. 37, 759-772 
(2010). 
194 Butzin, N. C., Owen, H. A. & Collins, M. L. A new system for heterologous 
expression of membrane proteins: Rhodospirillum rubrum. Protein expression and 
purification 70, 88-94 (2010). 
195 Klask, C. Heterologous Expression of Various PHA Synthase Genes in 
Rhodospirillum rubrum. Chemical and Biochemical Engineering Quarterly 29, 75-85 
(2015). 
196 Rolf Jansen, H. I., Hans Reichenbach, Victor Wray, & Gerhard Höfle. Disorazoles, 
Highly Cytotoxic Metabolites from the Sorangicin-Producing Bacterium Sorangium 
Cellulosum, Strain So ce12. Liebigs Ann. Chem., 759-773 (1994). 
197 Elnakady, Y. A., Sasse, F., Lünsdorf, H. & Reichenbach, H. Disorazol A1, a highly 
effective antimitotic agent acting on tubulin polymerization and inducing apoptosis in 
mammalian cells. Biochemical Pharmacology 67, 927-935 (2004). 
198 Schackel, R., Hinkelmann, B., Sasse, F. & Kalesse, M. The synthesis of novel 
disorazoles. Angew. Chem. Int. Ed. Engl. 49, 1619-1622 (2010). 
199 Lee, C., An, D., Lee, H. & Cho, K. Correlation between Sorangium cellulosum 
subgroups and their potential for secondary metabolite production. J. Microbiol. 
Biotechnol. 23, 297-303 (2013). 
200 Frankel, R.B, et al. Structure and function of the bacterial magnetosome. ASM News 
61, 337–343 (1995). 
201 Mitani, M., Yamanishi, T. & Miyazaki, Y. Salinomycin: a new monovalent cation 
ionophore. Biochemical and biophysical research communications 66, 1231-1236 
(1975). 
202 Singh, M., Yadav, A., Ma, X., & Amoah, E. Plasmid DNA Transformation in 
Escherichia Coli Effect of Heat Shock Temperature, Duration, and Cold Incubation of 
51 
 
 
D. References 
CaCl2 Treated Cells. International Journal of Biotechnology and Biochemistry 6, 
561–568. (2010). 
203 Miller, J. F., Dowert, W.J., & Tompkins, L.S. High-voltage electroporation of bacteria: 
genetic transformation of Campylobacter jejuni with plasmid DNA. Proc. Natl. Acad. 
Sci. USA 85, 856-860. (1988). 
204 Zhang Y. M., Testa G and Stewart AF. DNA cloning by homologous recombination in 
Escherichia coli. Nat. Biotechnol. 18, 1314-1317 (2000). 
205 Kandušer, M., Šentjurc, M. & Miklavčič, D. The temperature effect during pulse 
application on cell membrane fluidity and permeabilization. Bioelectrochemistry 74, 
52-57 (2008). 
206 Quinn. A lipid-phase separation model of low-temperature damage to biological 
membranes. Cryobiology 22, 128-146 (1985). 
207 Gray, M. H., et al. Effect of chromosomal locus, GC content and length of homology 
on PCR-mediated targeted gene replacement in Saccharomyces. Nucleic Acids Res. 
29, 5156-5162 (2001). 
208 Cobb, R. E. & Zhao, H. Direct cloning of large genomic sequences. Nat. Biotechnol. 
30, 405-406 (2012). 
209 Lee, C., An, D., Lee, H., & Cho, K. Correlation between Sorangium cellulosum 
subgroups and their potential for secondary metabolite production. J. Microbiol. 
Biotechnol. 23, 297-303 (2013). 
210 Hopkins, C. D. & Wipf, P. Isolation, biology and chemistry of the disorazoles: new 
anti-cancer macrodiolides. Nat. Prod. Rep. 26, 585-601 (2009). 
211 Elisângela Soares Gomes, V. S., & Eliana Gertrudes de Macedo Lemos. 
Biotechnology of polyketides: New breath of life for the novel antibiotic genetic 
pathways discovery through metagenomics. Brazilian Journal of Microbiology 44, 
1007-1034 (2013). 
212 Kopp, M., Irschik, H., Pradella, S. & Müller, R. Production of the tubulin destabilizer 
disorazol in Sorangium cellulosum: biosynthetic machinery and regulatory genes. 
Chembiochem 6, 1277-1286 (2005). 
213 Carvalho, R., Reid, R., Viswanathan, N., Gramajo, H. & Julien, B. The biosynthetic 
genes for disorazoles, potent cytotoxic compounds that disrupt microtubule formation. 
Gene 359, 91-98 (2005). 
214 Stevens, D. C., Hari, T. P. & Boddy, C. N. The role of transcription in heterologous 
expression of polyketides in bacterial hosts. Nat. Prod. Rep. 30, 1391-1411 (2013). 
215 Bian, X. et al. Direct cloning, genetic engineering, and heterologous expression of the 
syringolin biosynthetic gene cluster in E. coli through Red/ET recombineering. 
Chembiochem 13, 1946-1952 (2012). 
216 Herbert Irschik, R. J., Klaus Gerth, Gerhard Hofle & Hans Reichenbach. Disorazol A, 
an Efficient Inhibitor of Eukaryotic Organisms Isolated from Myxobacteria. J. 
Antibiot. 48, 21-25 (1995). 
217 Miyazaki, Y. et al. Salinomycin, a new polyether antibiotic. J. Antibiot. 27, 814–821 
(1974). 
218 Gupta PB, O. T., Jiang G, Tao K, Kuperwasser C, Weinberg RA, & Lander ES. 
Identification of selective inhibitors of cancer stem cells by high-throughput 
52 
 
 
D. References 
screening. Cell 138, 645-659 (2009). 
219 Huczynski, A. Salinomycin: a new cancer drug candidate. Chemical biology & drug 
design 79, 235-238 (2012). 
220 Jiang, C., Wang, H., Kang, Q., Liu, J. & Bai, L. Cloning and characterization of the 
polyether salinomycin biosynthesis gene cluster of Streptomyces albus XM211. Appl. 
Environ. Microbiol. 78, 994-1003 (2012). 
221 Yurkovich, M. E. et al. A late-stage intermediate in salinomycin biosynthesis is 
revealed by specific mutation in the biosynthetic gene cluster. Chembiochem 13, 
66-71 (2012). 
222 Arakaki A, N. H., Nemoto M, Mori T, & Matsunaga T. Formation of magnetite by 
bacteria and its application. J. R. Soc. Interface. 5, 977–999 (2008). 
223 Richter M, K. M., Bazylinski DA, Lombardot T, Glöckner FO, Reinhardt R, & 
Schüler D. Comparative genome analysis of four magnetotactic bacteria reveals a 
complex set of group-specific genes implicated in magnetosome biomineralization 
and function. J. Bacteriol. 189, 4899-4910 (2007). 
224 Yan L, Z. S., Chen P, Liu H, Yin H, & Li H. Magnetotactic bacteria, magnetosomes 
and their application. Microbiol Res. 167, 507-519 (2012). 
225 Grünberg K., Tebo B.M., Schüler D. A large gene cluster encoding several 
magnetosome proteins is conserved in different species of magnetotactic bacteria. 
Appl. Environ. Microbiol. 67, 4573-4582 (2001). 
226 Scheffel A, et al. The acidic repetitive domain of the Magnetospirillum 
gryphiswaldense MamJ protein displays hypervariability but is not required for 
magnetosome chain assembly. J. Bacteriol. 189, 6437-6446 (2007). 
227 Schübbe S, K. M., Scheffel A, Wawer C, Heyen U, Meyerdierks A, Madkour MH, 
Mayer F, Reinhardt R, & Schüler D. Characterization of a spontaneous nonmagnetic 
mutant of Magnetospirillum gryphiswaldense reveals a large deletion comprising a 
putative magnetosome island. J. Bacteriol. 185, 5779-5790 (2003). 
228 Murat D, Q. A., Vali H, & Komeili A. Comprehensive genetic dissection of the 
magnetosome gene island reveals the step-wise assembly of a prokaryotic organelle. 
Proc. Natl. Acad. Sci. USA 107, 5593-5598 (2010). 
229 Alexander D, R. J., He X, Miao V, Brian P, & Baltz RH. Development of a genetic 
system for lipopeptide combinatorial biosynthesis in Streptomyces fradiae and 
heterologous expression of the A54145 biosynthetic gene cluster. Appl. Environ. 
Microbiol. 76, 6877–6887 (2010). 
230 RH, Bode. Combinatorial biosynthesis of cyclic lipopeptide antibiotics: a model for 
synthetic biology to accelerate the evolution of secondary metabolite biosynthetic 
pathways. ACS Synth. Biol. 3, 748-759 (2014). 
231 Nguyen K, R. D., Gu JQ, Alexander D, Chu M, Miao V, Brian P, & Baltz RH. 
Combinatorial biosynthesis of lipopeptide antibiotics related to daptomycin. Proc. 
Natl. Acad. Sci. USA 103, 17462–17467 (2006). 
232 Jun Fu. Difference between two phage-mediated homologous recombination systems 
and their application. Ph.D Dissertation. (2012). 
233 Lee, N. C., Larionov, V. & Kouprina, N. Highly efficient CRISPR/Cas9-mediated 
TAR cloning of genes and chromosomal loci from complex genomes in yeast. 
53 
 
 
D. References 
Nucleic Acids Res. 43, e55 (2015). 
234 Jiang, W. & Zhu, T. F. Targeted isolation and cloning of 100-kb microbial genomic 
sequences by Cas9-assisted targeting of chromosome segments. Nat. protocols 11, 
960-975 (2016). 
235 Du, D., W. L., Tian, Y, Liu, H., Tan, H., Niu, G. Genome engineering and direct 
cloning of antibiotic gene clusters via phage ϕBT1 integrase-mediated site-specific 
recombination in Streptomyces. Sci. Rep. 5, 8740 (2015). 
236   Zhang, Q., Pang, B., Ding, W., & Liu, W. Aromatic polyketides produced by bacterial  
iterative Type I polyketide synthases. Acs Catalysis, 3(7): 1439-1447 (2013). 
237   Qiang Tu, Jun Fu, Francis A. Stewart, Rolf Mueller and Youming Zhang. A new 
method for DNA transformation. United States of America patent application No: US 
61/730,772 (2012). International patent application No: PCT/IB2013/071546 (2013) 
238   Gerth K, Bedorf N, Hőfle G, Irschik H. & Reichenbach H. Epothilons A and B: 
antifungal and cytotoxic compounds from Sorangium cellulosum (myxobacteria). 
Production. J. Antibiot. 49: 560–563 (1996). 
239   Sasse, F., Steinmetz, H, Heil, J., Hőfle, G.& Reichenbach H. Tubulysins, new 
cytostatic peptides from myxobacteria acting on microtubuli. J. Antibiot. 53: 879–885 
(2000). 
240   Piel, J. A polyketide synthase-peptide synthetase gene cluster from an uncultured 
bacterial symbiont of Paederus beetles. Proc. Natl. Acad. Sci. 99: 14002–14007 
(2002). 
241   Calderone, C. T. Isoprenoid-like alkylations in polyketide biosynthesis, Nat. Prod. 
Rep. 25: 845–853 (2008). 
 
 
54 
 
 
E. Appendix 
E. Appendix 
 
Author’s efforts in publications presented in this work 
 
Publication I: 
Genetic engineering and heterologous expression of the disorazol biosynthetic 
gene cluster via Red/ET recombineering. 
Q.T., S.H. and Y.Z. planned and performed cloning experiments. Q.T. and X.B. 
performed genetic transfers, cultivation experiments and data analysis. Q.T. and R.R. 
performed HPLC and compound isolation. R.R. performed NMR experiments and 
data analysis. J.H. performed biological functional studies. Q.T., Y.Z. and R.M. 
designed the study and wrote the paper. All authors discussed the results and 
commented on the manuscript. 
 
Publication II: 
Room temperature electrocompetent bacterial cells improve DNA 
transformation and recombineering efficiency. 
Q.T. and J.Y. participated in the design of this study, performed data collection 
analysis, and drafted the manuscript; J.F, J.H, Y.L. and Y.Y. participated in 
interpretation data; A.F.S. and R.M. gave the advice for experimental design and 
discussed the data, also helped in the revision of the final manuscript. Y.Z. designed 
and oversaw the study, performed data interpretation and drafted the manuscript. All 
authors read and approved the final manuscript. 
 
Publication III: 
Biosynthesis of magnetic nanostructures in a foreign organism by transfer of 
bacterial magnetosome gene clusters. 
I.K., D.S., Y.Z., Q.T., C.J. and R.M. planned and performed cloning experiments. I.K. 
55 
 
 
E. Appendix 
and A.L. performed genetic transfers and cultivation experiments. G.W. prepared 
cryo- and chemically fixed cells. S.B., O.R. and G.W. performed TEM and I.K. 
analyzed the data. J.P. and O.R. performed cryo-electron tomography experiments. 
E.T. and M.P. took high-resolution TEM micrographs and analyzed the data. I.K. and 
A.L. took fluorescence micrographs and performed phenotypization experiments. I.K. 
performed western blot experiments and analyzed proteomic data. A.B. performed 
Illumina genome sequencing and I.K. analyzed the data. I.K. and D.S. designed the 
study and wrote the paper. All authors discussed the results and commented on the 
manuscript. 
 
Publication IV: 
Direct cloning and heterologous expression of the salinomycin biosynthetic gene 
cluster from Streptomyces albus DSM41398 in S. coelicolorA3 (2). 
J.Y. participated in the design of this study, performed data collection analysis, and 
drafted the manuscript; H.M., X.Y., T.Q., F.Y., L.Q. and X.Z. participated in 
interpretation data; A.F.S. and R.M. helped with the revision of the final manuscript. 
J.F. and Y.Z. designed and oversaw the study, performed data interpretation and 
drafted the manuscript. 
 
56 
 




